[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 360
1. McIver JI, Scheithauer BW, Atkinson JL: Deep Sylvian fissure chordoid meningioma: case report. Neurosurgery; 2005 Nov;57(5):E1064; discussion E1064
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deep Sylvian fissure chordoid meningioma: case report.
  • OBJECTIVE AND IMPORTANCE: A case of chordoid meningioma originating in the right sylvian fissure is reported.
  • This is the first reported case of a chordoid meningioma without dural attachment arising in the sylvian fissure.
  • A heterogeneously enhancing right frontotemporal mass was identified on magnetic resonance imaging of the brain.
  • The tumor was ultimately resected using standard microsurgical techniques.
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging / methods. Male. Meningioma. Neurosurgery / methods

  • Genetic Alliance. consumer health - Meningioma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16284544.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Ahn DK, Park HS, Choi DJ, Kim KS, Kim TW, Park SY: The surgical treatment for spinal intradural extramedullary tumors. Clin Orthop Surg; 2009 Sep;1(3):165-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The spinal IDEM tumor patients (11 cases) who had been treated by surgical excision and who were followed up more than 1 year were retrospectively analyzed.
  • The pathological diagnosis, the preoperative symptom duration, the tumor location on the sagittal and axial planes and the percentage of tumor occupying the intradural space were investigated.
  • On the last follow-up, the MRI was checked to evaluate whether or not the tumor had recurred.
  • The percentage of tumor occupying the intradural space was 82.9 +/- 9.4%.
  • The preoperative symptoms were correlated with only the percentage of tumor occupying the intradural space (VAS; r(2) = 0.75, p = 0.010, Nurick's grade; r(2) = 0.69, p = 0.019).
  • CONCLUSIONS: The degree of neurologic symptoms was correlated with the percentage of tumor occupying the intradural space.
  • [MeSH-minor] Adult. Aged. Female. Humans. Laminectomy / methods. Magnetic Resonance Imaging. Male. Meningioma / diagnosis. Meningioma / pathology. Meningioma / surgery. Middle Aged. Neurilemmoma / diagnosis. Neurilemmoma / pathology. Neurilemmoma / surgery. Prognosis. Retrospective Studies. Spine / pathology. Spine / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Neurosurg. 1999 Dec;13(6):550-7 [10715722.001]
  • [Cites] Neurosurgery. 2006 Feb;58(1 Suppl):ONS52-8; discussion ONS52-8 [16479629.001]
  • [Cites] Spine (Phila Pa 1976). 2001 Aug 15;26(16):1805-8 [11493855.001]
  • [Cites] J Neurosurg Sci. 2002 Mar;46(1):18-24 [12118219.001]
  • [Cites] Spinal Cord. 2003 Feb;41(2):85-9 [12595870.001]
  • [Cites] Arq Neuropsiquiatr. 2003 Jun;61(2A):241-7 [12806503.001]
  • [Cites] Neurosurg Focus. 2004 Jul 15;17(1):ECP2 [15264778.001]
  • [Cites] Brain. 1972;95(1):101-8 [5023079.001]
  • [Cites] Neurosurgery. 1989 Aug;25(2):153-60 [2671779.001]
  • [Cites] J Neurosurg. 1989 Dec;71(6):810-4 [2585070.001]
  • [Cites] J Neurosurg. 1989 Dec;71(6):842-5 [2585075.001]
  • [Cites] Acta Neurochir Suppl. 1996;65:77-81 [8738502.001]
  • [Cites] J Neurosurg. 1996 Oct;85(4):618-24 [8814165.001]
  • [Cites] J Neurooncol. 2004 Aug-Sep;69(1-3):291-318 [15527097.001]
  • [Cites] Neurosurg Focus. 2003 Jun 15;14(6):e2 [15669787.001]
  • [Cites] Spine (Phila Pa 1976). 2000 Mar 15;25(6):727-31 [10752106.001]
  • (PMID = 19885053.001).
  • [ISSN] 2005-4408
  • [Journal-full-title] Clinics in orthopedic surgery
  • [ISO-abbreviation] Clin Orthop Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2766751
  • [Keywords] NOTNLM ; Intradural extramedullary tumor / Prognosis / Surgical treatment
  •  go-up   go-down


3. Chung HT, Kim DG, Paek SH, Jung HW: Development of dose-volume relation model for gamma knife surgery of non-skull base intracranial meningiomas. Int J Radiat Oncol Biol Phys; 2009 Jul 15;74(4):1027-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mean patient age was 55.0 years (range, 26-78) and the mean tumor volume was 5.6 cm(3) (range, 0.5-16.8).
  • RESULTS: The actuarial tumor control rate was 91.6% at 5 years.
  • [MeSH-major] Brain Neoplasms / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Radiosurgery / methods
  • [MeSH-minor] Adult. Aged. Analysis of Variance. Female. Follow-Up Studies. Humans. Logistic Models. Male. Middle Aged. Probability. Prognosis. Radiotherapy Dosage. Tumor Burden

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19056186.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Jain D, Sharma MC, Sarkar C, Suri V, Garg A, Singh M, Sharma BS, Mahapatra AK: Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases. J Neurooncol; 2007 Feb;81(3):315-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases.
  • AIMS: Clear cell meningioma (CCM) is an uncommon variant of meningioma, which affect younger patients, occur more often in spinal or cerebello pontine locations and shows a higher recurrence rate.
  • Radiologically lesions showed homogenous enhancement and were isointense to brain parenchyma.
  • Histopathologic examination revealed tumor cells to be arranged in sheets with clear cytoplasm and monomorphic nuclei.
  • CONCLUSIONS: CCM is a rare variant of meningioma with poor outcome.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Immunohistochemistry. Male. Middle Aged. Sex Factors. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Meningioma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1995 May;19(5):493-505 [7726360.001]
  • [Cites] J Neurosurg. 2005 Sep;103(3):559-63 [16235691.001]
  • [Cites] Surg Neurol. 2005 Mar;63(3):285-8; discussion 288-9 [15734529.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Jan;21(1):130-2 [10669237.001]
  • [Cites] Am J Surg Pathol. 2003 Jan;27(1):131-5 [12502936.001]
  • [Cites] Pediatr Neurosurg. 1998 Jan;28(1):27-30 [9693326.001]
  • [Cites] Neurosurg Rev. 1998;21(2-3):171-3 [9795955.001]
  • [Cites] Acta Neuropathol. 1988;76(6):638-9 [3201928.001]
  • [Cites] Brain Pathol. 2006 Jan;16(1):15-9 [16612978.001]
  • [Cites] Neuroradiology. 1998 Nov;40(11):743-7 [9860126.001]
  • [Cites] Gen Diagn Pathol. 1996 Mar;141(3-4):261-7 [8705792.001]
  • [Cites] J Neurosurg. 2005 Apr;102(3 Suppl):303-6 [15881755.001]
  • [Cites] Pediatr Dev Pathol. 2005 May-Jun;8(3):386-90 [16010490.001]
  • [Cites] J Neurosurg. 1996 Feb;84(2):264-6 [8592230.001]
  • [Cites] Cancer Genet Cytogenet. 1995 Dec;85(2):101-4 [8548731.001]
  • (PMID = 16955223.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD: Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro Oncol; 2009 Dec;11(6):853-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
  • The North American Brain Tumor Consortium conducted a phase II study to evaluate the therapeutic potential of imatinib mesylate (Gleevec), a PDGFR inhibitor, in patients with recurrent meningiomas.

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Brain Tumor Pathol. 2001;18(1):1-5 [11517968.001]
  • [Cites] Blood. 2008 Apr 15;111(8):4022-8 [18256322.001]
  • [Cites] N Engl J Med. 2002 Aug 15;347(7):472-80 [12181401.001]
  • [Cites] J Neurosurg. 2001 Feb;94(2):293-300 [11213968.001]
  • [Cites] N Engl J Med. 2001 Apr 5;344(14):1031-7 [11287972.001]
  • [Cites] N Engl J Med. 2001 Apr 5;344(14):1038-42 [11287973.001]
  • [Cites] J Clin Neurosci. 2001 May;8 Suppl 1:49-53 [11386826.001]
  • [Cites] J Neurosurg. 2002 Aug;97(2):341-6 [12186462.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):39-44 [12798163.001]
  • [Cites] Neurology. 2004 Apr 13;62(7):1210-2 [15079029.001]
  • [Cites] Acta Neuropathol. 2004 Aug;108(2):135-42 [15148612.001]
  • [Cites] J Neurosurg. 1985 Jan;62(1):18-24 [3964853.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):299-304 [3403313.001]
  • [Cites] J Clin Oncol. 1990 Jul;8(7):1277-80 [2358840.001]
  • [Cites] Int J Cancer. 1990 Jul 15;46(1):16-21 [2163990.001]
  • [Cites] J Clin Invest. 1990 Jul;86(1):131-40 [2164040.001]
  • [Cites] Int J Cancer. 1990 Nov 15;46(5):772-8 [1699901.001]
  • [Cites] J Biol Chem. 1991 Sep 5;266(25):16755-63 [1653246.001]
  • [Cites] Cancer Res. 1992 Jun 1;52(11):3213-9 [1317261.001]
  • [Cites] J Neurooncol. 1992 Jun;13(2):157-64 [1432033.001]
  • [Cites] J Neurooncol. 1993 Jan;15(1):75-7 [8455065.001]
  • [Cites] J Neurosurg. 1994 Sep;81(3):388-93 [8057146.001]
  • [Cites] Int J Cancer. 1995 Jan 17;60(2):168-73 [7829210.001]
  • [Cites] Cancer Res. 1996 Jan 1;56(1):100-4 [8548747.001]
  • [Cites] J Neurosurg. 1996 May;84(5):852-8; discussion 858-9 [8622161.001]
  • [Cites] J Neurooncol. 1996 Sep;29(3):197-205 [8858525.001]
  • [Cites] J Neurooncol. 1996 Sep;29(3):261-7 [8858532.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):271-5 [9007858.001]
  • [Cites] J Neurosurg. 1997 May;86(5):840-4 [9126900.001]
  • [Cites] J Neurosurg. 1997 Aug;87(2):315-23 [9254099.001]
  • [Cites] J Neurooncol. 1997 Dec;35(3):289-301 [9440026.001]
  • [Cites] J Neurosurg. 1998 May;88(5):938-9 [9576275.001]
  • [Cites] J Neurosurg. 1999 Jul;91(1):44-50 [10389879.001]
  • [Cites] Science. 2005 Jan 7;307(5706):58-62 [15637262.001]
  • [Cites] Br J Neurosurg. 2004 Oct;18(5):495-9 [15799152.001]
  • [Cites] Clin Pharmacokinet. 2005;44(9):879-94 [16122278.001]
  • [Cites] Ann Oncol. 2005 Oct;16(10):1702-8 [16033874.001]
  • [Cites] J Clin Oncol. 2005 Dec 20;23(36):9359-68 [16361636.001]
  • [Cites] J Neurooncol. 2006 Jul;78(3):271-6 [16628476.001]
  • [Cites] Br J Clin Pharmacol. 2006 Jul;62(1):97-112 [16842382.001]
  • [Cites] Clin Cancer Res. 2006 Aug 15;12(16):4899-907 [16914578.001]
  • [Cites] Neuro Oncol. 2007 Apr;9(2):145-60 [17293590.001]
  • [Cites] Blood. 2007 Apr 15;109(8):3496-9 [17192396.001]
  • [Cites] Neurosurg Focus. 2007;23(4):E12 [17961036.001]
  • [Cites] PLoS Med. 2008 Jan 29;5(1):e24 [18232729.001]
  • [Cites] Neurosurgery. 2001 Nov;49(5):1029-37; discussion 1037-8 [11846894.001]
  • (PMID = 19293394.001).
  • [ISSN] 1523-5866
  • [Journal-full-title] Neuro-oncology
  • [ISO-abbreviation] Neuro-oncology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / U01 CA062407; United States / NCRR NIH HHS / RR / M01 RR000079; United States / NCRR NIH HHS / RR / M01 RR003186; United States / NCRR NIH HHS / RR / M01 RR000056; United States / NCRR NIH HHS / RR / M01 RR000865; United States / NCI NIH HHS / CA / U01 CA062399; United States / NCRR NIH HHS / RR / M01 RR000633; United States / NCI NIH HHS / CA / U01 CA062412; United States / NCI NIH HHS / CA / CA 62399; United States / NCI NIH HHS / CA / CA062421-07; United States / NCI NIH HHS / CA / U01 CA062421-07; United States / NCI NIH HHS / CA / U01 CA062421; United States / NCI NIH HHS / CA / U01 CA105663
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor alpha; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor beta
  • [Other-IDs] NLM/ PMC2802405
  •  go-up   go-down


6. Epari S, Sharma MC, Sarkar C, Garg A, Gupta A, Mehta VS: Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases. J Neurooncol; 2006 Jul;78(3):263-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.
  • AIMS: The study has been undertaken to document the clinicopathological features of 12 cases of chordoid meningioma, operated at All India Institute of Medical Sciences during 1996 to June 2005.
  • The location of tumor in eight cases was in the supratentorial and rest four in the infratentorial compartments.
  • Microscopic examination showed lobulation with chordoid elements constituting > 95% of the entire tumor area in 11 of the total 12 cases.
  • In one case, chordoid pattern constituted about 30% of the total tumor area; the rest was predominant meningothelial (60%).
  • [MeSH-major] Choroid Neoplasms / pathology. Meningioma / pathology. Supratentorial Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Infratentorial Neoplasms / metabolism. Infratentorial Neoplasms / pathology. Ki-67 Antigen / metabolism. Male. Mast Cells / pathology. Middle Aged

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Res Pract. 1985 Oct;180(4):364-8 [4070069.001]
  • [Cites] West J Med. 1980 Aug;133(2):160-3 [7233896.001]
  • [Cites] J Neurosurg. 2001 Jan;94(1):122-6 [11147880.001]
  • [Cites] Hosp Pract (Off Ed). 1985 Nov 15;20(11):50, 56-7, 60 [3932390.001]
  • [Cites] J Neurosurg Spine. 2005 Feb;2(2):195-8 [15739533.001]
  • [Cites] Folia Neuropathol. 1999;37(3):138-42 [10581846.001]
  • [Cites] Arq Neuropsiquiatr. 2003 Mar;61(1):91-4 [12715027.001]
  • [Cites] Pathol Res Pract. 1992 Feb;188(1-2):61-6 [1594501.001]
  • [Cites] J Neurosurg. 2005 Apr;102(4):733-7 [15871519.001]
  • [Cites] Virchows Arch. 2005 Mar;446(3):333-7 [15714337.001]
  • [Cites] Brain Tumor Pathol. 2000;17 (3):153-7 [11310923.001]
  • [Cites] Neurol India. 2003 Dec;51(4):522-4 [14742937.001]
  • [Cites] Am J Surg Pathol. 1997 Dec;21(12):1455-65 [9414189.001]
  • [Cites] Acta Neuropathol. 1979 Dec;48(3):235-7 [525263.001]
  • [Cites] Pathol Oncol Res. 2004;10(4):219-24 [15619643.001]
  • [Cites] J Neurosurg. 1998 Feb;88(2):319-23 [9452243.001]
  • [Cites] Mod Pathol. 1999 May;12(5):456-62 [10349982.001]
  • [Cites] Acta Pathol Jpn. 1977 Jul;27(4):557-66 [910629.001]
  • [Cites] Neuropathol Appl Neurobiol. 1992 Dec;18(6):548-58 [1488087.001]
  • [Cites] Pathology. 2004 Jun;36(3):258-61 [15203731.001]
  • [Cites] Am J Surg Pathol. 2000 Jul;24(7):899-905 [10895812.001]
  • [Cites] Surg Neurol. 2003 Jun;59(6):491-503; discussion 503-4 [12826353.001]
  • [Cites] Surg Neurol. 1986 Mar;25(3):233-42 [3945904.001]
  • [Cites] Pathology. 2004 Apr;36(2):198-201 [15203760.001]
  • [Cites] Neuropathology. 2004 Sep;24(3):243-7 [15484703.001]
  • [Cites] Clin Exp Metastasis. 1986 Apr-Jun;4(2):141-52 [3013478.001]
  • [Cites] Surg Neurol. 1994 Jul;42(1):8-13 [7524172.001]
  • [Cites] Neurochirurgie. 1989;35(1):5-12 [2654684.001]
  • [Cites] Cancer. 1988 Jul 15;62(2):391-406 [3383139.001]
  • [Cites] Int Arch Allergy Immunol. 2003 Mar;130(3):216-23 [12660426.001]
  • (PMID = 16628477.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen
  •  go-up   go-down


7. Kashimura H, Ogasawara K, Arai H, Beppu T, Inoue T, Takahashi T, Matsuda K, Takahashi Y, Fujiwara S, Ogawa A: Fusion of magnetic resonance angiography and magnetic resonance imaging for surgical planning for meningioma--technical note. Neurol Med Chir (Tokyo); 2008 Sep;48(9):418-21; discussion 422
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fusion of magnetic resonance angiography and magnetic resonance imaging for surgical planning for meningioma--technical note.
  • A fusion technique for magnetic resonance (MR) angiography and MR imaging was developed to help assess the peritumoral angioarchitecture during surgical planning for meningioma.
  • Three-dimensional time-of-flight (3D-TOF) and 3D-spoiled gradient recalled (SPGR) datasets were obtained from 10 patients with intracranial meningioma, and fused using newly developed volume registration and visualization software.
  • Fusion images showed displacement of the anterior cerebral or middle cerebral artery in 7 patients and encasement of the anterior cerebral arteries in 1 patient, with no relationship between the main arterial trunk and tumor in 2 patients.
  • Fusion of MR angiography and MR imaging can clarify relationships between the intracranial vasculature and meningioma, and may be helpful for surgical planning for meningioma.
  • [MeSH-major] Brain Neoplasms / surgery. Magnetic Resonance Angiography / methods. Magnetic Resonance Imaging / methods. Meningioma / surgery. Surgery, Computer-Assisted / methods
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Patient Care Planning. Software

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18812687.001).
  • [ISSN] 1349-8029
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  •  go-up   go-down


8. Wallis LI, Griffiths PD, Ritchie SJ, Romanowski CA, Darwent G, Wilkinson ID: Proton spectroscopy and imaging at 3T in ataxia-telangiectasia. AJNR Am J Neuroradiol; 2007 Jan;28(1):79-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two patients showed multiple small foci of hypointensity on T2*-weighted images throughout their brain suggestive of capillary telangiectasia.
  • One patient had a tumor, thought to be meningioma radiologically, that was not suspected clinically.
  • CONCLUSION: The findings suggest increased Cho signal intensity in the cerebellum of adult A-T patients.
  • [MeSH-minor] Adult. Energy Metabolism / physiology. Female. Humans. Male. Middle Aged. Reference Values


9. Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH: Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. J Neurooncol; 2007 Aug;84(1):49-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature.
  • Atypical teratoid/rhabdoid tumors (AT/RTs) are rare, malignant brain tumors which occur almost exclusively in infants and young children.
  • There have been only 17 cases of AT/RT in adults reported in the medical literature and the rarity of this tumor makes the diagnosis in adults difficult.
  • We describe a case of an AT/RT of the spinal cord in an adult.
  • In consultation with senior pathologists at other institutions, the lesion was initially diagnosed as a rhabdoid meningioma.
  • The patient underwent three additional surgical procedures for recurrent disease throughout the neuraxis secondary to leptomeningeal spread of the tumor.
  • To our knowledge, this is the first case of a spinal atypical teratoid/rhabdoid tumor in an adult fully documented with molecular, immunohistochemical, cytogenetic and autopsy findings.
  • [MeSH-major] Chromosomal Proteins, Non-Histone / genetics. Chromosomes, Human, Pair 22 / genetics. DNA-Binding Proteins / genetics. Neoplasm Recurrence, Local / pathology. Rhabdoid Tumor / pathology. Spinal Cord Neoplasms / pathology. Teratoma / pathology. Transcription Factors / genetics
  • [MeSH-minor] Adult. Cervical Vertebrae. Diagnosis, Differential. Fatal Outcome. Female. Humans. Immunohistochemistry. Monosomy / diagnosis. Monosomy / genetics. SMARCB1 Protein

  • Genetic Alliance. consumer health - Rhabdoid tumor.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurooncol. 2001 Mar;52(1):49-56 [11451202.001]
  • [Cites] J Neurooncol. 2003 Jan;61(2):121-6 [12622450.001]
  • [Cites] Nature. 1998 Jul 9;394(6689):203-6 [9671307.001]
  • [Cites] Genes Dev. 2005 Mar 15;19(6):665-70 [15769941.001]
  • [Cites] Mod Pathol. 2005 Jul;18(7):951-8 [15761491.001]
  • [Cites] J Neurooncol. 1995;24(1):21-8 [8523069.001]
  • [Cites] Cancer Res. 2005 May 15;65(10 ):4012-9 [15899790.001]
  • [Cites] Can J Neurol Sci. 1996 Nov;23(4):257-63 [8951203.001]
  • [Cites] Neuroradiology. 2000 May;42(5):363-7 [10872158.001]
  • [Cites] Pathol Int. 1999 Dec;49(12):1114-8 [10632935.001]
  • [Cites] Acta Neuropathol. 1992;83(4):445-8 [1575023.001]
  • [Cites] J Neurooncol. 2005 Sep;74(3):311-9 [16132523.001]
  • [Cites] J Pediatr Hematol Oncol. 2002 Jun-Jul;24(5):337-42 [12142780.001]
  • [Cites] Med Pediatr Oncol. 1997 Mar;28(3):223-7 [9024522.001]
  • [Cites] Brain Pathol. 2005 Jan;15(1):23-8 [15779233.001]
  • [Cites] Mol Cell Biol. 2006 Apr;26(7):2661-74 [16537910.001]
  • [Cites] Neurochirurgie. 1999 Sep;45(3):237-42 [10567965.001]
  • [Cites] Nat Rev Cancer. 2004 Feb;4(2):133-42 [14964309.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1993;422(1):81-5 [7679853.001]
  • [Cites] J Neurosurg. 1996 Jul;85(1):56-65 [8683283.001]
  • [Cites] Mod Pathol. 2006 May;19(5):717-25 [16528370.001]
  • [Cites] Acta Neurochir (Wien). 2004 Sep;146(9):1033-8; discussion 1038 [15340816.001]
  • [Cites] J Neurooncol. 2005 Mar;72(1):77-84 [15803379.001]
  • [Cites] Am J Surg Pathol. 2004 May;28(5):644-50 [15105654.001]
  • [Cites] Am J Surg Pathol. 2004 Nov;28(11):1485-91 [15489652.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1038-43 [16406394.001]
  • [Cites] Hum Pathol. 2001 Feb;32(2):156-62 [11230702.001]
  • [Cites] Neuropathology. 2006 Feb;26(1):57-61 [16521480.001]
  • [Cites] J Clin Neurosci. 2003 May;10 (3):325-8 [12763338.001]
  • [Cites] Cancer Res. 1999 Jan 1;59(1):74-9 [9892189.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17745-50 [16301525.001]
  • [Cites] Am J Surg Pathol. 1998 Sep;22(9):1083-92 [9737241.001]
  • (PMID = 17377740.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA46274
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromosomal Proteins, Non-Histone; 0 / DNA-Binding Proteins; 0 / SMARCB1 Protein; 0 / SMARCB1 protein, human; 0 / Transcription Factors
  • [Number-of-references] 34
  •  go-up   go-down


10. Acioly MA, Carvalho CH, Koerbel A, Löwenheim H, Tatagiba M, Gharabaghi A: Intraoperative brainstem auditory evoked potential observations after trigeminocardiac reflex during cerebellopontine angle surgery. J Neurosurg Anesthesiol; 2010 Oct;22(4):347-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The occurrence of trigeminocardiac reflex (TCR) is known to be a negative prognostic factor for hearing preservation in cerebellopontine angle tumor surgery.
  • Our study was conducted to investigate brainstem auditory evoked potential (BAEP) changes after this reflex in cerebellopontine angle tumor surgery and to evaluate their impact on postoperative hearing function.
  • [MeSH-major] Cerebellopontine Angle / surgery. Evoked Potentials, Auditory, Brain Stem / physiology. Heart / physiology. Reflex / physiology. Trigeminal Nerve / physiology
  • [MeSH-minor] Adolescent. Adult. Anesthesia. Audiometry, Pure-Tone. Cerebellar Neoplasms / pathology. Cerebellar Neoplasms / surgery. Epidermal Cyst / surgery. Female. Hearing. Humans. Male. Meningioma / surgery. Monitoring, Intraoperative. Neurilemmoma / surgery. Prognosis. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20706143.001).
  • [ISSN] 1537-1921
  • [Journal-full-title] Journal of neurosurgical anesthesiology
  • [ISO-abbreviation] J Neurosurg Anesthesiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


11. Bauchet L, Rigau V, Mathieu-Daudé H, Fabbro-Peray P, Palenzuela G, Figarella-Branger D, Moritz J, Puget S, Bauchet F, Pallusseau L, Duffau H, Coubes P, Trétarre B, Labrousse F, Dhellemmes P, Société Française de Neurochirurgie Pédiatrique, Société Française de Neurochirurgie, Société Française de Neuropathologie, Association des Neuro-Oncologues d'Expression Française: Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol; 2009 Mar;92(1):87-98
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical epidemiology for childhood primary central nervous system tumors.
  • This work was conducted by the French Brain Tumor Data Bank (FBTDB) and aims to prospectively record all primary central nervous system tumors (PCNST), in France, for which histological diagnosis is available.
  • The Tumor Registry from Herault was authorized to compile the data files with personal identifiers.
  • About 1,017 cases (533 boys and 484 girls) of newly diagnosed childhood PCNST have been recorded (gliomas: 52%, all other neuroepithelial tumors: 31%, craniopharyngioma: 5%, germ cell tumors, meningioma and neurinoma: approximately 3% each, all histological subtypes have been detailed).
  • Tumor resections were performed in 83.3%, and biopsies in 16.7%.
  • The distributions by histology, cryopreservation of the samples, age, sex, tumor site and surgery have been detailed.
  • The long term goals of the FBTDB are to create a national registry and a network to perform epidemiological studies, to implement clinical and basic research protocols, and to evaluate and harmonize the healthcare of children and adult patients affected by PCNST.
  • [MeSH-major] Central Nervous System Neoplasms / epidemiology. Registries
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Female. France / epidemiology. Humans. Infant. Infant, Newborn. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatr Blood Cancer. 2004 Dec;43(7):749-57 [15390289.001]
  • [Cites] Cancer. 2001 Dec 15;92(12):3155-64 [11753995.001]
  • [Cites] J Clin Oncol. 2005 Jun 1;23(16):3742-51 [15923571.001]
  • [Cites] J Clin Oncol. 2004 Jul 15;22(14):2877-84 [15254056.001]
  • [Cites] Neuro Oncol. 2005 Apr;7(2):196-201 [15831238.001]
  • [Cites] Pediatr Neurol. 1999 Mar;20(3):198-203 [10207928.001]
  • [Cites] Int J Cancer. 1996 Dec 11;68(6):759-65 [8980180.001]
  • [Cites] Neuroepidemiology. 2004 May-Jun;23(3):101-9 [15084778.001]
  • [Cites] Childs Nerv Syst. 1998 Jul;14(7):302-11 [9726580.001]
  • [Cites] Eur J Cancer. 2006 Sep;42(13):2064-80 [16919771.001]
  • [Cites] Neuro Oncol. 2002 Oct;4(4):278-99 [12356358.001]
  • [Cites] Neuroepidemiology. 2004 May-Jun;23(3):110-7 [15084779.001]
  • [Cites] Int J Oncol. 1999 Oct;15(4):721-5 [10493954.001]
  • [Cites] Toxicol Appl Pharmacol. 2004 Sep 1;199(2):118-31 [15313584.001]
  • [Cites] Cancer. 1999 May 1;85(9):2077-90 [10223251.001]
  • [Cites] Pediatr Neurosurg. 1996 Nov;25(5):240-6; discussion 247 [9309787.001]
  • [Cites] Brain. 1998 Aug;121 ( Pt 8):1429-36 [9712005.001]
  • [Cites] Cancer. 2008 Jan 15;112(2):416-32 [18074355.001]
  • [Cites] Acta Neuropathol. 2007 Aug;114(2):97-109 [17618441.001]
  • [Cites] NeuroRx. 2005 Apr;2(2):333-47 [15897954.001]
  • [Cites] Childs Nerv Syst. 2007 Feb;23(2):157-62 [16953459.001]
  • [Cites] Childs Nerv Syst. 2002 Feb;18(1-2):30-7 [11935241.001]
  • [Cites] Childs Nerv Syst. 2005 Nov;21(11):940-4 [16044344.001]
  • [Cites] J Neurooncol. 2007 Sep;84(2):189-99 [17431547.001]
  • [Cites] Neuro Oncol. 2002 Apr;4(2):134-45 [11916506.001]
  • [Cites] Childs Nerv Syst. 1999 Nov;15(11-12):758-63 [10603019.001]
  • [Cites] Pediatr Blood Cancer. 2004 Dec;43(7):742-8 [15390305.001]
  • [Cites] Arch Pediatr. 2005 Nov;12(11):1577-86 [16099145.001]
  • [Cites] Neuro Oncol. 2006 Jan;8(1):27-37 [16443945.001]
  • [Cites] Ann Pathol. 2000 Oct;20(5):413-28 [11084409.001]
  • [Cites] Lancet Oncol. 2007 Aug;8(8):685-95 [17644483.001]
  • [Cites] Cancer. 2005 Nov 15;104(10):2156-67 [16220552.001]
  • [Cites] Cancer. 2005 Apr 1;103(7):1457-67 [15712273.001]
  • [Cites] Neuroepidemiology. 1997;16(6):308-16 [9430131.001]
  • [Cites] Eur J Cancer. 2006 Sep;42(13):2183-90 [16919780.001]
  • [Cites] Eur J Cancer. 2006 Feb;42(3):403-9 [16386892.001]
  • [Cites] Arch Pediatr. 2006 Feb;13(2):121-9 [16376530.001]
  • [Cites] Neurochirurgie. 2004 Nov;50(5):540-7 [15654308.001]
  • [Cites] Neuroradiology. 1992;34(2):122-5 [1603309.001]
  • [Cites] Lancet. 2004 Dec 11-17;364(9451):2097-105 [15589307.001]
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • (PMID = 19020806.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Investigator] Aghakhani N; Ali Benali M; Alliez B; Amat D; Amlashi A; Arbez-Gindre F; Arbion F; Assaker R; Aubriot Lorton MH; Auque J; Autricque A; Auvigne I; Averous G; Baldet P; Bataille B; Bazin A; Beaurain J; Benezech J; Bergemer Fouquet A; Besson G; Beuvon F; Billotet C; Blond S; Boetto S; Boissonnet H; Bonyhay G; Bouillot P; Bourgeois P; Bouvier C; Brassier G; Broche C; Brunon J; Cabal P; Cahn V; Caire F; Calvet P; Cazals-Hatem D; Chapon F; Chazal J; Civit T; Colnat S; Colombat M; Comoy J; Couvelard A; Czorny A; Dam Hieu P; Daumas-Duport C; Dautheribes M; David P; Debono B; Delage Corre M; Delhaye M; Delisle MB; Delsol G; Derlon JM; Desenclos C; Desplat A; Devaux B; Di Rocco F; Diaz A; Diebold MD; Dorfmuller G; Dran G; Dufour T; Dumas B; Dumollard JM; Durand L; Duthel R; Eimer S; El Fertit H; Emery E; Espagno C; Esposito P; Etchandy MP; Eyremandi RP; Faillot T; Felix S; Fernandez C; Fesselet J; Fontaine D; Fournier D; François P; Froelich S; Fuentes JM; Fuentes S; Gadan R; Gaspard C; Gay G; Gigaud M; Gil Robles S; Godard J; Gontier MF; Goujon JM; Gray F; Grignon Y; Grisoli F; Guarnieri J; Guyotat J; Hallacq P; Hamlat A; Hayek G; Heitzmann A; Hennequin V; Huot JC; Irthum B; Jacquet G; Jan M; Jaubert F; Jouanneau E; Jouvet A; Justrabo E; Kalamarides M; Kehrli P; Kemeny JL; Keravel Y; Kerdraon R; Khalil T; Khouri K; Khouri S; Klein O; Kujas M; Lacroix C; Lagarrigue J; Langlois O; Lapierre F; Laquerriere A; Laurent MC; Le Gall F; Le Guerinel C; Le Houcq M; Lechapt E; Legars D; Lemaire JJ; Lena G; Lepeintre JF; Leriche B; Lescure JP; Levillain P; Liguoro D; Lioret E; Listrat A; Loiseau H; Lonjon M; Lopes M; Lot G; Louis E; Maheut-Lourmière J; Maillard A; Maitre F; Maitrot D; Majek-Zakine E; Mandonnet E; Manzo N; Marchal JC; Marie B; Maurage CA; Menei P; Mercier P; Mergey E; Metellus P; Michalak S; Michiels JF; Milinkevitch S; Mineo JF; Miquel C; Mireau E; Mohr M; Mokhtari K; Morandi X; Morar S; Moreau JJ; Moreno S; Mourier KL; Mottolese C; Nataf F; Neuville A; Nogues L; Noudel R; Nuti C; Page P; Paquis P; Parent M; Parker F; Pasqualini F; Patey M; Pelissou-Guyotat I; Peoc'h M; Peragut JC; Peruzzi P; Pierre-Kahn A; Pinelli C; Polivka M; Pommepuy I; Ponnelle T; Porhiel V; Proust F; Quintin-Roue I; Ragragui O; Rasendrarijao D; Raynaud P; Redondo A; Renjard L; Reyns N; Richard S; Richaud J; Riem T; Riffaud L; Ringenbach F; Robert G; Roche PH; Rodriguez MA; Roujeau T; Rousseaux P; Rousselet MC; Roux FE; Roux FX; Ruchoux MM; Sabatier J; Sabatier P; Saïkali S; Saint Andre JP; Saint Pierre G; Saint-Rose C; San Galli F; Sautreaux JL; Sawan B; Scavarda D; Segnarbieux F; Seigneuret E; Sindou M; Sorbara R; Sorin A; Stilhart B; Straub P; Taha S; Ternier JP; Tortel MC; Toussaint P; Touzet G; Tremoulet M; Trouillas J; Tubiana A; Uro-Coste E; Vandenbos F; Varlet P; Velut S; Vidal J; Viennet G; Vignaud JM; Vignes JR; Vinchon M; Vital A; Wager M; Weinbreck N; Zerah M
  •  go-up   go-down


12. Das S, Isiah R, Rajesh B, Ravindran BP, Singh RR, Backianathan S, Subhashini J: Accuracy of relocation, evaluation of geometric uncertainties and clinical target volume (CTV) to planning target volume (PTV) margin in fractionated stereotactic radiotherapy for intracranial tumors using relocatable Gill-Thomas-Cosman (GTC) frame. J Appl Clin Med Phys; 2010 Dec 28;12(2):3260
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • According to the ICRU formula, a margin of 2 mm around the tumor seems to be adequate.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21587166.001).
  • [ISSN] 1526-9914
  • [Journal-full-title] Journal of applied clinical medical physics
  • [ISO-abbreviation] J Appl Clin Med Phys
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Kozler P, Benes V, Netuka D, Kramár F, Charvát F: [Intracranial meningiomas; standard diagnostic procedure and results of surgical treatment]. Rozhl Chir; 2006 Sep;85(9):431-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of the study is to define radiological parameters which may indirectly indicate invasive expansion of a meningioma and thus forecast potential risks of postoperative neurological deficits.
  • The study group includes 40 adult patients in comparable physical conditions (age 18-75, CRS 70-100, ASA 1-2) with meningiomas, affecting the brain tissue only.
  • The results indicate that unfavorable parametres, predicting potential postoperative neurological deficits include: growth of a meningioma in eloquent regions and presence of a peritumoral oedema.
  • Positive parametres, indicating that no neurological deficit would arise, include: dural supply, visible brain-tumor barrier, non-eloquent location of a meningioma and absence of a peritumoral oedema.
  • [MeSH-major] Meningeal Neoplasms / radiography. Meningioma / radiography
  • [MeSH-minor] Adult. Aged. Brain Neoplasms / radiography. Brain Neoplasms / surgery. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17323765.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


14. Wentworth S, Pinn M, Bourland JD, Deguzman AF, Ekstrand K, Ellis TL, Glazier SS, McMullen KP, Munley M, Stieber VW, Tatter SB, Shaw EG: Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors. Int J Radiat Oncol Biol Phys; 2009 Jan 1;73(1):208-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors.
  • PURPOSE: Patients with neurofibromatosis (NF) develop tumors of the central nervous system (CNS).
  • METHODS AND MATERIALS: Eighteen patients with NF with CNS tumors were treated from 1986 to 2007.
  • Progression was defined as growth or recurrence of an irradiated tumor on serial imaging.
  • Tumor types included acoustic neuroma (16%), ependymoma (6%), low-grade glioma (11%), meningioma (60%), and schwanomma/neurofibroma (7%).
  • Five-year PFS rates were 75% (acoustic neuroma), 100% (ependymoma), 75% (low-grade glioma), 86% (meningioma), and 100% (schwanomma/neurofibroma).
  • Radiation therapy should be considered in NF patients with imaging progression of CNS tumors.
  • [MeSH-major] Brain Neoplasms / mortality. Brain Neoplasms / radiotherapy. Neurofibromatoses / mortality. Neurofibromatoses / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Humans. Middle Aged. North Carolina / epidemiology. Survival Analysis. Survival Rate. Treatment Outcome. Young Adult


15. Finn MA, Blumenthal DT, Salzman KL, Jensen RL: Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol; 2007 Mar;67(3):246-50; discussion 250
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transient postictal MRI changes in patients with brain tumors may mimic disease progression.
  • BACKGROUND: Transient postictal imaging abnormalities in patients with non-tumor-related seizures are well documented and include fluid-attenuated inversion recovery/T2 hyperintensity and parenchymal and meningeal contrast enhancement.
  • In contrast, transient postictal imaging abnormalities in patients with tumor-related seizures have been poorly described.
  • Fifty percent of patients with brain tumors have a seizure during the course of their illness and are often imaged after a seizure or after a change in seizure character or frequency.
  • METHODS: We describe 3 patients with brain tumors and transient postictal MRI changes that mimicked disease progression and infection.
  • These changes were suspicious for tumor progression in 2 cases and for recurrent infection in the third.
  • CONCLUSIONS: Imaging shortly after an ictal event can potentially mislead the clinician to interpret changes as tumor or pathologic progression.
  • We recommend repeat imaging be performed in patients with brain tumors and seizures several weeks after seizure control if clinically feasible.
  • [MeSH-major] Astrocytoma / complications. Astrocytoma / pathology. Brain Neoplasms / complications. Brain Neoplasms / pathology. Glioma / complications. Glioma / pathology. Magnetic Resonance Imaging. Meningeal Neoplasms / complications. Meningeal Neoplasms / pathology. Meningioma / complications. Meningioma / pathology. Seizures / diagnosis. Seizures / etiology
  • [MeSH-minor] Adult. Diagnosis, Differential. Disease Progression. Female. Humans. Male. Middle Aged. Severity of Illness Index. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Seizures.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17320628.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD: Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol; 2006 Apr;8(2):145-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.
  • Genes involved in phase I and phase II regulation of aromatic hydrocarbon-induced effects exhibit sequence variability that may mediate the risk of adult brain tumors.
  • We evaluated associations between gene variants in CYP1A1, CYP1B1, GSTM3, EPHX1, and NQO1 and adult brain tumor incidence.
  • Cases were patients with glioma (n = 489), meningioma (n = 197), or acoustic neuroma (n = 96) diagnosed from 1994 to 1998 at three U.S. hospitals.
  • The CYP1B1 V432L homozygous variant was associated with decreased risk of meningioma (odds ratio [OR] = 0.6; 95% CI, 0.3-1.0) but not the other tumor types.
  • The GSTM3 *B/*B genotype was associated with increased risk of glioma (OR = 2.3; 95% CI, 1.0-5.2) and meningioma (OR = 3.6; 95% CI, 1.3-9.8).
  • The magnitude of association for GSTM3 with glioma and meningioma was greater among ever-smokers than among those who had never smoked.
  • None of the other genotypes showed consistent associations with any tumor type.

  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pharmacol Rev. 1982 Jun;34(2):189-222 [6287505.001]
  • [Cites] Scand J Work Environ Health. 1986 Apr;12(2):121-7 [3726493.001]
  • [Cites] J Natl Cancer Inst. 1987 Apr;78(4):601-9 [3104645.001]
  • [Cites] Neuroepidemiology. 2005;24(3):117-22 [15637448.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):987-91 [11008920.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):147-50 [10698474.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):185-91 [10698480.001]
  • [Cites] Toxicol Lett. 2000 Mar 15;112-113:365-70 [10720753.001]
  • [Cites] Pharmacogenetics. 2000 Mar;10(2):123-31 [10762000.001]
  • [Cites] Scand J Work Environ Health. 1987 Oct;13(5):417-23 [2829348.001]
  • [Cites] Biometrics. 1989 Mar;45(1):53-70 [2720060.001]
  • [Cites] Neuroepidemiology. 1989;8(6):283-95 [2586698.001]
  • [Cites] J Occup Med. 1991 Sep;33(9):1001-6 [1660541.001]
  • [Cites] J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):309-16 [7901425.001]
  • [Cites] Hum Mol Genet. 1994 Mar;3(3):421-8 [7516776.001]
  • [Cites] Carcinogenesis. 1994 Dec;15(12):2961-3 [8001264.001]
  • [Cites] Toxicol Lett. 1995 May;77(1-3):357-62 [7618162.001]
  • [Cites] Biochem J. 1995 Dec 15;312 ( Pt 3):713-6 [8554510.001]
  • [Cites] Jpn J Cancer Res. 1996 Jan;87(1):18-24 [8609043.001]
  • [Cites] Cancer Res. 1996 May 1;56(9):1974-7 [8616834.001]
  • [Cites] Cancer Res. 1996 Jul 1;56(13):2979-84 [8674051.001]
  • [Cites] Epidemiol Rev. 1995;17(2):382-414 [8654518.001]
  • [Cites] Methods Enzymol. 1996;272:199-210 [8791778.001]
  • [Cites] Carcinogenesis. 1996 Sep;17(9):1919-22 [8824514.001]
  • [Cites] Mol Carcinog. 1996 Nov;17(3):160-2 [8944076.001]
  • [Cites] Br J Cancer. 1997;75(1):69-75 [9000600.001]
  • [Cites] Arch Biochem Biophys. 1997 Jan 15;337(2):275-83 [9016823.001]
  • [Cites] Cancer Causes Control. 1997 Jan;8(1):13-24 [9051318.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S147-9 [9065651.001]
  • [Cites] Cancer. 1997 Sep 1;80(5):852-7 [9307183.001]
  • [Cites] Br J Cancer. 1997;76(7):852-4 [9328142.001]
  • [Cites] Br J Cancer. 1998 Mar;77(5):709-19 [9514048.001]
  • [Cites] Carcinogenesis. 1998 Mar;19(3):387-93 [9525271.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):553-5 [9641501.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):703-9 [9718223.001]
  • [Cites] Pharmacogenetics. 1998 Aug;8(4):315-23 [9731718.001]
  • [Cites] Cancer Res. 1998 Nov 15;58(22):5038-41 [9823305.001]
  • [Cites] Jpn J Clin Oncol. 1998 Nov;28(11):657-60 [9861231.001]
  • [Cites] Pharmacogenetics. 1998 Apr;8(2):91-100 [10022746.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8150-5 [10393963.001]
  • [Cites] Carcinogenesis. 1999 Aug;20(8):1607-13 [10426814.001]
  • [Cites] Hum Genomics. 2004 Mar;1(3):209-17 [15588480.001]
  • [Cites] Oral Oncol. 2000 May;36(3):267-71 [10793329.001]
  • [Cites] Neurochem Res. 2000 May;25(5):733-8 [10905636.001]
  • [Cites] Pharmacogenetics. 2000 Oct;10(7):617-27 [11037803.001]
  • [Cites] Am J Epidemiol. 2000 Nov 1;152(9):838-46 [11085395.001]
  • [Cites] Chem Biol Interact. 2000 Dec 1;129(1-2):77-97 [11154736.001]
  • [Cites] N Engl J Med. 2001 Jan 11;344(2):79-86 [11150357.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):151-2 [11219774.001]
  • [Cites] Cytogenet Cell Genet. 2000;91(1-4):234-8 [11173863.001]
  • [Cites] Cancer Lett. 2001 Apr 26;165(2):171-7 [11275366.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):209-16 [11303589.001]
  • [Cites] Carcinogenesis. 2001 Jul;22(7):1053-60 [11408349.001]
  • [Cites] J Natl Cancer Inst. 2001 Aug 1;93(15):1166-70 [11481389.001]
  • [Cites] J Invest Dermatol. 2001 Aug;117(2):251-5 [11511301.001]
  • [Cites] Mutat Res. 2001 Oct 1;482(1-2):21-6 [11535245.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1239-48 [11751440.001]
  • [Cites] World J Gastroenterol. 2002 Feb;8(1):49-53 [11833070.001]
  • [Cites] Genet Med. 2002 Mar-Apr;4(2):62-70 [11882782.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):489-92 [12010864.001]
  • [Cites] J Biol Chem. 2002 Jul 5;277(27):24799-808 [11978787.001]
  • [Cites] Biomarkers. 2002 May-Jun;7(3):230-41 [12141066.001]
  • [Cites] Int J Cancer. 2002 Nov 10;102(2):172-8 [12385014.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):14-22 [12540498.001]
  • [Cites] Oral Oncol. 2003 Jul;39(5):483-90 [12747973.001]
  • [Cites] Carcinogenesis. 2003 May;24(5):875-82 [12771031.001]
  • [Cites] World J Gastroenterol. 2003 Jul;9(7):1394-7 [12854128.001]
  • [Cites] Br J Cancer. 2003 Oct 20;89(8):1524-9 [14562027.001]
  • [Cites] J Neurooncol. 2004 May;68(1):57-69 [15174522.001]
  • (PMID = 16598069.001).
  • [ISSN] 1522-8517
  • [Journal-full-title] Neuro-oncology
  • [ISO-abbreviation] Neuro-oncology
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Hydrocarbons, Aromatic; EC 1.14.14.1 / Aryl Hydrocarbon Hydroxylases; EC 1.14.14.1 / CYP1B1 protein, human; EC 1.14.14.1 / Cytochrome P-450 CYP1A1; EC 1.14.14.1 / Cytochrome P-450 CYP1B1; EC 1.6.5.2 / NAD(P)H Dehydrogenase (Quinone); EC 1.6.5.2 / NQO1 protein, human; EC 3.3.2.- / Epoxide Hydrolases
  • [Other-IDs] NLM/ PMC1871937
  •  go-up   go-down


17. Armstrong L, Graham GE, Schimke RN, Collins DL, Kirse DJ, Costello F, Ardinger HH: The Hunter-MacDonald syndrome with expanded phenotype including risk of meningioma: an update and review. Am J Med Genet A; 2008 Jan 1;146A(1):83-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Hunter-MacDonald syndrome with expanded phenotype including risk of meningioma: an update and review.
  • Decreased hearing acuity, transient cranial nerve palsies, congenital heart defects, and meningioma are also reported.
  • Herein, we present two cases, and, through review of the manifestations of HMS in affected and at-risk family members, we have observed that predisposition to brain tumor is a cardinal feature of this condition.
  • [MeSH-major] Abnormalities, Multiple / genetics. Meningeal Neoplasms / genetics. Meningioma / genetics. Phenotype
  • [MeSH-minor] Adult. Child. Female. Genes, Dominant. Hearing Loss / genetics. Hearing Loss / physiopathology. Humans. Male. Pedigree. Risk Factors. Syndrome

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - Mucopolysaccharidosis type II.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17972300.001).
  • [ISSN] 1552-4833
  • [Journal-full-title] American journal of medical genetics. Part A
  • [ISO-abbreviation] Am. J. Med. Genet. A
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 17
  •  go-up   go-down


18. Colli BO, Carlotti CG Jr, Assirati JA Jr, Dos Santos MB, Neder L, Dos Santos AC: Parasagittal meningiomas: follow-up review. Surg Neurol; 2006;66 Suppl 3:S20-7; discussion S27-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Parasagittal meningioma is one that fills the parasagittal angle, with no brain tissue between the tumor and the SSS.
  • The RF survival curve was better for patients with grade I meningioma (grades I vs II vs III, P = .0001).
  • [MeSH-major] Meningeal Neoplasms / surgery. Meningioma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Recovery of Function. Retrospective Studies. Survival Rate. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17081848.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Fan YS, Lui PC, Tam FK, Hung KN, Ng HK, Leung SY: A 33-year-old Chinese woman with a left frontal tumor. Brain Pathol; 2009 Apr;19(2):337-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A 33-year-old Chinese woman with a left frontal tumor.
  • Rhabdoid tumor cells are typically observed in atypical teratoid/rhabdoid tumor (AT/RT) but may also be seen in meningioma,glioma, melanoma, rhabdomyosarcoma and metastatic carcinoma.We present an astroblastoma with unusual rhabdoid features which is rarely described in the English literature.
  • Apart from the rhabdoid tumor cells, all the histopathological features typical for astroblastoma are present in this case.
  • These features include pseudopapillary arrangement, astroblastic pseudorosettes, perivascular hyalinization and calcifications, absence of fibrillary background and a pushing tumor border.
  • The tumor cells display a multilineage immunohistochemical profile.
  • The diagnosis of astroblastoma is also well supported by the age of presentation, anatomical location and radiological features of the tumor.We believe that on top of the above-mentioned unusual tumors with rhabdoid cells, astroblastoma should also be considered in the list of differential diagnosis.
  • [MeSH-major] Brain Neoplasms / pathology. Frontal Lobe. Neoplasms, Neuroepithelial / pathology
  • [MeSH-minor] Adult. China. Female. Humans

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19291001.001).
  • [ISSN] 1750-3639
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


20. Anton T, Guttierez J, Rock J: Tentorial schwannoma: a case report and review of the literature. J Neurooncol; 2006 Feb;76(3):307-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Magnetic resonance imaging revealed a large tentorial-based tumor.
  • At surgery the origin of the tumor was clearly the tentorium, and while the trigeminal nerve was displaced, it easily separated from the mass.
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Meningioma / pathology. Neurosurgical Procedures. Tomography, X-Ray Computed. Trigeminal Nerve / pathology

  • Genetic Alliance. consumer health - Schwannoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosurg Rev. 1996;19(4):269-74 [9007892.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1958 May;21(2):92-4 [13539649.001]
  • [Cites] Acta Neurochir Suppl (Wien). 1991;53:166-70 [1803875.001]
  • [Cites] Am J Ophthalmol. 1999 Feb;127(2):183-8 [10030561.001]
  • [Cites] Br J Radiol. 2003 Jun;76(906):421-4 [12814930.001]
  • [Cites] Acta Neurochir (Wien). 1997;139(8):756-60 [9309291.001]
  • [Cites] Br J Neurosurg. 1994;8(2):219-23 [7917097.001]
  • [Cites] J Neurosurg. 1990 Nov;73(5):777-81 [2213169.001]
  • [Cites] Surg Neurol. 1984 Oct;22(4):360-4 [6433498.001]
  • [Cites] No Shinkei Geka. 1991 Jan;19(1):47-51 [2000157.001]
  • [Cites] Brain. 1970;93(3):475-90 [4097005.001]
  • [Cites] Neurosurgery. 1997 Jan;40(1):194-7 [8971843.001]
  • [Cites] Br J Neurosurg. 1999 Apr;13(2):212-3 [10616595.001]
  • [Cites] No Shinkei Geka. 1992 Nov;20(11):1189-94 [1448194.001]
  • [Cites] Surg Neurol. 1990 Sep;34(3):160-3 [2385823.001]
  • [Cites] No Shinkei Geka. 1974 Sep;2(9):643-7 [4477644.001]
  • [Cites] Neurosurgery. 2002 Jun;50(6):1352-5 [12015855.001]
  • [Cites] Pediatr Neurosurg. 2003 Apr;38(4):167-73 [12646734.001]
  • [Cites] Neurology. 1972 Jul;22(7):726-31 [4673254.001]
  • [Cites] Pediatr Neurosurg. 2002 Mar;36(3):153-6 [11919450.001]
  • [Cites] J Neuropathol Exp Neurol. 1971 Oct;30(4):603-12 [5135015.001]
  • (PMID = 16200344.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Han SJ, Yang I, Ahn BJ, Otero JJ, Tihan T, McDermott MW, Berger MS, Prados MD, Parsa AT: Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer; 2010 Mar 1;116(5):1358-66
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Primary gliosarcoma (PGS) is a rare central nervous system tumor with limited experience reported in the literature.
  • Cases were determined to be PGS by central pathology review using the 2007 World Health Organization criteria.
  • Patients with gliosarcomas resembling meningioma were found to have a significantly prolonged median survival compared with patients harboring gliosarcoma resembling glioblastoma multiforme (16 months vs 9.6 months; P = .011).
  • The type mimicking the appearance of a meningioma appears to carry a significantly more favorable prognosis, most likely due to an increased chance at achieving macroscopic total resection.
  • [MeSH-major] Brain Neoplasms / therapy. Gliosarcoma / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Agents, Alkylating / therapeutic use. Chemotherapy, Adjuvant. Combined Modality Therapy. Dacarbazine / analogs & derivatives. Dacarbazine / therapeutic use. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Gliosarcoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DACARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20052717.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Grant] United States / Howard Hughes Medical Institute / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide
  •  go-up   go-down


22. Kawashima M, Matsushima T, Nakahara Y, Takase Y, Masuoka J, Ohata K: Trans-cerebellomedullary fissure approach with special reference to lateral route. Neurosurg Rev; 2009 Oct;32(4):457-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Based on the anatomic findings, we adopted the lateral route of the trans-CMF approach for four patients, each with a tumor near the jugular tubercle extending into the fourth ventricle through the CMF.
  • A tumor is safely removed by this approach with easy feeder or tumor bed controls, especially if it is anchored at the lateral part of the CMF as is the jugular tubercle meningioma.
  • [MeSH-minor] Adult. Brain Stem Neoplasms / pathology. Brain Stem Neoplasms / surgery. Cerebellar Neoplasms / pathology. Cerebellar Neoplasms / surgery. Cerebellopontine Angle / pathology. Cerebellopontine Angle / surgery. Cranial Nerve Neoplasms / pathology. Cranial Nerve Neoplasms / surgery. Ependymoma / pathology. Ependymoma / surgery. Female. Humans. Hypoglossal Nerve Diseases / pathology. Hypoglossal Nerve Diseases / surgery. Magnetic Resonance Imaging. Male. Meningioma / pathology. Meningioma / surgery. Middle Aged. Neurilemmoma / pathology. Neurilemmoma / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] No Shinkei Geka. 1996 Feb;24(2):119-24 [8849471.001]
  • [Cites] J Neurosurg. 1997 Oct;87(4):555-85 [9322846.001]
  • [Cites] J Neurosurg. 2001 Feb;94(2):257-64 [11213963.001]
  • [Cites] Neurosurgery. 1993 Jan;32(1):38-44 [8421555.001]
  • [Cites] Acta Neurochir Suppl. 1996;65:82-5 [8738503.001]
  • [Cites] Neurosurgery. 2003 Apr;52(4):860-6; discussion 866 [12657182.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(12):1359-63 [11214629.001]
  • [Cites] Pediatr Neurosurg. 1997 Jul;27(1):28-33 [9486833.001]
  • [Cites] Neuropediatrics. 1992 Jun;23(3):144-6 [1641081.001]
  • [Cites] Neurosurgery. 1982 Nov;11(5):631-67 [7155330.001]
  • [Cites] Neurosurgery. 1992 Mar;30(3):325-30 [1620293.001]
  • [Cites] Neurosurgery. 2000 Sep;47(3 Suppl):S195-209 [10983309.001]
  • [Cites] Neurosurgery. 1996 Jan;38(1):60-5;discussion 66 [8747952.001]
  • [Cites] Neurosurgery. 2003 Dec;53(6):1436-41; discussion 1442-3 [14633313.001]
  • [Cites] J Neurosurg. 2001 Aug;95(2):268-74 [11780897.001]
  • [Cites] Skull Base Surg. 1998;8(3):119-25 [17171046.001]
  • [Cites] Neurol Med Chir (Tokyo). 2001 Sep;41(9):458-62 [11593975.001]
  • [Cites] Neurosurgery. 2000 Sep;47(3 Suppl):S7-27 [10983303.001]
  • [Cites] J Neurosurg. 2004 Sep;101(3):484-98 [15352607.001]
  • [Cites] Neurosurgery. 1991 Dec;29(6):815-21 [1758590.001]
  • [Cites] J Neurosurg. 2000 May;92(5):812-23 [10794296.001]
  • (PMID = 19609581.001).
  • [ISSN] 1437-2320
  • [Journal-full-title] Neurosurgical review
  • [ISO-abbreviation] Neurosurg Rev
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


23. Liu RS, Chang CP, Guo WY, Pan DH, Ho DM, Chang CW, Yang BH, Wu LC, Yeh SH: 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med; 2010 Jun;51(6):883-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery.
  • METHODS: Twenty-two patients with the neuroradiologic diagnosis of meningioma were examined by 1-(11)C-acetate and (18)F-FDG PET on the same day.
  • There were 12 cases of histopathologically proven meningioma (8 grade I, 2 grade II, and 2 grade III), 1 of tuberculous granuloma, and 1 of degenerative tissue.
  • The PET images were evaluated by a qualitative method and semiquantitative analysis using standardized uptake value and tumor-to-cortex ratio.
  • High uptake of 1-(11)C-acetate was observed in all 20 meningiomas, in contrast to the low uptake in surrounding normal brain tissue, allowing a clearer demarcation of the tumor boundary than that provided by (18)F-FDG.
  • Dissociation of regional accumulation of 1-(11)C-acetate and (18)F-FDG within the tumor was also noted on the coregistered images.
  • The standardized uptake value for 1-(11)C-acetate was not different from that for (18)F-FDG (mean +/- SD, 3.16 +/- 1.75 vs. 3.22 +/- 1.50, P = 0.601), but the tumor-to-cortex ratio for 1-(11)C-acetate was higher than that for (18)F-FDG (3.46 +/- 1.38 vs. 0.93 +/- 1.08, P < 0.005). (18)F-FDG was able to differentiate grade I from grade II-III meningiomas, whereas 1-(11)C-acetate was unable to do so.
  • Tuberculous granuloma had a high 1-(11)C-acetate and (18)F-FDG uptake similar to that of grade II/III meningioma.
  • 1-(11)C-acetate performed better than did (18)F-FDG in monitoring the response of tumor metabolism to radiosurgery.
  • CONCLUSION: 1-(11)C-acetate was found to be useful for detecting meningiomas and evaluating the extent of meningiomas and potentially useful for monitoring tumor response to radiosurgery.
  • However, 1-(11)C-acetate was not useful for evaluating the tumor grade. (18)F-FDG was found to be less useful than 1-(11)C-acetate for evaluating the extent of meningiomas and the response to radiosurgical treatment but may be useful for differentiating benign from malignant meningiomas. (18)F-FDG and 1-(11)C-acetate are complementary for assessing diverse cell metabolism of meningioma.
  • [MeSH-major] Acetates. Carbon. Fluorodeoxyglucose F18. Meningioma / radionuclide imaging. Meningioma / surgery. Positron-Emission Tomography / methods. Radiosurgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biological Transport. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Regression Analysis. Retrospective Studies. Treatment Outcome. Tumor Burden

  • Genetic Alliance. consumer health - Meningioma.
  • Hazardous Substances Data Bank. CARBON .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20484430.001).
  • [ISSN] 1535-5667
  • [Journal-full-title] Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • [ISO-abbreviation] J. Nucl. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acetates; 0 / carbon-11 acetate; 0Z5B2CJX4D / Fluorodeoxyglucose F18; 7440-44-0 / Carbon
  •  go-up   go-down


24. Jensen TR, Schmainda KM: Computer-aided detection of brain tumor invasion using multiparametric MRI. J Magn Reson Imaging; 2009 Sep;30(3):481-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Computer-aided detection of brain tumor invasion using multiparametric MRI.
  • PURPOSE: To determine the potential of using a computer-aided detection method to intelligently distinguish peritumoral edema alone from peritumor edema consisting of tumor using a combination of high-resolution morphological and physiological magnetic resonance imaging (MRI) techniques available on most clinical MRI scanners.
  • MATERIALS AND METHODS: This retrospective study consisted of patients with two types of primary brain tumors: meningiomas (n = 7) and glioblastomas (n = 11).
  • Meningiomas are typically benign and have a clear delineation of tumor and edema.
  • Four classifiers of differing designs were trained using morphological, diffusion-weighted, and perfusion-weighted features derived from MRI to discriminate tumor and edema, tested on edematous regions surrounding tumors, and assessed for their ability to detect nonenhancing tumor invasion.
  • Each classifier was able to identify areas of nonenhancing tumor invasion supported with adjunct images or follow-up studies.
  • CONCLUSION: The combination of features derived from morphological and physiological imaging techniques contains the information necessary for computer-aided detection of tumor invasion and allows for the identification of tumor invasion not previously visualized on morphological, diffusion-weighted, and perfusion-weighted images and maps.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19711398.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA028500; United States / NCRR NIH HHS / RR / M01 RR000058; United States / NCI NIH HHS / CA / R21 CA109280; United States / NCI NIH HHS / CA / R01 CA082500; United States / NCRR NIH HHS / RR / M01-RR00058; United States / NCI NIH HHS / CA / R21 CA10928; United States / NCI NIH HHS / CA / R01 CA082500-06
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 84F6U3J2R6 / gadodiamide; K2I13DR72L / Gadolinium DTPA
  • [Other-IDs] NLM/ NIHMS185656; NLM/ PMC4321878
  •  go-up   go-down


25. Stagno D, Guex P: [Dynamic investigation and the question of early transference in a case of cancer patient]. Rev Med Suisse; 2006 Feb 8;2(52):409-10, 412-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article explores the early interaction between a patient with a brain tumor and his psychiatrist, Analysis of the relationship allows to refine the diagnosis and to develop an etiological psychodynamic hypothesis.
  • [MeSH-major] Meningeal Neoplasms / psychology. Meningioma / psychology. Transference (Psychology)
  • [MeSH-minor] Adult. Depression / psychology. Humans. Male

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16521717.001).
  • [ISSN] 1660-9379
  • [Journal-full-title] Revue médicale suisse
  • [ISO-abbreviation] Rev Med Suisse
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


26. Hashemi M, Schick U, Hassler W, Hefti M: Tentorial meningiomas with special aspect to the tentorial fold: management, surgical technique, and outcome. Acta Neurochir (Wien); 2010 May;152(5):827-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present our experience with this rare tumor entity and demonstrate the surgical outcome related to a topographical classification.
  • The cases were classified according to tumor extension in three different types: type I, TF meningiomas with compression of the brain stem; type II, with extension into the anterior portion of middle fossa; and type III, a combination of type I and II.
  • Depending on tumor location, surgical approaches consisted of pterional (nine cases), subtemporal (nine cases), or combined subtemporal-pterional craniotomies (three cases).
  • RESULTS: Tumor size ranged from 1 to 6 cm in diameter, with a median at 2.5 cm.
  • Extent of tumor resection was Simpson grade II in 19 patients, grade III in one patient, and grade IV in one patient.
  • [MeSH-major] Cranial Fossa, Middle / surgery. Dura Mater / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Neurosurgical Procedures / methods. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Anisocoria / etiology. Ataxia / etiology. Blepharoptosis / etiology. Cerebrovascular Disorders / etiology. Cerebrovascular Disorders / pathology. Cerebrovascular Disorders / surgery. Cranial Nerve Diseases / etiology. Cranial Nerve Diseases / pathology. Cranial Nerve Diseases / surgery. Craniotomy / methods. Decompression, Surgical / methods. Diplopia / etiology. Female. Hemianopsia / etiology. Humans. Male. Middle Aged. Postoperative Complications / epidemiology. Postoperative Complications / prevention & control. Radiotherapy / standards. Retrospective Studies. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20148271.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


27. Lin JW, Ho JT, Lin YJ, Wu YT: Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution. J Neurooncol; 2010 Dec;100(3):465-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution.
  • Chordoid meningioma is an uncommon variant of meningioma, which histologically bears a great resemblance to chordoma and often follows an aggressive clinical course.
  • We examine clinicopathologic features of 11 cases of this rare tumor to further elucidate its behavior.
  • Thirteen specimens of chordoid meningioma belonging to 11 patients were obtained at a single institution from 1995 to 2009.
  • Two patients each had a local tumor recurrence.
  • Lymphoplasmacytic infiltrate was moderate in one tumor (7%), mild in eight tumors (62%), and absent in four tumors (31%).
  • There was a wide range of MIB-1 labeling indices (0.3-25.8%, mean 7.5%), which increased following tumor recurrence.
  • [MeSH-major] Choroid Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Antigens, CD / metabolism. Female. Humans. Ki-67 Antigen / metabolism. Male. Middle Aged. Mucin-1 / metabolism. Retrospective Studies. Taiwan

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurooncol. 2011 Aug;104(1):395-7 [21136280.001]
  • [Cites] J Neurooncol. 2006 Jul;78(3):263-9 [16628477.001]
  • [Cites] Acta Neuropathol. 2005 May;109(5):497-502 [15864611.001]
  • [Cites] Clin Neurol Neurosurg. 2008 Jul;110(7):743-6 [18514392.001]
  • [Cites] Eur J Histochem. 1995;39(1):21-30 [7612954.001]
  • [Cites] J Neurosurg. 2001 Jan;94(1):122-6 [11147880.001]
  • [Cites] Mod Pathol. 2005 Nov;18(11):1490-7 [15990898.001]
  • [Cites] J Neurosurg Spine. 2005 Feb;2(2):195-8 [15739533.001]
  • [Cites] Pathol Int. 2006 Jul;56(7):397-401 [16792549.001]
  • [Cites] Ultrastruct Pathol. 2006 Jul-Aug;30(4):309-14 [16971356.001]
  • [Cites] Virchows Arch. 2006 Apr;448(4):493-9 [16411134.001]
  • [Cites] Clin Neuropathol. 2004 Nov-Dec;23(6):277-85 [15584212.001]
  • [Cites] Arq Neuropsiquiatr. 2003 Mar;61(1):91-4 [12715027.001]
  • [Cites] J Neurosurg. 2005 Sep;103(3):555-8 [16235690.001]
  • [Cites] J Neurosurg. 2005 Apr;102(4):733-7 [15871519.001]
  • [Cites] Int Ophthalmol. 2008 Oct;28(5):355-7 [17898939.001]
  • [Cites] J Neurosurg Pediatr. 2008 Oct;2(4):269-72 [18831662.001]
  • [Cites] Acta Neuropathol. 1989;79(2):211-6 [2596270.001]
  • [Cites] Brain Tumor Pathol. 2000;17 (3):153-7 [11310923.001]
  • [Cites] Brain Tumor Pathol. 2009;26(1):37-42 [19408096.001]
  • [Cites] Neurol India. 2003 Dec;51(4):522-4 [14742937.001]
  • [Cites] J Neurooncol. 1994;18(3):199-206 [7525890.001]
  • [Cites] Adv Anat Pathol. 2006 Mar;13(2):83-8 [16670463.001]
  • [Cites] J Neurosurg. 1998 Feb;88(2):319-23 [9452243.001]
  • [Cites] J Neurooncol. 2008 May;88(1):115-20 [18320142.001]
  • [Cites] J Neurooncol. 2009 Dec;95(3):445-447 [19557500.001]
  • [Cites] Pathol Res Pract. 2001;197(7):515-8; discussion 519 [11482583.001]
  • [Cites] Proc Natl Acad Sci U S A. 1986 Jul;83(14):5291-5 [3523489.001]
  • [Cites] Am J Surg Pathol. 2000 Jul;24(7):899-905 [10895812.001]
  • [Cites] Acta Neuropathol. 2007 Jan;113(1):87-94 [17021752.001]
  • [Cites] Neurosurgery. 2005 Nov;57(5):E1064; discussion E1064 [16284544.001]
  • [Cites] Lancet. 2004 May 8;363(9420):1535-43 [15135603.001]
  • [Cites] Am J Surg Pathol. 2009 May;33(5):669-81 [19194275.001]
  • [Cites] Neuropathology. 2004 Sep;24(3):243-7 [15484703.001]
  • [Cites] Am J Pathol. 1997 Oct;151(4):1141-52 [9327748.001]
  • [Cites] Cancer. 1988 Jul 15;62(2):391-406 [3383139.001]
  • [Cites] Am J Pathol. 2005 Mar;166(3):913-21 [15743802.001]
  • (PMID = 20454999.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Ki-67 Antigen; 0 / Mucin-1
  •  go-up   go-down


28. Lee JW, Kang KW, Park SH, Lee SM, Paeng JC, Chung JK, Lee MC, Lee DS: 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging; 2009 Oct;36(10):1574-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma.
  • PURPOSE: The purpose of this study was to investigate the role of (18)F-fluorodeoxyglucose (FDG) PET in detecting high-grade meningioma and predicting the recurrence in patients with meningioma after surgical resection.
  • METHODS: Fifty-nine patients (27 men and 32 women) with intracranial meningioma who underwent preoperative FDG PET and subsequent surgical resection were enrolled.
  • All patients underwent clinical follow-up for tumor recurrence with a mean duration of 34+/-20 months.
  • The tumor to gray matter ratio (TGR) of FDG uptake was calculated and a receiver-operating characteristic (ROC) curve of the TGR was drawn to determine the cutoff value of the TGR for detection of high-grade meningioma.
  • Further, univariate analysis with the log-rank test was performed to assess the predictive factors of meningioma recurrence.
  • RESULTS: The TGR in high-grade meningioma (WHO grade II and III) was significantly higher than that in low-grade ones (WHO grade I) (p=0.002) and significantly correlated with the MIB-1 labeling index (r=0.338, p=0.009) and mitotic count of the tumor (r=0.284, p=0.03).
  • The ROC analysis revealed that the TGR of 1.0 was the best cutoff value for detecting high-grade meningioma with a sensitivity of 43%, specificity of 95%, and accuracy of 81%.
  • In the log-rank test, the TGR, MIB-1 labeling index, presence of brain invasion, and WHO grade were significantly associated with tumor recurrence.
  • The cumulative recurrence-free survival rate of patients with a TGR of 1.0 or less was significantly higher than that of patients with a TGR of more than 1.0 (p=0.0003) CONCLUSION: FDG uptake in meningioma was the significant predictive factor of tumor recurrence and significantly correlated with the proliferative potential of the tumor.
  • [MeSH-major] Brain Neoplasms / diagnostic imaging. Fluorodeoxyglucose F18. Meningioma / diagnostic imaging. Radiopharmaceuticals
  • [MeSH-minor] Adult. Aged. Disease-Free Survival. Female. Fluorine Radioisotopes. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / diagnostic imaging. Positron-Emission Tomography. ROC Curve

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Neurol. 2004 Feb;61(2):149-55; discussion 155-6 [14751627.001]
  • [Cites] Radiology. 1987 Aug;164(2):521-6 [3496626.001]
  • [Cites] Neurol Res. 1999 Oct;21(7):640-4 [10555183.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):176-82 [11926379.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):339-44 [16765533.001]
  • [Cites] J Neurosurg. 1992 Oct;77(4):616-23 [1527622.001]
  • [Cites] Semin Nucl Med. 2003 Apr;33(2):148-62 [12756647.001]
  • [Cites] Radiology. 2004 May;231(2):305-32 [15044750.001]
  • [Cites] Radiol Clin North Am. 2005 Jan;43(1):35-47 [15693646.001]
  • [Cites] Eur J Nucl Med. 2000 May;27(5):542-9 [10853810.001]
  • [Cites] Crit Rev Oncol Hematol. 2008 Aug;67(2):153-71 [18342535.001]
  • [Cites] J Clin Neurosci. 2007 Aug;14(8):747-53 [17499508.001]
  • [Cites] J Clin Oncol. 2005 Feb 20;23(6):1136-43 [15718309.001]
  • [Cites] J Neurosurg. 1998 May;88(5):831-9 [9576250.001]
  • [Cites] Radiology. 1995 Apr;195(1):47-52 [7892494.001]
  • [Cites] Int J Oncol. 2001 Jul;19(1):53-8 [11408922.001]
  • [Cites] Cancer. 1994 May 1;73(9):2386-94 [8168042.001]
  • [Cites] Eur J Nucl Med. 2000 Dec;27(12 ):1793-9 [11189942.001]
  • [Cites] Surg Neurol. 1986 Mar;25(3):233-42 [3945904.001]
  • [Cites] Mol Imaging Biol. 2008 Jan-Feb;10(1):1-18 [17957408.001]
  • [Cites] Ann Thorac Surg. 2004 Oct;78(4):1152-60; discussion 1152-60 [15464463.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):57-61 [10656373.001]
  • [Cites] Acta Neurochir Suppl. 1996;65:108-11 [8738510.001]
  • [Cites] J Nucl Med. 1997 Jan;38(1):26-30 [8998144.001]
  • [Cites] J Neurooncol. 2003 Sep;64(3):227-37 [14558598.001]
  • [Cites] J Neurosurg Sci. 1985 Jan-Mar;29(1):11-7 [4067631.001]
  • [Cites] Neurosurg Focus. 2007;23(4):E3 [17961040.001]
  • [Cites] Cancer. 1988 Sep 15;62(6):1074-8 [3261622.001]
  • (PMID = 19377904.001).
  • [ISSN] 1619-7089
  • [Journal-full-title] European journal of nuclear medicine and molecular imaging
  • [ISO-abbreviation] Eur. J. Nucl. Med. Mol. Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


29. Lehnhardt FG, Bock C, Röhn G, Ernestus RI, Hoehn M: Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed; 2005 Oct;18(6):371-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
  • Spectroscopic features of tumor types, as determined on samples of the primary occurrences, were in good agreement with previous studies.
  • Metabolic changes of an evolving tumor were observed in recurrent astrocytomas: owing to their consecutive assessments, more indicators of malignant degeneration were detected in astrocytoma recurrences (e.g.
  • The present investigation demonstrated a correlation of the tCho-signal with tumor progression.
  • This may be related to an early stage of malignant transformation, not yet detectable morphologically, and emphasizes the high sensitivity of 1H NMR spectroscopy in elucidating characteristics of brain tumor metabolism.
  • [MeSH-major] Astrocytoma / metabolism. Biomarkers, Tumor / metabolism. Brain Neoplasms / metabolism. Glioblastoma / metabolism. Magnetic Resonance Spectroscopy / methods. Meningioma / metabolism. Neoplasm Recurrence, Local / metabolism
  • [MeSH-minor] Adult. Humans. Middle Aged. Protons

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 John Wiley & Sons, Ltd
  • (PMID = 15959923.001).
  • [ISSN] 0952-3480
  • [Journal-full-title] NMR in biomedicine
  • [ISO-abbreviation] NMR Biomed
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Protons
  •  go-up   go-down


30. McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY: A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg; 2010 May;112(5):925-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
  • METHODS: Records of 216 patients with WHO Grade I, II, or III meningioma that were initially treated between 1965 and 2001 were retrospectively reviewed.
  • Unexpectedly, patients with non-skull base tumors who experienced a recurrence (8 of 22 [36%]) were more likely than patients with skull base tumors (1 of 19 [5%]) to have a higher grade tumor at recurrence (p = 0.024).
  • [MeSH-major] Brain Neoplasms / pathology. Meningioma / pathology. Neoplasm Recurrence, Local. Skull Base Neoplasms / pathology. World Health Organization
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease Progression. Female. Humans. Male. Middle Aged. Neoplasm Staging. Neurosurgical Procedures. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19799498.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Terry MB, Howe G, Pogoda JM, Zhang FF, Ahlbom A, Choi W, Giles GG, Little J, Lubin F, Menegoz F, Ryan P, Schlehofer B, Preston-Martin S: An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol; 2009 Mar;19(3):161-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group.
  • PURPOSE: Existing studies of diet and adult brain tumors have been limited by small numbers in histology-specific subgroups.
  • Dietary data from an international collaborative case-control study on adult brain tumors were used to evaluate associations between histology-specific risk and consumption of specific food groups.
  • Of the 1548 cases, 1185 were gliomas, 332 were meningiomas, and 31 were other tumor types.
  • We also found positive associations between egg, grain, and citrus fruit consumption and glioma but not meningioma risk.
  • CONCLUSIONS: Our study suggests that selected dietary food groups may be associated with adult gliomas and its subtypes but not meningiomas.

  • Genetic Alliance. consumer health - Brain Tumor, Adult.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Epidemiol. 2000 May 15;151(10):939-45 [10853631.001]
  • [Cites] Int J Cancer. 1992 Apr 22;51(1):20-7 [1563840.001]
  • [Cites] Eur J Cancer. 2002 Mar;38(5):696-704 [11916553.001]
  • [Cites] Cancer Causes Control. 2002 Sep;13(7):647-55 [12296512.001]
  • [Cites] Cancer Causes Control. 2004 Feb;15(1):99-100 [15049327.001]
  • [Cites] J Natl Cancer Inst. 1980 Jul;65(1):67-73 [6930521.001]
  • [Cites] J Natl Cancer Inst. 1983 May;70(5):863-6 [6573530.001]
  • [Cites] IARC Sci Publ. 1984;(57):887-94 [6533073.001]
  • [Cites] Int J Cancer. 1993 Feb 20;53(4):561-5 [8436429.001]
  • [Cites] Int J Cancer. 1994 Nov 1;59(3):357-62 [7927941.001]
  • [Cites] Cancer Causes Control. 1997 Jan;8(1):3-4 [9051316.001]
  • [Cites] Cancer Causes Control. 1997 Jan;8(1):5-12 [9051317.001]
  • [Cites] Cancer Causes Control. 1997 Jan;8(1):13-24 [9051318.001]
  • [Cites] Am J Epidemiol. 1997 Nov 15;146(10):832-41 [9384204.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):635-8 [9681534.001]
  • [Cites] Int J Epidemiol. 1998 Aug;27(4):579-86 [9758110.001]
  • [Cites] Int J Cancer. 1999 Mar 31;81(1):20-3 [10077146.001]
  • [Cites] Am J Clin Nutr. 1999 Jun;69(6):1315S-1321S [10359232.001]
  • [Cites] Int J Cancer. 1999 Jul 19;82(2):155-60 [10389745.001]
  • [Cites] Int J Cancer. 2005 Jan 1;113(1):116-25 [15386358.001]
  • [Cites] Am J Clin Nutr. 2007 Mar;85(3):877-86 [17344512.001]
  • [Cites] Ann Epidemiol. 2009 Mar;19(3):148-60 [19216997.001]
  • [Cites] Biometrics. 1986 Mar;42(1):121-30 [3719049.001]
  • [Cites] Am J Epidemiol. 1986 Oct;124(4):595-602 [3752053.001]
  • [Cites] J Natl Cancer Inst. 1987 Apr;78(4):601-9 [3104645.001]
  • [Cites] IARC Sci Publ. 1989;(96):17-34 [2553598.001]
  • [Cites] IARC Sci Publ. 1991;(105):197-203 [1855850.001]
  • [Cites] Int J Epidemiol. 2001 Apr;30(2):317-9 [11369736.001]
  • (PMID = 19216998.001).
  • [ISSN] 1873-2585
  • [Journal-full-title] Annals of epidemiology
  • [ISO-abbreviation] Ann Epidemiol
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / K07 CA090685; United States / NCI NIH HHS / CA / T32 CA009529; United States / NCI NIH HHS / CA / K07CA90685
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS469516; NLM/ PMC3832293
  •  go-up   go-down


32. Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW: Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry; 2008 May;79(5):574-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To evaluate patient outcome and investigate the prognostic factors of high-grade meningiomas by adopting the 2000 World Health Organization (WHO) classification system.
  • METHODS: Between 1986 and 2004, 74 patients were diagnosed with high-grade meningioma: 33 with atypical and 41 with anaplastic meningioma.
  • We reclassified all surgical specimens, according to the 2000 WHO classification system, using two expert neuropathologists.
  • RESULTS: Forty of 74 meningiomas were reclassified as atypical meningioma and 24 as anaplastic meningioma.
  • Overall and recurrence-free survivals were significantly longer in patients with atypical than in those with anaplastic meningioma: 142.5 versus 39.8 months and 138.5 versus 32.2 months, respectively (p<0.001).
  • In patients with atypical meningiomas, brain invasion and adjuvant radiotherapy were not associated with survival; however, in the brain invasion subgroup, adjuvant radiotherapy improved patients' survival.
  • In patients with anaplastic meningioma, the prognostic factors were brain invasion, adjuvant radiotherapy, malignant progression, p53 overexpression and extent of resection.
  • A precise meningioma grading system may help to avoid over-treatment of patients with an atypical meningioma as, once the tumour has "declared itself" by recurrence and histological features, it becomes a tumour that is poorly amenable to current therapies.
  • [MeSH-major] Meningeal Neoplasms / diagnosis. Meningioma / diagnosis
  • [MeSH-minor] Adult. Aged. Brain / pathology. Combined Modality Therapy. Cranial Irradiation. Disease Progression. Female. Follow-Up Studies. Gene Expression Regulation, Neoplastic / genetics. Humans. Ki-67 Antigen / genetics. Korea. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Recurrence, Local / classification. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Prognosis. Radiotherapy, Adjuvant. Survival Rate. Treatment Outcome. Tumor Suppressor Protein p53 / genetics. World Health Organization

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17766430.001).
  • [ISSN] 1468-330X
  • [Journal-full-title] Journal of neurology, neurosurgery, and psychiatry
  • [ISO-abbreviation] J. Neurol. Neurosurg. Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


33. Dehdashti AR, Ganna A, Witterick I, Gentili F: Expanded endoscopic endonasal approach for anterior cranial base and suprasellar lesions: indications and limitations. Neurosurgery; 2009 Apr;64(4):677-87; discussion 687-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: From June 2005 to June 2007, the expanded endoscopic endonasal approach was used in 22 patients with the following pathologies: 6 craniopharyngiomas; 4 esthesioneuroblastomas; 3 giant pituitary macroadenomas; 2 suprasellar Rathke's pouch cysts; 2 angiofibromas; and 1 each of suprasellar meningioma, germinoma, ethmoidal carcinoma, adenoid cystic carcinoma, and large suprasellar arachnoid cyst.
  • RESULTS: Gross total tumor removal, as assessed by postoperative magnetic resonance imaging, was possible in the majority of patients (73%), with the exception of the craniopharyngioma group, in which only 1 lesion was completely removed.
  • Large lesions, significant lateral extension, encasement of neurovascular structures, and brain invasion in malignant lesions are considered some of the contraindications for this technique.
  • The avoidance of craniotomy and brain retraction and reduced neurovascular manipulation with less morbidity are potential advantages.
  • [MeSH-major] Brain Neoplasms / surgery. Nasal Cavity / surgery. Neuroendoscopy / methods. Neurosurgical Procedures / methods. Sella Turcica / surgery. Skull Base / surgery
  • [MeSH-minor] Adult. Aged. Craniopharyngioma / surgery. Esthesioneuroblastoma, Olfactory / surgery. Female. Humans. Magnetic Resonance Imaging / methods. Male. Middle Aged. Neurofibroma / surgery. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19349826.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Umansky F, Shoshan Y, Rosenthal G, Fraifeld S, Spektor S: Radiation-induced meningioma. Neurosurg Focus; 2008;24(5):E7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-induced meningioma.
  • The long-term or delayed side effects of irradiation on neural tissue are now known to include the induction of new central nervous system neoplasms.
  • Emphasis is placed on meningiomas resulting from childhood treatment for primary brain tumor or tinea capitis, exposure to dental x-rays, and exposure to atomic explosions in Hiroshima and Nagasaki.
  • The authors review the typical presentation of patients with RIMs and discuss unique aspects of the surgical management of these tumors compared with sporadic meningioma, based on their clinical experience in treating these lesions.
  • [MeSH-major] Cranial Irradiation / adverse effects. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology
  • [MeSH-minor] Adolescent. Adult. Alopecia / etiology. Brain Neoplasms / radiotherapy. Child. Cohort Studies. Dose-Response Relationship, Radiation. Female. Humans. Japan / epidemiology. Male. Neoplasm Invasiveness. Neoplasms, Second Primary / etiology. Neoplasms, Second Primary / radiotherapy. Neoplasms, Second Primary / surgery. Nuclear Warfare. Radiation Injuries / epidemiology. Radiation Injuries / etiology. Radiation Injuries / prevention & control. Radiography, Dental / adverse effects. Radiosurgery / adverse effects. Radiotherapy / trends. Tinea Capitis / radiotherapy


35. Yrjänä SK, Tuominen H, Karttunen A, Lähdesluoma N, Heikkinen E, Koivukangas J: Low-field MR imaging of meningiomas including dynamic contrast enhancement study: evaluation of surgical and histopathologic characteristics. AJNR Am J Neuroradiol; 2006 Nov-Dec;27(10):2128-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND PURPOSE: Risks associated with surgery of meningiomas, especially those located in the skull base, are influenced by tumor consistency and vascularity.
  • The purpose of this study was to find out if vascularity, consistency, and histologic characteristics of meningioma can be predicted preoperatively by using low-field MR imaging, including dynamic imaging of contrast enhancement.
  • MATERIALS AND METHODS: Twenty-one patients (mean age, 56; range, 34-73 years; 16 women, 5 men) with meningioma requiring first surgery were imaged by a 0.23T scanner.
  • Relative intensity of tumor in fluid-attenuated inversion recovery (FLAIR) and T2-weighted images was calculated.
  • The neurosurgeon evaluated surgical bleeding and hardness of tumor on a visual analog scale.
  • Surgical bleeding (tau = 0.49, P = .002), blood loss during surgery (tau = 0.49, P = .002), progesterone receptor expression (tau = 0.59, P < .001), and collagen content (tau = -0.54, P < .001) were statistically best correlated with the relative intensity of meningioma on FLAIR images.
  • CONCLUSION: Assessment of microvessel density, collagen content, and progesterone receptor expression of meningioma may be clinically feasible by using low-field MR imaging.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / surgery. Contrast Media. Magnetic Resonance Imaging / methods. Meningioma / diagnosis. Meningioma / surgery
  • [MeSH-minor] Adult. Aged. Humans. Male. Middle Aged. Preoperative Care. Prospective Studies

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17110681.001).
  • [ISSN] 0195-6108
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


36. Tufan K, Dogulu F, Kurt G, Emmez H, Ceviker N, Baykaner MK: Intracranial meningiomas of childhood and adolescence. Pediatr Neurosurg; 2005 Jan-Feb;41(1):1-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Atypical and malignant meningiomas seem to be more common in childhood and adolescence with respect to adult meningiomas.
  • Tumor location, completeness of tumor removal, and pathological grade are the most important prognostic factors.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / surgery. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / surgery. Meningioma / diagnosis. Meningioma / surgery
  • [MeSH-minor] Adolescent. Age Distribution. Brain / pathology. Brain / radiography. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Incidence. Infant. Male. Prognosis. Retrospective Studies. Sex Distribution. Turkey / epidemiology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 S. Karger AG, Basel.
  • (PMID = 15886506.001).
  • [ISSN] 1016-2291
  • [Journal-full-title] Pediatric neurosurgery
  • [ISO-abbreviation] Pediatr Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


37. Apollonsky N, Edelman M, Johnson A, Bhuiya T, Karayalcin G: Intracerebral presentation of Hodgkin disease mimicking meningioma in a young woman: case presentation with literature review. J Pediatr Hematol Oncol; 2008 May;30(5):369-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracerebral presentation of Hodgkin disease mimicking meningioma in a young woman: case presentation with literature review.
  • Until now, 9 cases of initial presentation of the HD as a brain tumor with appropriate morphologic and histochemical confirmation were reported.
  • We describe a patient with systemic nodular sclerosing HD, who initially presented with a brain mass mimicking meningioma and was found to have disseminated lymphadenopathy and bone involvement.
  • [MeSH-major] Brain Neoplasms / pathology. Brain Neoplasms / radiography. Hodgkin Disease / pathology. Hodgkin Disease / radiography. Meningioma / pathology. Meningioma / radiography
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Meningeal Neoplasms / pathology. Meningeal Neoplasms / radiography

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18458571.001).
  • [ISSN] 1077-4114
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 19
  •  go-up   go-down


38. Ozen O, Demirhan B, Altinörs N: Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas. Clin Neuropathol; 2005 Sep-Oct;24(5):219-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to re-evaluate tumors diagnosed as meningioma previously in our hospital, according to the latest World Health Organization classification.
  • We also examined the relationships among parameters such as brain invasion, histological grade and Ki-67 and p53 expression in these tumors.
  • MATERIALS AND METHODS: Meningioma biopsy specimens numbering 60 (48 grade I, 11 grade II, and 1 grade III tumors) were examined immunohistochemically using monoclonal antibodies for Ki-67 (MIB-1) and p53 protein.
  • The MIB-1 labeling index (LI) for each tumor was calculated as a percentage based on the number of stained cells per total cells counted.
  • RESULTS: Of the 60 meningiomas, 7 (11.7%) exhibited brain invasion.
  • The MIB-1 LI and the level of p53 expression in the one grade III meningioma were 6.7% and 10 - 70%, respectively.
  • Brain invasion was not correlated with histological grade, MIB-1 LI, or p53 expression.
  • CONCLUSION: The results indicate that MIB-1 LI and p53 protein expression are good indicators of histological grade in meningioma and may be particularly valuable for distinguishing borderline atypical meningiomas.
  • The number of cases was limited, but the findings also suggest that brain invasion is a prognostic parameter independent of grade, MIB-1 LI and p53 expression.
  • [MeSH-major] Biomarkers, Tumor / analysis. Ki-67 Antigen / biosynthesis. Meningeal Neoplasms / pathology. Meningioma / pathology. Tumor Suppressor Protein p53 / biosynthesis
  • [MeSH-minor] Adult. Aged. Female. Humans. Immunohistochemistry. Male. Middle Aged. Prognosis. Retrospective Studies

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16167545.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


39. Pfisterer WK, Nieman RA, Scheck AC, Coons SW, Spetzler RF, Preul MC: Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas. Neurosurg Focus; 2010 Jan;28(1):E12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECT: The goal in this study was to determine if proton ((1)H) MR spectroscopy can differentiate meningioma grade and is associated with interpretations of biological behavior; the study was performed using ex vivo high-resolution spectra indicating metabolic characteristics.
  • Invasion of adjacent tissue (dura mater, bone, venous sinus, brain) was found in 32 cases.
  • CONCLUSIONS: These data indicate that meningioma tissue can be characterized by metabolic parameters that are not typically identified by histopathological analysis alone.
  • Creatine, glycine, and alanine may be used as markers of meningioma grade, recurrence, and the likelihood of rapid recurrence.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Magnetic Resonance Spectroscopy / methods. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / metabolism. Meningioma / diagnosis. Meningioma / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Alanine / metabolism. Choline / metabolism. Creatine / metabolism. Diagnosis, Differential. Female. Follow-Up Studies. Glutamic Acid / metabolism. Glycine / metabolism. Humans. Male. Middle Aged. Prognosis

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GLUTAMIC ACID HYDROCHLORIDE .
  • Hazardous Substances Data Bank. GLYCINE .
  • Hazardous Substances Data Bank. (L)-ALANINE .
  • Hazardous Substances Data Bank. CREATINE .
  • Hazardous Substances Data Bank. CHOLINE CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20043716.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 3KX376GY7L / Glutamic Acid; MU72812GK0 / Creatine; N91BDP6H0X / Choline; OF5P57N2ZX / Alanine; TE7660XO1C / Glycine
  •  go-up   go-down


40. Deltour I, Johansen C, Auvinen A, Feychting M, Klaeboe L, Schüz J: Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst; 2009 Dec 16;101(24):1721-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003.
  • In Denmark, Finland, Norway, and Sweden, the use of mobile phones increased sharply in the mid-1990s; thus, time trends in brain tumor incidence after 1998 may provide information about possible tumor risks associated with mobile phone use.
  • We investigated time trends in the incidence of glioma and meningioma in Denmark, Finland, Norway, and Sweden from 1974 to 2003, using data from national cancer registries.
  • We used joinpoint regression models to analyze the annual incidence rates of glioma and meningioma.
  • During this period, 59,984 men and women aged 20-79 years were diagnosed with brain tumors in a population of 16 million adults.
  • From 1974 to 2003, the incidence rate of glioma increased by 0.5% per year (95% confidence interval [CI] = 0.2% to 0.8%) among men and by 0.2% per year (95% CI = -0.1% to 0.5%) among women and that of meningioma increased by 0.8% per year (95% CI = 0.4% to 1.3%) among men, and after the early 1990s, by 3.8% per year (95% CI = 3.2% to 4.4%) among women.
  • [MeSH-major] Brain Neoplasms / epidemiology
  • [MeSH-minor] Adult. Aged. Denmark / epidemiology. Female. Finland / epidemiology. Glioma / epidemiology. Humans. Incidence. Male. Meningeal Neoplasms / epidemiology. Meningioma / epidemiology. Middle Aged. Norway / epidemiology. Registries. Sweden / epidemiology. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Natl Cancer Inst. 2010 May 19;102(10):740-1; author reply 742-3 [20403845.001]
  • [CommentIn] J Natl Cancer Inst. 2010 May 19;102(10):741-2; author reply 742-3 [20403846.001]
  • (PMID = 19959779.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


41. Takanashi M, Fukuoka S, Hojyo A, Sasaki T, Nakagawara J, Nakamura H: Gamma knife radiosurgery for skull-base meningiomas. Prog Neurol Surg; 2009;22:96-111
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The overall tumor control rates were 95.5% in CSMs and 98.4% in PFMs.
  • CONCLUSION: Our results indicate that GKRS is a safe and effective primary treatment for SBMs with small to moderate tumor volumes.
  • We also found that larger SBMs compressing the optic pathway or brain stem can be effectively treated, minimizing any possible functional damage, by a combination of partial resection with subsequent GKRS.
  • [MeSH-major] Meningeal Neoplasms / surgery. Meningioma / surgery. Radiosurgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cavernous Sinus / pathology. Cavernous Sinus / surgery. Cerebellopontine Angle / pathology. Cerebellopontine Angle / surgery. Decision Making. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Radiation Dosage. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18948722.001).
  • [ISSN] 0079-6492
  • [Journal-full-title] Progress in neurological surgery
  • [ISO-abbreviation] Prog Neurol Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


42. Fukushima S, Terasaki M, Shigemori M: Chordoid meningioma arising in the pineal region: a case report. Brain Tumor Pathol; 2008;25(2):91-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chordoid meningioma arising in the pineal region: a case report.
  • We report a rare case of chordoid meningioma arising in the pineal region, which presented in a 22-year-old woman.
  • We performed subtotal removal of the tumor with an occipital transtentorial approach (OTA), and all her preoperative symptoms completely abated.
  • Histological examination of this tumor specimen showed the typical pattern of chordoid meningioma.
  • Chordoid meningioma has been known to correspond with Castleman's disease, and pineal meningiomas are extremely rare among intracranial meningiomas.
  • [MeSH-major] Meningioma / pathology. Pinealoma / pathology
  • [MeSH-minor] Adult. Anemia / blood. Anemia / complications. Angiography. Blood Cell Count. Blood Chemical Analysis. C-Reactive Protein / metabolism. Contrast Media. Female. Gadolinium DTPA. Headache / etiology. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Tissue Fixation

  • Genetic Alliance. consumer health - Meningioma.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18987835.001).
  • [ISSN] 1433-7398
  • [Journal-full-title] Brain tumor pathology
  • [ISO-abbreviation] Brain Tumor Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media; 9007-41-4 / C-Reactive Protein; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


43. Nakaya K, Niranjan A, Kondziolka D, Kano H, Khan AA, Nettel B, Koebbe C, Pirris S, Flickinger JC, Lunsford LD: Gamma knife radiosurgery for benign tumors with symptoms from brainstem compression. Int J Radiat Oncol Biol Phys; 2010 Jul 15;77(4):988-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Median tumor volumes were 3.9 cm(3) (range, 0.8-39.0 mL) and 6.6 mL (range, 1.6-25.1 mL) for vestibular schwannomas and meningiomas, respectively.
  • Patients were categorized into four groups on the basis of the tumor-brainstem relationship on neuroimaging.
  • The tumor control rate was 100 % for meningioma and 97% for vestibular schwannomas (although 5% required an additional procedure such as a ventriculoperitoneal shunt).
  • Balance improved significantly in patients who had less tumor compression (p = 0.0357) after radiosurgery.
  • Symptoms improved in 43.2% of patients with meningioma.
  • A high tumor growth control rate and satisfactory rate of neurological preservation and symptom control can be obtained with radiosurgery.
  • [MeSH-major] Brain Stem. Meningeal Neoplasms / surgery. Meningioma / surgery. Neuroma, Acoustic / surgery. Radiosurgery / methods. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Analysis of Variance. Constriction, Pathologic / surgery. Female. Humans. Male. Middle Aged. Statistics, Nonparametric. Young Adult

  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20381265.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Pećina-Slaus N, Nikuseva Martić T, Tomas D, Beros V, Zeljko M, Cupić H: Meningiomas exhibit loss of heterozygosity of the APC gene. J Neurooncol; 2008 Mar;87(1):63-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study 33 meningiomas were analyzed regarding genetic changes of tumor suppressor gene Adenomatous polyposis coli (APC), a component of the wnt signaling.
  • The changes were distributed according to pathohistological grade as follows: 46% of meningothelial meningioma showed LOH; 33% of fibrous; 75% of mixed (transitional); 75% of angiomatous, and one LOH was found in a single case of psammomatous meningioma.
  • The results of this investigation suggest that genetic changes of APC gene play a role in meningioma formation.
  • [MeSH-major] Genes, APC. Loss of Heterozygosity. Meningeal Neoplasms / genetics. Meningioma / genetics
  • [MeSH-minor] Adult. Aged. Female. Humans. Immunohistochemistry. Male. Middle Aged. Polymorphism, Restriction Fragment Length

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 [11895036.001]
  • [Cites] Clin Neuropathol. 2005 Jan-Feb;24(1):8-12 [15696778.001]
  • [Cites] Nature. 2005 Oct 27;437(7063):1370-5 [16251967.001]
  • [Cites] Science. 1998 Sep 4;281(5382):1509-12 [9727977.001]
  • [Cites] J Biol Chem. 2006 Aug 11;281(32):22429-33 [16793760.001]
  • [Cites] Histopathology. 2006 Aug;49(2):178-87 [16879395.001]
  • [Cites] Neurosurgery. 2004 Nov;55(5):1163-73 [15509323.001]
  • [Cites] Cell. 1991 Aug 9;66(3):589-600 [1651174.001]
  • [Cites] Nat Neurosci. 2003 Nov;6(11):1169-77 [14528308.001]
  • [Cites] Genes Chromosomes Cancer. 1994 Mar;9(3):168-72 [7515658.001]
  • [Cites] J Neurobiol. 2005 Sep 15;64(4):458-75 [16041741.001]
  • [Cites] Science. 2000 Mar 3;287(5458):1606-9 [10733430.001]
  • [Cites] Virchows Arch. 1998 Feb;432(2):163-7 [9504862.001]
  • [Cites] Cancer Cell Int. 2003 Oct 14;3(1):17 [14613514.001]
  • [Cites] N Engl J Med. 1995 Mar 30;332(13):839-47 [7661930.001]
  • [Cites] Curr Opin Neurobiol. 2000 Jun;10(3):392-9 [10851180.001]
  • [Cites] Neuroscience. 1999;91(2):661-72 [10366023.001]
  • [Cites] Adv Anat Pathol. 2005 Jul;12(4):180-94 [16096380.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):183-202 [15674477.001]
  • [Cites] Pathology. 2004 Apr;36(2):145-51 [15203750.001]
  • [Cites] Cell. 2000 Mar 3;100(5):525-35 [10721990.001]
  • [Cites] Int J Cancer. 2001 Aug 1;93(3):445-9 [11433413.001]
  • [Cites] Cancer Lett. 2002 Sep 8;183(1):95-101 [12049819.001]
  • [Cites] Int J Cancer. 2005 Mar 20;114(2):249-56 [15540215.001]
  • [Cites] Lancet Neurol. 2006 Dec;5(12):1045-54 [17110285.001]
  • (PMID = 18066497.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


45. Mawrin C, Perry A: Pathological classification and molecular genetics of meningiomas. J Neurooncol; 2010 Sep;99(3):379-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Meningiomas are extremely common adult brain tumors originating from meningeal coverings of the brain and spinal cord.
  • While most are slowly growing Word Health organization (WHO) grade I tumors, rare variants (clear cell, chordoid, papillary, and rhabdoid), as well as brain invasive (WHO grade II), atypical (WHO grade II), and anaplastic (WHO grade III) meningiomas are considerably more aggressive.
  • Early stages of meningioma tumorigenesis are closely linked to inactivation of one or more members of the 4.1 superfamily, including the neurofibromatosis type 2 (NF2) and 4.1B (DAL-1) genes, which interact with the 14-3-3 protein family.
  • In addition to alterations of CDKN2A, p14(ARF), and CDKN2B tumor suppressor genes on 9p21, a contribution of the wingless (wnt) pathway with alterations of the E-cadherin and beta-catenin proteins, as well as alterations of the hedgehog signaling pathway have been implicated in anaplastic meningiomas.
  • The integration of histopathological appearance, complex genetic/genomic data, and outcome will likely result in the identification of clinically distinct meningioma subgroups, which in turn can facilitate the development of targeted therapeutic strategies.
  • [MeSH-major] Meningeal Neoplasms / classification. Meningeal Neoplasms / genetics. Meningioma / classification. Meningioma / genetics

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Genet Cytogenet. 2005 Oct 15;162(2):135-9 [16213361.001]
  • [Cites] Hum Pathol. 2005 Apr;36(4):416-25 [15892004.001]
  • [Cites] Surg Neurol. 1987 Apr;27(4):319-22 [3824137.001]
  • [Cites] Neurosurgery. 2009 Jan;64(1):56-60; discussion 60 [19145156.001]
  • [Cites] Clin Neuropathol. 2009 Nov-Dec;28(6):453-9 [19919820.001]
  • [Cites] Minim Invasive Neurosurg. 2009 Oct;52(5-6):216-21 [20077361.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):183-90 [11958372.001]
  • [Cites] J Neurooncol. 2008 Mar;87(1):63-70 [18066497.001]
  • [Cites] Brain Res. 2010 Jun 8;1336:98-102 [20388496.001]
  • [Cites] J Neurooncol. 2010 Aug;99(1):41-8 [20094774.001]
  • [Cites] Cancer Res. 2005 Apr 1;65(7):2653-61 [15805262.001]
  • [Cites] Brain Pathol. 2004 Oct;14(4):457-9 [15605995.001]
  • [Cites] J Neurosurg. 1997 May;86(5):853-8 [9126902.001]
  • [Cites] Mol Med. 2010 Jul-Aug;16(7-8):262-70 [20386868.001]
  • [Cites] J Neurooncol. 2008 Mar;87(1):43-50 [18060363.001]
  • [Cites] Cancer Genet Cytogenet. 2010 Jan 1;196(1):1-6 [19963129.001]
  • [Cites] Mod Pathol. 2004 Jun;17 (6):705-10 [15073599.001]
  • [Cites] Clin Neuropathol. 1995 Nov-Dec;14(6):327-30 [8605738.001]
  • [Cites] Br J Neurosurg. 2007 Dec;21(6):588-92 [18071986.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):180-4 [8162072.001]
  • [Cites] J Pathol. 2001 Jul;194(3):367-72 [11439370.001]
  • [Cites] Neurology. 2010 Apr 27;74(17):1396 [20421586.001]
  • [Cites] J Neurosurg. 1991 Jan;74(1):129-32 [1984492.001]
  • [Cites] Am J Pathol. 2001 Aug;159(2):661-9 [11485924.001]
  • [Cites] Cancer Sci. 2009 Dec;100(12):2235-41 [19737147.001]
  • [Cites] Brain Tumor Pathol. 2009;26(2):69-72 [19856217.001]
  • [Cites] J Clin Neurosci. 2010 Feb;17(2):253-5 [20036547.001]
  • [Cites] Virchows Arch. 1998 Feb;432(2):163-7 [9504862.001]
  • [Cites] Am J Surg Pathol. 1997 Dec;21(12):1455-65 [9414189.001]
  • [Cites] Cancer Genet Cytogenet. 2008 Jul 15;184(2):87-93 [18617056.001]
  • [Cites] Am J Pathol. 1995 Apr;146(4):827-32 [7717450.001]
  • [Cites] J Neuropathol Exp Neurol. 1995 Sep;54(5):698-703 [7666059.001]
  • [Cites] Cancer Genet Cytogenet. 2005 Oct 1;162(1):63-7 [16157202.001]
  • [Cites] N Engl J Med. 2007 Nov 1;357(18):1821-8 [17978290.001]
  • [Cites] J Neurooncol. 2010 Dec;100(3):465-73 [20454999.001]
  • [Cites] Cancer. 1998 Jun 1;82(11):2262-9 [9610708.001]
  • [Cites] Pathology. 2009;41(7):649-54 [19672786.001]
  • [Cites] Neurosurgery. 2008 Oct;63(4):771-80; discussion 780-1 [18981889.001]
  • [Cites] J Neurosurg. 1986 Jan;64(1):58-63 [3941351.001]
  • [Cites] Cancer Res. 2010 Mar 15;70(6):2350-8 [20179190.001]
  • [Cites] Brain Pathol. 2006 Jan;16(1):15-9 [16612978.001]
  • [Cites] Hum Pathol. 2010 Feb;41(2):199-207 [19801161.001]
  • [Cites] PLoS One. 2010 Jun 21;5(6):e11231 [20574529.001]
  • [Cites] Genes Chromosomes Cancer. 2005 Mar;42(3):314-9 [15609345.001]
  • [Cites] Brain Tumor Pathol. 2009;26(2):51-7 [19856215.001]
  • [Cites] Virchows Arch. 2010 Apr;456(4):343-54 [20165866.001]
  • [Cites] Oncogene. 2004 Apr 29;23(20):3589-96 [15116094.001]
  • [Cites] Hum Mol Genet. 1994 Aug;3(8):1393-9 [7987321.001]
  • [Cites] J Neuropathol Exp Neurol. 2009 Oct;68(10):1155-65 [19918127.001]
  • [Cites] Am J Surg Pathol. 2000 Jul;24(7):899-905 [10895812.001]
  • [Cites] Int J Cancer. 2001 Oct 15;94(2):218-21 [11668501.001]
  • [Cites] Brain Pathol. 2010 May;20(3):623-31 [19922547.001]
  • [Cites] Histol Histopathol. 2010 Mar;25(3):341-9 [20054806.001]
  • [Cites] Cancer Res. 1997 Jun 15;57(12):2369-72 [9192811.001]
  • [Cites] Am J Surg Pathol. 2001 Apr;25(4):472-8 [11257621.001]
  • [Cites] Am J Clin Pathol. 2001 Feb;115(2):213-8 [11211609.001]
  • [Cites] Mol Cell Biol. 2005 Nov;25(22):10052-9 [16260618.001]
  • [Cites] Brain Pathol. 2005 Apr;15(2):109-15 [15912882.001]
  • [Cites] J Pathol. 2006 Mar;208(4):564-73 [16353169.001]
  • [Cites] J Neurooncol. 2009 Dec;95(3):367-375 [19562258.001]
  • [Cites] Cancer. 1999 May 1;85(9):2046-56 [10223247.001]
  • [Cites] Nat Med. 1998 Aug;4(8):915-22 [9701243.001]
  • [Cites] Hum Pathol. 1998 Feb;29(2):140-5 [9490273.001]
  • [Cites] Cancer Invest. 2006 Dec;24(8):727-33 [17162554.001]
  • [Cites] J Neurosurg Sci. 2003 Sep;47(3):167-71; discussion 171 [14618130.001]
  • [Cites] Cancer Genet Cytogenet. 2007 Apr 1;174(1):48-53 [17350466.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] J Neurosurg. 1994 Sep;81(3):466-71 [8057157.001]
  • [Cites] Cancer Genet Cytogenet. 2008 May;183(1):14-20 [18474292.001]
  • [Cites] Brain Pathol. 2010 Jul;20(4):751-62 [20015288.001]
  • [Cites] Mol Cancer. 2007 Oct 15;6:64 [17937814.001]
  • [Cites] Int J Cancer. 2003 Feb 10;103(4):483-8 [12478663.001]
  • [Cites] Int J Oncol. 2010 Apr;36(4):983-90 [20198344.001]
  • [Cites] J Cancer Res Clin Oncol. 2010 May;136(5):695-702 [19908067.001]
  • [Cites] Orphanet J Rare Dis. 2006 Oct 02;1:38 [17014705.001]
  • [Cites] Clin Neuropathol. 2001 Sep-Oct;20(5):190-5 [11594503.001]
  • [Cites] J Clin Oncol. 2008 Oct 1;26(28):4688-90 [18824717.001]
  • [Cites] Mol Cell Biol. 2009 Nov;29(21):5923-40 [19703993.001]
  • [Cites] Am J Surg Pathol. 1998 Dec;22(12):1482-90 [9850174.001]
  • [Cites] J Neuropathol Exp Neurol. 2004 Oct;63(10):1015-27 [15535129.001]
  • [Cites] Am J Surg Pathol. 2004 Nov;28(11):1532-6 [15489659.001]
  • [Cites] J Neurosurg. 2004 Aug;101(2):210-8 [15309910.001]
  • [Cites] Ann Neurol. 2004 Aug;56(2):295-8 [15293284.001]
  • [Cites] Cancer. 1988 Jul 15;62(2):391-406 [3383139.001]
  • [Cites] BMC Genomics. 2007 Jan 12;8:16 [17222329.001]
  • [Cites] Cancer Res. 2005 Aug 15;65(16):7121-6 [16103061.001]
  • [Cites] Surg Neurol. 1986 Nov;26(5):461-9 [3764651.001]
  • [Cites] Int J Cancer. 2005 Mar 20;114(2):249-56 [15540215.001]
  • [Cites] Hum Mol Genet. 2000 Jun 12;9(10):1495-500 [10888600.001]
  • [Cites] Cancer. 2001 Aug 1;92(3):701-11 [11505418.001]
  • (PMID = 20809251.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  •  go-up   go-down


46. Righi V, Andronesi OC, Mintzopoulos D, Black PM, Tzika AA: High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors. Int J Oncol; 2010 Feb;36(2):301-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.
  • The non-essential amino acid neurotransmitter glycine (Gly) may serve as a biomarker for brain tumors.
  • Using 36 biopsies from patients with brain tumors [12 glioblastoma multiforme (GBM); 10 low-grade (LG), including 7 schwannoma and 3 pylocytic astrocytoma; 7 meningioma (MN); 7 brain metastases (MT), including 3 adenocarcinoma and 4 breast cancer] and 9 control biopsies from patients undergoing surgery for epilepsy, we tested the hypothesis that the presence of glycine may distinguish among these brain tumor types.
  • Quantitative analysis revealed higher levels of Gly in tumor biopsies (all combined) relative to controls; Gly levels were significantly elevated in LG, MT and GBM biopsies (P<or=0.05).
  • We conclude from these findings that Gly can serve as a biomarker for brain tumors and that the Gly:Myo ratio may be a useful index for brain tumor classification.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GLYCINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11528-33 [11016963.001]
  • [Cites] Radiology. 2008 Sep;248(3):1028-35 [18710991.001]
  • [Cites] Nat Med. 2000 Nov;6(11):1287-9 [11062544.001]
  • [Cites] Radiology. 2001 May;219(2):316-33 [11323453.001]
  • [Cites] Eur Radiol. 2001;11(9):1784-91 [11511902.001]
  • [Cites] Eur Radiol. 2002 Apr;12(4):858-61 [11960238.001]
  • [Cites] Pediatr Res. 2002 Aug;52(2):292-300 [12149509.001]
  • [Cites] J Neurochem. 2002 Aug;82(4):736-54 [12358779.001]
  • [Cites] Magn Reson Med. 2003 Jan;49(1):29-36 [12509817.001]
  • [Cites] J Neurosurg. 2003 Feb;98(2):269-76 [12593610.001]
  • [Cites] Eur Radiol. 2003 Mar;13(3):582-91 [12594562.001]
  • [Cites] Biol Psychiatry. 2004 Jan 15;55(2):165-71 [14732596.001]
  • [Cites] Biol Psychiatry. 1988 Jan 15;23(2):210-1 [3334889.001]
  • [Cites] Magn Reson Med. 1992 Mar;24(1):123-36 [1556919.001]
  • [Cites] Neurosurgery. 1994 Oct;35(4):606-13; discussion 613-4 [7808603.001]
  • [Cites] MAGMA. 1996 Jun;4(2):139-50 [8875400.001]
  • [Cites] Br J Psychiatry. 1996 Nov;169(5):610-7 [8932891.001]
  • [Cites] NMR Biomed. 1997 Jan;10(1):2-12 [9251109.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Oct 9;251(1):277-82 [9790946.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1696-704 [15569733.001]
  • [Cites] NMR Biomed. 2005 Oct;18(6):371-82 [15959923.001]
  • [Cites] Biochem Soc Trans. 2006 Feb;34(Pt 1):55-8 [16417482.001]
  • [Cites] Magn Reson Med. 2006 Mar;55(3):681-6 [16453318.001]
  • [Cites] NMR Biomed. 2006 Apr;19(2):223-30 [16485320.001]
  • [Cites] NMR Biomed. 2006 Apr;19(2):255-63 [16541464.001]
  • [Cites] Magn Reson Med. 2006 Jun;55(6):1257-64 [16685733.001]
  • [Cites] Int J Mol Med. 2007 Aug;20(2):199-208 [17611638.001]
  • [Cites] Neoplasia. 2007 Nov;9(11):882-92 [18030356.001]
  • [Cites] NMR Biomed. 2008 Mar;21(3):233-41 [17562554.001]
  • [Cites] Magn Reson Med. 2008 Sep;60(3):727-31 [18727088.001]
  • [Cites] Magn Reson Med. 2008 Oct;60(4):782-9 [18816828.001]
  • [Cites] MAGMA. 2009 Feb;22(1):33-41 [18830648.001]
  • [Cites] MAGMA. 2009 Feb;22(1):1-4 [18949497.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Oct;21(9):1645-9 [11039343.001]
  • (PMID = 20043062.001).
  • [ISSN] 1791-2423
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / P50 GM021700; United States / NIGMS NIH HHS / GM / P50GM021700
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 4L6452S749 / Inositol; TE7660XO1C / Glycine
  • [Other-IDs] NLM/ PMC3715372
  •  go-up   go-down


47. Pirouzmand F, Sadanand V: The incidence trends of primary brain tumors in Saskatchewan from 1970 to 2001. Can J Neurol Sci; 2007 May;34(2):181-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The incidence trends of primary brain tumors in Saskatchewan from 1970 to 2001.
  • OBJECTIVE: There has been a paucity of information on the epidemiology of primary brain tumors (BTs) in Canada.
  • METHODS: Data on all primary BTs from 1970 to 2001 from the Brain Tumor Registry in Saskatchewan was collected.
  • No difference was found in the rate of all the diagnosed primary BTs combined, meningioma and lymphoma between the northern part (Regina) and southern part (Saskatoon) of the province.
  • [MeSH-major] Brain Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Humans. Incidence. Infant. Male. Middle Aged. Registries. Retrospective Studies. Saskatchewan / epidemiology. Sex Distribution

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17598595.001).
  • [ISSN] 0317-1671
  • [Journal-full-title] The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  • [ISO-abbreviation] Can J Neurol Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


48. Kondziolka D, Kano H, Kanaan H, Madhok R, Mathieu D, Flickinger JC, Lunsford LD: Stereotactic radiosurgery for radiation-induced meningiomas. Neurosurgery; 2009 Mar;64(3):463-9; discussion 469-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Radiation-induced meningiomas of the brain are typically managed with surgical resection.
  • The patients met criteria for a radiation-induced meningioma and underwent gamma knife radiosurgery.
  • The World Health Organization tumor grades for those with prior histology were Grade I (n = 5) and Grade II (n = 2).
  • The median tumor volume was 4.4 cm3.
  • No patient developed a subsequent radiation-induced tumor.
  • [MeSH-major] Meningeal Neoplasms / radiotherapy. Meningeal Neoplasms / surgery. Meningioma / etiology. Meningioma / surgery. Neoplasms, Radiation-Induced / etiology. Neoplasms, Radiation-Induced / surgery. Radiosurgery / methods. Radiotherapy, Conformal / adverse effects
  • [MeSH-minor] Adult. Aged. Brain Neoplasms / etiology. Brain Neoplasms / surgery. Child. Female. Humans. Male. Middle Aged. Treatment Outcome. Young Adult

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19240608.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Matsuda R, Nikaido Y, Yamada T, Mishima H, Tamaki R: [High-dose radiation-induced meningioma following prophylactic cranial irradiation for acute lymphoblastic leukaemia]. No Shinkei Geka; 2005 Mar;33(3):277-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [High-dose radiation-induced meningioma following prophylactic cranial irradiation for acute lymphoblastic leukaemia].
  • The high cure rate in childhood ALL, attributable to aggressive chemotherapy and prophylatic cranial irradiation, is capable of inducing secondary brain tumor.
  • Twelve cases of high-dose radiation-induced meningioma following ALL are also reviewed.
  • [MeSH-major] Cranial Irradiation / adverse effects. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Second Primary / etiology. Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
  • [MeSH-minor] Adult. Central Nervous System Neoplasms / prevention & control. Female. Humans. Radiotherapy Dosage

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - Radiation induced meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15773318.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 11
  •  go-up   go-down


50. Saeed P, Tanck MW, Freling N, Baldeschi L, Mourits MP, Bennink RJ: Somatostatin receptor scintigraphy for optic nerve sheath meningiomas. Ophthalmology; 2009 Aug;116(8):1581-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PARTICIPANTS: SSRS was used to investigate 68 orbits in 61 patients diagnosed with an orbital tumor.
  • MAIN OUTCOME MEASURES: The (111)In-octreotide uptake in orbital lesions was determined by semiquantitative uptake-ratio analysis (lesion/brain) on attenuation-corrected transverse SPECT slices.
  • [MeSH-major] Indium Radioisotopes. Meningeal Neoplasms / radionuclide imaging. Meningioma / radionuclide imaging. Octreotide. Optic Nerve Neoplasms / radionuclide imaging. Receptors, Somatostatin / metabolism
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Prospective Studies. Tomography, Emission-Computed, Single-Photon. Tomography, X-Ray Computed. Young Adult


51. Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, Loeffler JS, Hutchinson AA, Inskip PD: Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol; 2008 Aug;10(4):553-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetic variation in insulin-like growth factors and brain tumor risk.
  • Many studies support a role for insulin-like growth factors (IGFs) in the regulation of tumor cell biology.
  • We hypothesized that single-nucleotide polymorphisms (SNPs) in IGF genes are risk factors for glioma and meningioma.
  • To test the hypothesis, we examined associations of brain tumor risk with nine variants in five IGF genes in a hospital-based case-control study.
  • Eligible cases were individuals (18 years or older) newly diagnosed with glioma or meningioma.
  • DNA was extracted from blood samples collected from 354 glioma cases, 133 meningioma cases, and 495 control individuals.
  • The majority of the analyzed IGF SNPs did not display statistically significant associations with glioma or meningioma.
  • Overall, our results do not provide strong evidence of associations of brain tumor risk with IGF polymorphic variants but identify several associations for glioma that warrant further examination in other, larger studies.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):844-6 [17416782.001]
  • [Cites] Hum Hered. 2007;63(3-4):196-204 [17317968.001]
  • [Cites] Endocr Rev. 2000 Jun;21(3):215-44 [10857553.001]
  • [Cites] Lancet. 2004 Apr 24;363(9418):1346-53 [15110491.001]
  • [Cites] Endocr Rev. 1995 Feb;16(1):3-34 [7758431.001]
  • [Cites] Epidemiol Rev. 1995;17(2):382-414 [8654518.001]
  • [Cites] Methods Enzymol. 1996;272:199-210 [8791778.001]
  • [Cites] Cancer Res. 1996 Oct 1;56(19):4522-9 [8813151.001]
  • [Cites] Breast Cancer Res Treat. 1998 Feb;47(3):235-53 [9516079.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):144-51 [15668488.001]
  • [Cites] Acta Neuropathol. 2005 Jan;109(1):93-108 [15685439.001]
  • [Cites] Endocr Rev. 2005 Dec;26(7):916-43 [16131630.001]
  • [Cites] Hum Mol Genet. 2006 Jan 1;15(1):1-10 [16306136.001]
  • [Cites] J Natl Cancer Inst. 2006 Jan 18;98(2):123-34 [16418515.001]
  • [Cites] Am J Epidemiol. 2006 Feb 15;163(4):300-9 [16410351.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2461-6 [17164371.001]
  • [Cites] Lancet Oncol. 2002 May;3(5):298-302 [12067807.001]
  • (PMID = 18562769.001).
  • [ISSN] 1522-8517
  • [Journal-full-title] Neuro-oncology
  • [ISO-abbreviation] Neuro-oncology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Somatomedins
  • [Other-IDs] NLM/ PMC2666228
  •  go-up   go-down


52. Hsu CC, Pai CY, Kao HW, Hsueh CJ, Hsu WL, Lo CP: Do aggressive imaging features correlate with advanced histopathological grade in meningiomas? J Clin Neurosci; 2010 May;17(5):584-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • (iv) extracranial tumor extension through the skull base foramina;.
  • (v) arterial encasement; and (vi) peritumoral brain edema.
  • Only intratumoral cystic change and extracranial tumor extension through the skull base foramina were more prevalent in atypical/malignant meningiomas (p=0.001).
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningeal Neoplasms / radiography. Meningioma / pathology. Meningioma / radiography
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chi-Square Distribution. Female. Humans. Image Interpretation, Computer-Assisted. Magnetic Resonance Imaging. Male. Middle Aged. Patient Selection. Severity of Illness Index

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20219376.001).
  • [ISSN] 1532-2653
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


53. Amin A, Balderacchi JL: Trigeminal neurosarcoidosis: case report and literature review. Ear Nose Throat J; 2010 Jul;89(7):320-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Computed tomography and magnetic resonance imaging suggested an intracranial tumor, favoring a meningioma.
  • The patient underwent emergent surgical decompression and tumor excision.
  • Histopathology of the resected tumor revealed classic features of sarcoidosis, and she received steroid treatment accordingly.
  • [MeSH-minor] Adult. Biopsy. Brain Neoplasms / pathology. Cavernous Sinus / pathology. Cavernous Sinus / radiography. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Meningioma / pathology. Meningioma / radiography. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Sarcoidosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20628992.001).
  • [ISSN] 1942-7522
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 11
  •  go-up   go-down


54. Hänninen MM, Haapasalo J, Haapasalo H, Fleming RE, Britton RS, Bacon BR, Parkkila S: Expression of iron-related genes in human brain and brain tumors. BMC Neurosci; 2009;10:36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of iron-related genes in human brain and brain tumors.
  • BACKGROUND: Defective iron homeostasis may be involved in the development of some diseases within the central nervous system.
  • Although the expression of genes involved in normal iron balance has been intensively studied in other tissues, little is known about their expression in the brain.
  • We investigated the mRNA levels of hepcidin (HAMP), HFE, neogenin (NEO1), transferrin receptor 1 (TFRC), transferrin receptor 2 (TFR2), and hemojuvelin (HFE2) in normal human brain, brain tumors, and astrocytoma cell lines.
  • The specimens included 5 normal brain tissue samples, 4 meningiomas, one medulloblastoma, 3 oligodendrocytic gliomas, 2 oligoastrocytic gliomas, 8 astrocytic gliomas, and 3 astrocytoma cell lines.
  • In most tumor types, the pattern of gene expression was diverse.
  • Notable findings include high expression of transferrin receptor 1 in the hippocampus and medulla oblongata compared to other brain regions, low expression of HFE in normal brain with elevated HFE expression in meningiomas, and absence of hepcidin mRNA in astrocytoma cell lines despite expression in normal brain and tumor specimens.
  • CONCLUSION: These results indicate that several iron-related genes are expressed in normal brain, and that their expression may be dysregulated in brain tumors.
  • [MeSH-major] Brain / metabolism. Brain Neoplasms / metabolism. Gene Expression Regulation, Neoplastic / physiology. Histocompatibility Antigens Class I / metabolism. Membrane Proteins / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antigens, CD / genetics. Antigens, CD / metabolism. Antimicrobial Cationic Peptides / genetics. Antimicrobial Cationic Peptides / metabolism. Astrocytoma / genetics. Astrocytoma / metabolism. Cell Line, Tumor. Female. GPI-Linked Proteins. Hepcidins. Humans. Male. Meningioma / genetics. Meningioma / metabolism. Middle Aged. Oligodendroglioma / genetics. Oligodendroglioma / metabolism. RNA, Messenger / analysis. Receptors, Transferrin / genetics. Receptors, Transferrin / metabolism. Statistics, Nonparametric. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histochem Cell Biol. 2001 Mar;115(3):195-203 [11326747.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G590-4 [16537971.001]
  • [Cites] Clin Cancer Res. 2001 Aug;7(8):2213-21 [11489794.001]
  • [Cites] J Natl Cancer Inst. 2001 Sep 5;93(17):1337-43 [11535709.001]
  • [Cites] Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 [12184808.001]
  • [Cites] J Clin Invest. 2002 Oct;110(7):1037-44 [12370282.001]
  • [Cites] Biometals. 2003 Mar;16(1):63-75 [12572665.001]
  • [Cites] Blood. 2003 Aug 1;102(3):783-8 [12663437.001]
  • [Cites] Brain Res Bull. 2003 Aug 30;61(4):365-74 [12909279.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 May;5(5):343-54 [15122348.001]
  • [Cites] Nat Rev Neurosci. 2004 Nov;5(11):863-73 [15496864.001]
  • [Cites] J Neurosurg. 1990 Jun;72(6):941-5 [2159987.001]
  • [Cites] Nat Genet. 1996 Aug;13(4):399-408 [8696333.001]
  • [Cites] J Comp Neurol. 1996 Nov 25;375(4):675-92 [8930792.001]
  • [Cites] J Neurol Sci. 2004 Dec 15;227(1):27-33 [15546588.001]
  • [Cites] Science. 2004 Dec 17;306(5704):2090-3 [15514116.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Dev Comp Immunol. 2005;29(11):939-50 [15935472.001]
  • [Cites] J Biol Chem. 2005 Oct 7;280(40):33885-94 [16103117.001]
  • [Cites] BMC Neurol. 2006;6:24 [16824219.001]
  • [Cites] J Neurosci Res. 2006 Sep;84(4):790-800 [16933319.001]
  • [Cites] J Alzheimers Dis. 2006 Nov;10(2-3):215-22 [17119289.001]
  • [Cites] J Alzheimers Dis. 2006 Nov;10(2-3):267-76 [17119292.001]
  • [Cites] J Histochem Cytochem. 2007 Jan;55(1):85-96 [16982849.001]
  • [Cites] Eur J Haematol. 2007 Jan;78(1):1-10 [17042775.001]
  • [Cites] J Clin Invest. 2007 Jul;117(7):1926-32 [17557118.001]
  • [Cites] Retina. 2007 Oct;27(8):997-1003 [18040235.001]
  • [Cites] Blood. 2008 Jan 15;111(2):924-31 [17938254.001]
  • [Cites] Biochemistry. 2008 Apr 8;47(14):4237-45 [18335997.001]
  • [Cites] Cell Metab. 2008 Apr;7(4):288-90 [18396134.001]
  • [Cites] J Biol Chem. 2008 Jun 20;283(25):17494-502 [18445598.001]
  • [Cites] Nat Rev Cancer. 2008 Dec;8(12):967-75 [18987634.001]
  • [Cites] BMC Cancer. 2005;5:154 [16324219.001]
  • [Cites] Brain Pathol. 2005 Oct;15(4):297-310 [16389942.001]
  • [Cites] J Clin Oncol. 2006 Mar 10;24(8):1253-65 [16525180.001]
  • [Cites] J Biol Chem. 2001 Mar 16;276(11):7806-10 [11113131.001]
  • (PMID = 19386095.001).
  • [ISSN] 1471-2202
  • [Journal-full-title] BMC neuroscience
  • [ISO-abbreviation] BMC Neurosci
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antimicrobial Cationic Peptides; 0 / CD71 antigen; 0 / GPI-Linked Proteins; 0 / HAMP protein, human; 0 / HFE protein, human; 0 / HFE2 protein, human; 0 / Hepcidins; 0 / Histocompatibility Antigens Class I; 0 / Membrane Proteins; 0 / RNA, Messenger; 0 / Receptors, Transferrin; 0 / TFR2 protein, human; 0 / neogenin
  • [Other-IDs] NLM/ PMC2679039
  •  go-up   go-down


55. Yang Y, Shao N, Luo G, Li L, Nilsson-Ehle P, Xu N: Relationship between PTEN gene expression and differentiation of human glioma. Scand J Clin Lab Invest; 2006;66(6):469-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor-adjacent normal tissues and benign brain tumors were used as controls.
  • RESULTS: PTEN mRNA levels were significantly lower in the glioma tissues than in the benign brain tumors and tumor-adjacent normal tissues, whereas there were no statistical differences between benign brain tumor and the tumor-adjacent normal tissues.
  • [MeSH-major] Brain Neoplasms / genetics. Brain Neoplasms / pathology. Glioma / genetics. Glioma / pathology. PTEN Phosphohydrolase / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Astrocytoma / genetics. Astrocytoma / pathology. Child. Female. Gene Expression. Genes, Tumor Suppressor. Glioblastoma / genetics. Glioblastoma / pathology. Glyceraldehyde-3-Phosphate Dehydrogenases / genetics. Humans. Male. Meningioma / genetics. Meningioma / pathology. Middle Aged. Mutation. Neuroma, Acoustic / genetics. Neuroma, Acoustic / pathology. RNA, Messenger / genetics. RNA, Messenger / metabolism. RNA, Neoplasm / genetics. RNA, Neoplasm / metabolism. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17000554.001).
  • [ISSN] 0036-5513
  • [Journal-full-title] Scandinavian journal of clinical and laboratory investigation
  • [ISO-abbreviation] Scand. J. Clin. Lab. Invest.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / RNA, Neoplasm; EC 1.2.1.- / Glyceraldehyde-3-Phosphate Dehydrogenases; EC 3.1.3.48 / PTEN protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


56. Bizzi A, Blasi V, Falini A, Ferroli P, Cadioli M, Danesi U, Aquino D, Marras C, Caldiroli D, Broggi G: Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology; 2008 Aug;248(2):579-89
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirty-four consecutive patients (16 women, 18 men; mean age, 43.2 years) were included who met the following three criteria: They had a focal mass in or adjacent to eloquent cortex of the language or motor system, they had the ability to perform the functional MR imaging task, and they had to undergo surgery with intraoperative ECM.
  • Sensitivity and specificity were calculated according to task performed, histopathologic findings, and tumor grade.
  • RESULTS: For 34 consecutive patients, there were 28 with gliomas, two with metastases, one with meningioma, and three with cavernous angiomas.
  • [MeSH-major] Brain Mapping. Brain Neoplasms / physiopathology. Frontal Lobe / physiopathology. Language. Magnetic Resonance Imaging / methods. Motor Cortex / physiology
  • [MeSH-minor] Adult. Aged. Electromyography. Female. Humans. Image Processing, Computer-Assisted. Male. Middle Aged. Prospective Studies. Sensitivity and Specificity


57. Sasajima T, Kinouchi H, Naitoh Y, Tomura N, Watarai J, Mizoi K: 123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors - a preliminary study. J Neurooncol; 2006 Apr;77(2):185-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors - a preliminary study.
  • The present study aimed to explore a potential of (123)I-MIBG to differentiate embryonal tumors from other types of brain tumors.
  • METHODS: Sixteen patients with brain tumors including three medulloblastomas, one neuroblastoma, six gliomas, and six meningiomas were examined with single-photon emission computerized tomography (SPECT) using (123)I-MIBG.
  • The (123)I-MIBG uptake of tumors was defined as the ratios of tumor/nontumor (early and delayed T/NT) on SPECT images scanned 30 min and 6 h after intravenous injection of the tracer, respectively.
  • CONCLUSION: Early high accumulation and high retention on delayed imaging may indicate a possibility of (123)I-MIBG SPECT in differentiating embryonal brain tumors from gliomas and meningiomas.
  • [MeSH-major] 3-Iodobenzylguanidine. Brain Neoplasms / diagnostic imaging. Glioma / diagnostic imaging. Meningioma / diagnostic imaging. Neoplasms, Germ Cell and Embryonal / diagnostic imaging. Radiopharmaceuticals
  • [MeSH-minor] Adult. Aged, 80 and over. Animals. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Infant. Magnetic Resonance Imaging. Male. Middle Aged. Sensitivity and Specificity. Tomography, Emission-Computed, Single-Photon

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Magn Reson Imaging. 1989 Nov-Dec;7(6):635-42 [2630846.001]
  • [Cites] J Cereb Blood Flow Metab. 1988 Dec;8(6):S90-4 [2848045.001]
  • [Cites] Eur J Nucl Med. 1994 Jun;21(6):561-81 [7915987.001]
  • [Cites] Neuroradiology. 1988;30(4):351-4 [3262837.001]
  • [Cites] J Neurooncol. 1995;25(1):9-17 [8523094.001]
  • [Cites] Clin Nucl Med. 1998 Jul;23(7):441-5 [9676949.001]
  • [Cites] Nucl Med Commun. 1991 Jan;12 (1):3-13 [2023691.001]
  • [Cites] AJNR Am J Neuroradiol. 2002 Oct;23 (9):1564-7 [12372749.001]
  • [Cites] Cancer Res. 1985 Dec;45(12 Pt 1):6366-70 [3864530.001]
  • [Cites] Int J Cancer. 1991 Apr 1;47(6):875-80 [2010230.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Apr;21(4):717-20 [10782784.001]
  • [Cites] J Neurosurg. 2000 Jul;93(1):145 [10883920.001]
  • [Cites] J Nucl Med. 1988 Oct;29(10 ):1627-32 [3262724.001]
  • [Cites] J Nucl Med. 1993 Sep;34(9):1565-70 [8355077.001]
  • (PMID = 16314956.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 35MRW7B4AD / 3-Iodobenzylguanidine
  •  go-up   go-down


58. Stein PJ: A case of cerebellopontine angle meningioma presenting with neck and upper extremity pain. J Manipulative Physiol Ther; 2009 Nov-Dec;32(9):776-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of cerebellopontine angle meningioma presenting with neck and upper extremity pain.
  • OBJECTIVE: The purpose of this case report is to describe and discuss the clinical presentation, diagnosis, and management of a patient with a cerebellopontine angle meningioma.
  • INTERVENTION AND OUTCOME: Magnetic resonance imaging studies of the neck and brain revealed a posterior fossa tumor, which was eventually diagnosed as a benign meningioma.
  • Partial surgical removal of the tumor mass was followed by radiation therapy.
  • CONCLUSION: Patients with brain lesions may present to chiropractic practices with predominantly musculoskeletal symptoms.
  • [MeSH-major] Cerebellar Neoplasms / pathology. Cerebellar Neoplasms / radiography. Cerebellopontine Angle / pathology. Cerebellopontine Angle / radiography. Meningioma / pathology. Meningioma / radiography. Neck / physiopathology. Pain / etiology. Pain / physiopathology. Upper Extremity / physiopathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20004806.001).
  • [ISSN] 1532-6586
  • [Journal-full-title] Journal of manipulative and physiological therapeutics
  • [ISO-abbreviation] J Manipulative Physiol Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Haba D, Indrei A, Dumitrescu GF, Cuvinciuc V, Costea C, Popa S, Costin D: [CT and anatomo-pathologic examination in the diagnosis of cavernous sinus lesions]. Rev Med Chir Soc Med Nat Iasi; 2007 Jan-Mar;111(1):89-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIAL AND METHODS: All 47 patients were CT explored with and without intravenous contrast, using specific protocols for orbit and brain.
  • RESULTS: We found 26 cases with sellar origin of the tumor and 21 cases of para-sellar origin, with a significant extension in 22 cases.
  • CONCLUSIONS: CT imaging allows a fast and accurate analysis of sellar and para-sellar tumors, with a tumor extension assessment.
  • [MeSH-minor] Adenoma / pathology. Adenoma / radiography. Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Exophthalmos / etiology. Female. Humans. Infant. Male. Meningeal Neoplasms / pathology. Meningeal Neoplasms / radiography. Meningioma / pathology. Meningioma / radiography. Middle Aged. Orbital Neoplasms / pathology. Orbital Neoplasms / radiography. Pituitary Neoplasms / pathology. Pituitary Neoplasms / radiography. Retrospective Studies. Sella Turcica. Sphenoid Bone / radiography

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17595851.001).
  • [ISSN] 0048-7848
  • [Journal-full-title] Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
  • [ISO-abbreviation] Rev Med Chir Soc Med Nat Iasi
  • [Language] rum
  • [Publication-type] English Abstract; Journal Article; Multicenter Study
  • [Publication-country] Romania
  •  go-up   go-down


60. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A: Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology; 2007 Apr;27(2):114-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
  • Meningiomas represent the second most common central nervous system neoplasms in adults and account for 26% of all primary brain tumors.
  • Although histological grade is the most relevant prognostic factor, there are some unusual cases in which establishing a diagnosis of high-grade meningioma following 2000 World Health Organization (WHO) histological criteria is extremely difficult.
  • Therefore, the aim of the present study was to evaluate the predictive value of Ki-67 labeling index and its contribution to current WHO classification in predicting tumor recurrence and overall survival in patients with high-grade meningiomas.
  • In the univariate analysis, Ki-67 labeling index and postoperative Karnofsky performance status were identified as significant prognostic factors of tumor recurrence and overall survival.
  • The multivariate analysis demonstrated that Ki-67 labeling index is the only independent predictor of both tumor recurrence and overall survival.
  • More importantly, this predictive value was maintained in both patients with atypical and patients with anaplastic meningioma.
  • [MeSH-major] Biomarkers, Tumor / analysis. Ki-67 Antigen / metabolism. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cell Proliferation. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Recurrence, Local / pathology. Prognosis. ROC Curve. Sensitivity and Specificity. Survival Analysis

  • Genetic Alliance. consumer health - Meningioma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Neuropathology. 2008 Feb;28(1):106-7 [18181839.001]
  • (PMID = 17494511.001).
  • [ISSN] 0919-6544
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen
  •  go-up   go-down


61. Kubo O, Chernov M, Izawa M, Hayashi M, Muragaki Y, Maruyama T, Hori T, Takakura K: Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation? Minim Invasive Neurosurg; 2005 Dec;48(6):334-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation?
  • Malignant transformation of benign neoplasm after radiosurgery is usually diagnosed based on the initial presence of benign tumor, its exposure to ionizing radiation, elapsed time from radiation exposure to malignant progression, and different histological characteristics or growth rate of the regrowing tumor comparing with those originally treated.
  • Three presented cases fulfilled these diagnostic criteria; however, it seems that progression of the tumors (schwannoma, meningioma, chordoma) resulted from the natural course of the disease, rather than represented side effects of gamma knife radiosurgery.
  • Evaluation of the proliferative potential of the benign neoplasm before radiosurgical treatment either directly, if tumor sampling is available, or indirectly, by calculation of the tumor growth rate and/or analysis of the data of the metabolic imaging (PET, MRS) is important for identification of "aggressive" subtypes, precise prediction of prognosis, and confirmation of the radiation-induced malignant transformation in cases of tumor regrowth.
  • [MeSH-major] Brain Neoplasms / surgery. Cell Transformation, Neoplastic / radiation effects. Chordoma / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Neoplasms, Radiation-Induced / physiopathology. Neurilemmoma / surgery. Radiosurgery / adverse effects
  • [MeSH-minor] Adult. Brain Diseases / surgery. Cell Proliferation. Female. Humans. Male. Middle Aged. Prognosis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16432782.001).
  • [ISSN] 0946-7211
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


62. Pećina-Slaus N, Nikuseva Martić T, Deak AJ, Zeljko M, Hrasćan R, Tomas D, Musani V: Genetic and protein changes of E-cadherin in meningiomas. J Cancer Res Clin Oncol; 2010 May;136(5):695-702
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: In the present study 60 meningiomas were analyzed regarding changes of tumor suppressor gene E-cadherin (CDH1), a component of adherens junction and an indirect modulator of the wnt signaling.
  • CONCLUSIONS: Our results suggest that genetic instabilities of the E-cadherin gene have a role in meningioma development and progression.
  • Detected microsatellite instability indicates that mismatch repair may also be targeted in meningioma.
  • [MeSH-major] Cadherins / genetics. Genomic Instability. Meningeal Neoplasms / genetics. Meningioma / genetics
  • [MeSH-minor] Adult. Aged. Female. Humans. Loss of Heterozygosity. Male. Middle Aged. beta Catenin / genetics

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurooncol. 2008 Aug;89(1):73-87 [18418552.001]
  • [Cites] J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 [11895036.001]
  • [Cites] Clin Neuropathol. 2005 Jan-Feb;24(1):8-12 [15696778.001]
  • [Cites] J Neurooncol. 2008 Mar;87(1):63-70 [18066497.001]
  • [Cites] Nature. 2005 Oct 27;437(7063):1370-5 [16251967.001]
  • [Cites] J Biol Chem. 2006 Aug 11;281(32):22429-33 [16793760.001]
  • [Cites] Coll Antropol. 2002 Jun;26(1):85-8 [12137327.001]
  • [Cites] J Clin Oncol. 2005 Nov 1;23 (31):7951-7 [16258095.001]
  • [Cites] Histopathology. 2006 Aug;49(2):178-87 [16879395.001]
  • [Cites] Curr Opin Genet Dev. 2007 Feb;17(1):45-51 [17208432.001]
  • [Cites] Nat Neurosci. 2003 Nov;6(11):1169-77 [14528308.001]
  • [Cites] J Neurobiol. 2005 Sep 15;64(4):458-75 [16041741.001]
  • [Cites] Brain Tumor Pathol. 2006 Apr;23(1):13-7 [18095114.001]
  • [Cites] Virchows Arch. 1998 Feb;432(2):163-7 [9504862.001]
  • [Cites] Acta Neuropathol. 2007 Aug;114(2):97-109 [17618441.001]
  • [Cites] Development. 1992 Dec;116(4):1011-9 [1295725.001]
  • [Cites] Cancer Cell Int. 2003 Oct 14;3(1):17 [14613514.001]
  • [Cites] Nature. 1993 Jun 10;363(6429):558-61 [8505985.001]
  • [Cites] Histol Histopathol. 2006 Jan;21(1):103-24 [16267791.001]
  • [Cites] Curr Opin Neurobiol. 2000 Jun;10(3):392-9 [10851180.001]
  • [Cites] Adv Anat Pathol. 2005 Jul;12(4):180-94 [16096380.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):183-202 [15674477.001]
  • [Cites] Cell. 2000 Mar 3;100(5):525-35 [10721990.001]
  • [Cites] Int J Cancer. 2001 Aug 1;93(3):445-9 [11433413.001]
  • [Cites] Cell Tissue Res. 2008 Feb;331(2):401-12 [17965884.001]
  • [Cites] Cancer Lett. 2002 Sep 8;183(1):95-101 [12049819.001]
  • [Cites] Int J Cancer. 2005 Mar 20;114(2):249-56 [15540215.001]
  • [Cites] Lancet Neurol. 2006 Dec;5(12):1045-54 [17110285.001]
  • (PMID = 19908067.001).
  • [ISSN] 1432-1335
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Cadherins; 0 / beta Catenin
  •  go-up   go-down


63. Schittenhelm J, Becker R, Capper D, Meyermann R, Iglesias-Rozas JR, Kaminsky J, Mittelbronn M: The clinico-surgico-pathological spectrum of myxopapillary ependymomas--report of four unusal cases and review of the literature. Clin Neuropathol; 2008 Jan-Feb;27(1):21-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • According to the WHO grading system, myxopapillary ependymomas are assigned to WHO Grade I.
  • Herein, we report 4 cases exhibiting lumbar tumor masses, 1 causing muscular atrophy over a 30-year period, 3 displaying clinical history of persisting lumbar pain for only several weeks.
  • On histological examination, two tumors were almost acellular and showed polycyclic hyaline and fibrotic extracellular matrix leading to differential diagnoses of chordoma, meningioma, fibrolipoma and ependymoma.
  • [MeSH-minor] Adult. Aged. Female. Humans. Immunohistochemistry. Lumbosacral Region. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / pathology. Neurosurgical Procedures

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18257471.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


64. De la Cruz A, Teufert KB: Transcochlear approach to cerebellopontine angle and clivus lesions: indications, results, and complications. Otol Neurotol; 2009 Apr;30(3):373-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MAIN OUTCOME MEASURES: Indications, postoperative outcomes, and complications including tumor removal and facial nerve status (House-Brackmann grade).
  • CONCLUSION: The TC and TO approaches provide access to midline intradural lesions, intradural petroclival tumors, and cerebellopontine angle tumors and cholesteatomas arising anterior to the internal auditory canal, without using brain retractors.
  • Total tumor removal, including its base and blood supply, is possible.
  • With these approaches, recurrence israre when all tumor has been removed.
  • [MeSH-minor] Adolescent. Adult. Aged. Carotid Arteries / anatomy & histology. Child, Preschool. Data Interpretation, Statistical. Ear Canal / anatomy & histology. Ear Canal / surgery. Facial Nerve / physiology. Facial Nerve / surgery. Female. Humans. Magnetic Resonance Imaging. Male. Meningioma / surgery. Middle Aged. Neoplasm Recurrence, Local. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19318889.001).
  • [ISSN] 1537-4505
  • [Journal-full-title] Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • [ISO-abbreviation] Otol. Neurotol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Chen CH, Shen CC, Sun MH, Ho WL, Huang CF, Kwan PC: Histopathology of radiation necrosis with severe peritumoral edema after gamma knife radiosurgery for parasagittal meningioma. A report of two cases. Stereotact Funct Neurosurg; 2007;85(6):292-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histopathology of radiation necrosis with severe peritumoral edema after gamma knife radiosurgery for parasagittal meningioma. A report of two cases.
  • We present 2 cases of parasagittal meningioma after GKS complicated with radiation necrosis and peritumoral edema.
  • CASE DESCRIPTION: Two cases of parasagittal meningioma received GKS.
  • Both of them underwent surgical resection of their tumor afterwards.
  • Histologic examination showed necrotic change inside the tumor and infiltration of inflammatory cells in both cases.
  • Imaging performed 3 months after surgical resection showed alleviation of brain edema.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningeal Neoplasms / surgery. Meningioma / pathology. Meningioma / surgery. Radiation Injuries / pathology. Radiosurgery / adverse effects
  • [MeSH-minor] Adult. Brain Edema / pathology. Female. Humans. Magnetic Resonance Imaging. Middle Aged. Necrosis

  • Genetic Alliance. consumer health - Edema.
  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 S. Karger AG, Basel.
  • (PMID = 17709982.001).
  • [ISSN] 1423-0372
  • [Journal-full-title] Stereotactic and functional neurosurgery
  • [ISO-abbreviation] Stereotact Funct Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


66. Zhu W, Mao Y, Zhou LF, Zhang R, Chen L: Combined subtemporal and retrosigmoid keyhole approach for extensive petroclival meningioma surgery: report of experience with 7 cases. Minim Invasive Neurosurg; 2007 Apr;50(2):106-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined subtemporal and retrosigmoid keyhole approach for extensive petroclival meningioma surgery: report of experience with 7 cases.
  • The extent of tumor resection was evaluated by MRI 3 months after surgery, and postoperative complications were investigated.
  • [MeSH-major] Cranial Fossa, Posterior / surgery. Craniotomy / methods. Infratentorial Neoplasms / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Neurosurgical Procedures / methods
  • [MeSH-minor] Adult. Brain / pathology. Brain / radiography. Brain / surgery. Cavernous Sinus / anatomy & histology. Cavernous Sinus / pathology. Cavernous Sinus / surgery. Cranial Fossa, Middle / anatomy & histology. Cranial Fossa, Middle / pathology. Cranial Fossa, Middle / surgery. Cranial Nerves / pathology. Cranial Nerves / physiopathology. Cranial Nerves / surgery. Dura Mater / anatomy & histology. Dura Mater / pathology. Dura Mater / surgery. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Occipital Bone / anatomy & histology. Occipital Bone / pathology. Occipital Bone / surgery. Postoperative Complications / etiology. Postoperative Complications / prevention & control. Treatment Outcome

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17674298.001).
  • [ISSN] 0946-7211
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


67. Ringel F, Cedzich C, Schramm J: Microsurgical technique and results of a series of 63 spheno-orbital meningiomas. Neurosurgery; 2007 Apr;60(4 Suppl 2):214-21; discussion 221-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Periorbital tumor infiltration led to intraorbital resection in 32 cases, and five cases presented a solid intraorbital tumor.
  • Seventy-six percent of patients had tumor residuals, of which 61% were stable and 39% were progressive.
  • Eleven tumor residuals were operated and four were treated by radiation.
  • Two-thirds of tumor rests remained stable during the follow-up period.
  • [MeSH-major] Brain Neoplasms / surgery. Meningioma / surgery. Microsurgery / methods. Neurosurgical Procedures / methods. Orbital Neoplasms / surgery. Skull Neoplasms / surgery. Sphenoid Bone / surgery
  • [MeSH-minor] Adult. Aged. Cranial Nerve Diseases / etiology. Exophthalmos / etiology. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm, Residual / radiotherapy. Neoplasm, Residual / surgery. Orbit / pathology. Orbit / surgery. Postoperative Complications / etiology. Reoperation. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17415156.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


68. Jain D, Ebrahimi KB, Miller NR, Eberhart CG: Intraorbital meningiomas: a pathologic review using current World Health Organization criteria. Arch Pathol Lab Med; 2010 May;134(5):766-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 21 patients, the tumor was associated with the optic nerve.
  • Four tumors (8%) were WHO grade II, with 4 or more mitotic figures per 10 high-power fields, brain invasion, chordoid histology, or a combination of these features.
  • One relatively common intracranial subtype, fibrous meningioma, was not encountered.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Female. Humans. Male. Middle Aged. Retrospective Studies. World Health Organization

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20441509.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Chan MD, Tatter SB, Lesser G, Shaw EG: Radiation oncology in brain tumors: current approaches and clinical trials in progress. Neuroimaging Clin N Am; 2010 Aug;20(3):401-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation oncology in brain tumors: current approaches and clinical trials in progress.
  • Radiation therapy remains a critical therapeutic modality in the treatment of adult brain tumors.
  • However, its use continues to evolve depending on the histologic findings of the brain tumor.
  • In low-grade gliomas, the life expectancy is much greater, and the possibility of late effects of radiotherapy have shaped contemporary trials to attempt to identify groups that benefit from radiotherapy versus the ones that may defer radiotherapy until tumor progression.
  • With primary central nervous system lymphoma, the advent of high-dose methotrexate-based chemotherapy and the risk of severe early neurocognitive toxicity have brought the role of radiotherapy into question.
  • With meningioma, the use of normal tissue-sparing techniques such as radiosurgery has allowed for the successful treatment of patients who are eminently curable and with a life expectancy that is generally no different than that of the general population.
  • [MeSH-major] Brain Neoplasms / radiotherapy. Glioma / radiotherapy. Lymphoma / radiotherapy. Meningioma / radiotherapy. Radiation Oncology / methods. Randomized Controlled Trials as Topic / methods
  • [MeSH-minor] Adult. Glioblastoma / radiotherapy. Glioblastoma / therapy. Humans

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20708554.001).
  • [ISSN] 1557-9867
  • [Journal-full-title] Neuroimaging clinics of North America
  • [ISO-abbreviation] Neuroimaging Clin. N. Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


70. Lok C, Viseux V, Avril MF, Richard MA, Gondry-Jouet C, Deramond H, Desfossez-Tribout C, Courtade S, Delaunay M, Piette F, Legars D, Dreno B, Saïag P, Longy M, Lorette G, Laroche L, Caux F, Cancerology Group of the French Society of Dermatology: Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine (Baltimore); 2005 Mar;84(2):129-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Brain magnetic resonance imaging in patients with Cowden syndrome.
  • Although Lhermitte-Duclos disease (LDD) or dysplastic gangliocytoma of the cerebellum, a slowly progressive unilateral tumor, is a major criterion of CS, its frequency in patients with CS is unknown.
  • Other cerebral abnormalities, especially meningioma and vascular malformations, have also been described, albeit rarely, in these patients.
  • The aim of the current study was to use cerebral magnetic resonance imaging (MRI) to evaluate LDD frequency and to investigate other brain abnormalities in CS patients recruited by dermatologists.
  • Cerebral MRI revealed LDD in 3 patients, a meningioma in 1, and numerous vascular malformations in 6 patients.
  • The discovery of asymptomatic LDD in 3 patients and a cavernous angioma in another prompted us to perform neurologic examinations regularly and MRI to estimate the size and the extension of the tumor, and to assess the need for surgery.
  • CS similarities with Bannayan-Riley-Ruvalcaba (BRR) are discussed because some patients could also have the BRR phenotype (for example, genital lentigines, macrocephaly, multiple lipomas) and because BRR seems to have more central nervous system vascular anomalies.
  • Our findings confirm the contribution of brain MRI to detecting asymptomatic LDD, vascular malformations, and meningiomas in patients with CS.
  • [MeSH-major] Brain / pathology. Hamartoma Syndrome, Multiple / pathology. Magnetic Resonance Imaging
  • [MeSH-minor] Adolescent. Adult. Aged. Central Nervous System Venous Angioma / complications. Central Nervous System Venous Angioma / pathology. Cerebellar Neoplasms / complications. Cerebellar Neoplasms / pathology. Child. Female. Ganglioneuroma / complications. Ganglioneuroma / pathology. Hemangioma / complications. Hemangioma / pathology. Humans. Male. Meningeal Neoplasms / complications. Meningeal Neoplasms / pathology. Meningioma / complications. Meningioma / pathology. Middle Aged. Mutation. PTEN Phosphohydrolase. Phosphoric Monoester Hydrolases / genetics. Tumor Suppressor Proteins / genetics

  • Genetic Alliance. consumer health - Cowden Syndrome.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15758842.001).
  • [ISSN] 0025-7974
  • [Journal-full-title] Medicine
  • [ISO-abbreviation] Medicine (Baltimore)
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Tumor Suppressor Proteins; EC 3.1.3.- / Phosphoric Monoester Hydrolases; EC 3.1.3.48 / PTEN protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


71. Williams HM, Lundberg GA Jr: Systemic lupus erythematosus, meningioma and carcinoma of the cervix--a case report. 1956. Conn Med; 2006 Aug;70(7):453-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Systemic lupus erythematosus, meningioma and carcinoma of the cervix--a case report. 1956.
  • The history of a patient with systemic lupus erythematosus, meningioma and carcinoma of the cervix is presented.
  • Although the meningioma originally masqueraded as a cerebral manifestation of lupus, lack of response to cortisone and progression of symptoms eventually indicated the diagnosis of brain tumor.
  • [MeSH-major] Lupus Erythematosus, Systemic / history. Meningioma / history. Uterine Cervical Neoplasms / history
  • [MeSH-minor] Adult. Female. History, 20th Century. Humans


72. Shnaper S, Desbaillets I, Brown DA, Murat A, Migliavacca E, Schluep M, Ostermann S, Hamou MF, Stupp R, Breit SN, de Tribolet N, Hegi ME: Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. Int J Cancer; 2009 Dec 1;125(11):2624-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For patients with brain tumors identification of diagnostic and prognostic markers in easy accessible biological material, such as plasma or cerebrospinal fluid (CSF), would greatly facilitate patient management.
  • Determination of MIC-1/GDF15 protein levels by ELISA in the CSF of a cohort of 94 patients with intracranial tumors including gliomas, meningioma and metastasis revealed significantly increased concentrations in glioblastoma patients (median, 229 pg/ml) when compared with control cohort of patients treated for non-neoplastic diseases (median below limit of detection of 156 pg/ml, p < 0.0001, Mann-Whitney test).
  • [MeSH-major] Biomarkers, Tumor / cerebrospinal fluid. Brain Neoplasms / cerebrospinal fluid. Glioblastoma / cerebrospinal fluid. Growth Differentiation Factor 15 / cerebrospinal fluid
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Case-Control Studies. Cohort Studies. Enzyme-Linked Immunosorbent Assay. Female. Humans. Immunoenzyme Techniques. Male. Middle Aged. Prognosis. RNA, Messenger / genetics. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Survival Rate. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Glioblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19521960.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / GDF15 protein, human; 0 / Growth Differentiation Factor 15; 0 / RNA, Messenger
  •  go-up   go-down


73. Jolapara M, Kesavadas C, Radhakrishnan VV, Thomas B, Gupta AK, Bodhey N, Patro S, Saini J, George U, Sarma PS: Role of diffusion tensor imaging in differentiating subtypes of meningiomas. J Neuroradiol; 2010 Dec;37(5):277-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Meningiomas are the most common extraaxial intracranial type of tumor, and their management and prognosis depend on their grade and histology.
  • Diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) are two new imaging techniques that have proved helpful in elucidating the microarchitecture of brain tumors.
  • The aim of the present study was to assess the role of diffusion and diffusion tensor metrics in the identification and classification of meningioma grades and subtypes.
  • METHODS AND MATERIALS: A total of 21 consecutive patients with meningioma were included in this retrospective study, of whom 16 had benign meningiomas (three fibroblastic, 11 transitional/mixed, two meningothelial) and five had atypical meningiomas.
  • Tumor mean diffusivity (Dav), fractional anisotropy (FA), linear anisotropy (CL), planar anisotropy (CP), spherical anisotropy (CS) and eigenvalues (e1, e2, e3) were measured in all cases, and differences in diffusion tensor metrics between atypical, fibroblastic and other benign (transitional, meningothelial) meningiomas were statistically analyzed using the Mann-Whitney test.
  • [MeSH-major] Diffusion Tensor Imaging. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Anisotropy. Female. Humans. Image Processing, Computer-Assisted. Male. Middle Aged. Retrospective Studies. Statistics, Nonparametric

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20381865.001).
  • [ISSN] 0150-9861
  • [Journal-full-title] Journal of neuroradiology. Journal de neuroradiologie
  • [ISO-abbreviation] J Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  •  go-up   go-down


74. Radić B, Vukelić Z, Bognar SK: Serum gangliosides in patients with brain tumors. Coll Antropol; 2008 Jan;32 Suppl 1:171-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum gangliosides in patients with brain tumors.
  • In order to determine possible differences in serum gangliosides content and composition before and after surgical removal of tumor, gangliosides isolated from preoperative and postoperative sera of patients with brain tumors were analyzed.
  • Serum samples were collected from patients with glioblastoma, meningioma, acoustic neurinoma, haemangioma, oligodendroglioma and astrocytoma, one week before and one week after surgical removal of the tumor.
  • However, a postoperative decreased proportion of ganglioside GD3 was observed in sera derived from patients with complete tumor removal.
  • The results of this study indicate that comparative quantitative and compositional analysis of both preoperative and postoperative serum gangliosides may provide useful information concerning tumor progression, surgical success and prognosis.
  • [MeSH-major] Brain Neoplasms / blood. Gangliosides / blood
  • [MeSH-minor] Adult. Aged. Chromatography, High Pressure Liquid. Female. Humans. Male. Middle Aged. Postoperative Period. Preoperative Care. Prognosis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18405078.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Croatia
  • [Chemical-registry-number] 0 / Gangliosides
  •  go-up   go-down


75. Bakar B, Sav A, Tekkok IH: Giant chordoid meningioma symptomatic immediately after pregnancy: report of a rare case. Clin Neuropathol; 2010 May-Jun;29(3):163-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant chordoid meningioma symptomatic immediately after pregnancy: report of a rare case.
  • BACKGROUND: Chordoid meningioma is a very rare subtype of meningioma with less than 90 cases reported in the literature.
  • Herein, we present a pregnancy-associated case of a chordoid meningioma and briefly discuss possible mechanisms.
  • The patient was immediately taken to the operating theater and the tumor was gross totally removed.
  • The postoperative period was uneventful; and histopathological diagnosis was chordoid meningioma.
  • As for this case of chordoid meningioma associated with pregnancy, we think mucin accumulation in tumor could be involved in an increase in the tumor size while delivery procedures with the common anaesthetic and sedative drugs may also have enhanced the peritumoral edema by causing a relative decrease in the cerebral blood flow.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningioma / pathology. Pregnancy Complications, Neoplastic / pathology
  • [MeSH-minor] Adult. Biopsy. Brain / pathology. Brain Edema / pathology. Brain Edema / radiography. Cesarean Section. Female. Humans. Magnetic Resonance Imaging. Pregnancy. Severity of Illness Index. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20423691.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


76. Tanaka A: Imaging diagnosis and fundamental knowledge of common brain tumors in adults. Radiat Med; 2006 Jul;24(6):482-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imaging diagnosis and fundamental knowledge of common brain tumors in adults.
  • The most common primary brain tumors in Japanese adults are meningiomas, gliomas, pituitary adenomas, and schwannomas, which together account for 84.0% of all primary brain tumors.
  • The molecular genetic analysis of brain tumors has recently become important.
  • Background factors such as hormones, history of cranial irradiation, and medications influence oncogenesis, tumor growth, and tumor appearances as seen by imaging modalities.
  • [MeSH-major] Brain Neoplasms / diagnosis. Magnetic Resonance Imaging. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Glioma / diagnosis. Humans. Image Processing, Computer-Assisted. Japan / epidemiology. Meningioma / diagnosis. Neurilemmoma / diagnosis. Pituitary Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 [11895036.001]
  • [Cites] AJNR Am J Neuroradiol. 1993 Sep-Oct;14(5):1241-7 [8237710.001]
  • [Cites] Neuromolecular Med. 2003;3(1):41-52 [12665675.001]
  • [Cites] AJNR Am J Neuroradiol. 1990 Sep-Oct;11(5):935-8 [2120998.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Nov;84(11):3972-82 [10566636.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):65-73 [10924973.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Aug;22(7):1306-15 [11498419.001]
  • [Cites] Radiology. 1999 Nov;213(2):383-8 [10551216.001]
  • [Cites] AJNR Am J Neuroradiol. 1994 Mar;15(3):525-32 [8197952.001]
  • [Cites] Oncogene. 1999 Jul 15;18(28):4144-52 [10435596.001]
  • [Cites] Int J Cancer. 2000 Jan 1;85(1):78-81 [10585587.001]
  • [Cites] J Neurosurg. 1998 Jul;89(1):69-73 [9647174.001]
  • [Cites] J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89 [15977639.001]
  • [Cites] J Neuroimaging. 1996 Apr;6(2):104-7 [8634482.001]
  • [Cites] Radiology. 1990 Aug;176(2):447-50 [2367659.001]
  • [Cites] Neuroradiology. 1997 Aug;39(8):593-8 [9272499.001]
  • [Cites] Surg Neurol. 2002 Dec;58(6):395-402; discussion 402 [12517619.001]
  • [Cites] Radiology. 1997 Apr;203(1):263-7 [9122405.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Mar;21(3):485-8 [10730639.001]
  • [Cites] AJNR Am J Neuroradiol. 1992 Sep-Oct;13(5):1279-91 [1414816.001]
  • [Cites] Radiology. 1994 Apr;191(1):41-51 [8134596.001]
  • [Cites] Cancer. 1975 Jul;36(1):216-20 [1203849.001]
  • [Cites] Nihon Igaku Hoshasen Gakkai Zasshi. 1998 Jun;58(7):349-52 [9711074.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Mar;18(3):551-4 [9090422.001]
  • [Cites] Surg Neurol. 1994 Jun;41(6):486-9 [8059328.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1081-8 [11415902.001]
  • [Cites] Radiology. 2002 Jul;224(1):177-83 [12091680.001]
  • [Cites] Radiology. 2003 Aug;228(2):533-8 [12819334.001]
  • [Cites] Jpn J Clin Oncol. 2001 Oct;31(10):510-3 [11696622.001]
  • (PMID = 16958433.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 31
  •  go-up   go-down


77. Yano S, Kuratsu J, Kumamoto Brain Tumor Research Group: Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg; 2006 Oct;105(4):538-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor growth was observed in 25 (37.3%) of 67 patients who participated in follow up for longer than 5 years, and symptoms developed in 11 (16.4%) of the 67 patients over a mean follow-up period of 3.9 years.
  • CONCLUSIONS: Approximately 63% of asymptomatic meningiomas did not exhibit tumor growth, and only 6% of all patients with these lesions experienced symptoms during the observation period.
  • [MeSH-major] Incidental Findings. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / surgery. Meningioma / diagnosis. Meningioma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Disease Progression. Female. Follow-Up Studies. Humans. Male. Middle Aged. Observation. Postoperative Complications / diagnosis. Postoperative Complications / etiology. Postoperative Complications / mortality. Prognosis. Radiosurgery. Risk Factors. Survival Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2006 Oct;105(4):536-7; discussion 537 [17044554.001]
  • (PMID = 17044555.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


78. Sanai N, McDermott MW: A modified far-lateral approach for large or giant meningiomas of the posterior fossa. J Neurosurg; 2010 May;112(5):907-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Limitations include a restricted angle of view, high venous pressures, and suboptimal brain relaxation.
  • The mean tumor volume was 72.6 cm3 (range 8-131 cm3).
  • [MeSH-major] Cranial Fossa, Posterior / pathology. Cranial Fossa, Posterior / surgery. Meningioma / pathology. Meningioma / surgery. Neurosurgical Procedures / methods
  • [MeSH-minor] Adult. Aged. Cerebellopontine Angle / pathology. Cerebellopontine Angle / surgery. Cerebral Veins / surgery. Craniotomy / methods. Decompression, Surgical. Female. Humans. Intraoperative Complications / prevention & control. Male. Mandibular Condyle / blood supply. Middle Aged. Neoplasm Invasiveness. Patient Positioning. Petrous Bone / pathology. Petrous Bone / surgery. Preoperative Care. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2010 May;112(5):905-6; discussion 906 [19877804.001]
  • (PMID = 19877805.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF: The endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience. Neurosurgery; 2008 Oct;63(4 Suppl 2):244-56; discussion 256
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • From July 1998 to January 2008, 812 patients underwent a total of 881 operations for a pituitary adenoma (n = 605), Rathke's cleft cyst (n = 59), craniopharyngioma (n = 26), parasellar meningioma (n = 23), chordoma (n = 18), or other pathological condition (n = 81).
  • [MeSH-minor] Adult. Aged. Chordoma / surgery. Cranial Fossa, Posterior / surgery. Craniopharyngioma / surgery. Databases, Factual. Female. Humans. Male. Medical Illustration. Middle Aged. Optic Chiasm / pathology. Postoperative Complications / etiology. Retrospective Studies. Sphenoid Bone / surgery. Young Adult


80. Okamoto K, Furusawa T, Ishikawa K, Sasai K, Tokiguchi S: Focal T2 hyperintensity in the dorsal brain stem in patients with vestibular schwannoma. AJNR Am J Neuroradiol; 2006 Jun-Jul;27(6):1307-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Focal T2 hyperintensity in the dorsal brain stem in patients with vestibular schwannoma.
  • BACKGROUND AND PURPOSE: The vestibular nucleus cannot be visualized on MR imaging, but some patients with vestibular schwannoma show a tiny area of hyperintensity in the dorsal brain stem on T2-weighted images.
  • METHODS: We retrospectively reviewed the postoperative MR images of 53 patients with cerebellopontine angle tumor.
  • Surgical and histopathologic diagnosis was vestibular schwannoma (41/53 = 77%), meningioma (7/53 = 13%), epidermoid cyst (3/53 = 6%), glioma with exophytic growth (1/53 = 2%), and chordoma (1/53 = 2%).
  • If such hyperintensity is seen in a patient with a large cerebellopontine angle tumor, a diagnosis of vestibular schwannoma is suggested.
  • [MeSH-major] Brain Stem / pathology. Magnetic Resonance Imaging. Neuroma, Acoustic / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Cerebellar Neoplasms / diagnosis. Cerebellar Neoplasms / pathology. Cerebellar Neoplasms / surgery. Cerebellopontine Angle. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16775286.001).
  • [ISSN] 0195-6108
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Brandt MG, Poirier J, Hughes B, Lownie SP, Parnes LS: The transcrusal approach: a 10-year experience at one Canadian center. Neurosurgery; 2010 May;66(5):1017-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Operative indications included meningioma (5 patients), epidermoid/dermoid cyst (3 patients), trigeminal schwannoma (3 patients), giant or large upper basilar artery aneurysm (3 patients), pontine cavernoma (1 patient), chondrosarcoma (1 patient), and clival melanocytoma (1 patient).
  • Average tumor size was 3.6 cm.
  • [MeSH-major] Brain Diseases / surgery. Neurosurgical Procedures / adverse effects. Neurosurgical Procedures / methods. Postoperative Complications / epidemiology
  • [MeSH-minor] Adult. Aged. Canada. Female. Hearing Loss / epidemiology. Hearing Loss / etiology. Humans. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20414979.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Mobley BC, Roulston D, Shah GV, Bijwaard KE, McKeever PE: Peripheral primitive neuroectodermal tumor/Ewing's sarcoma of the craniospinal vault: case reports and review. Hum Pathol; 2006 Jul;37(7):845-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral primitive neuroectodermal tumor/Ewing's sarcoma of the craniospinal vault: case reports and review.
  • The peripheral primitive neuroectodermal tumor/Ewing's sarcoma family tumor (pPNET/ESFT) group includes small round cell tumors of the bone, soft tissue, and nerve with morphological attributes of the germinal neuroepithelium.
  • Peripheral PNETs/ESFTs also occur within the craniospinal vault, a region including the central nervous system, the meninges, and the cranial and spinal nerve roots.
  • An intradural tumor arising from the nerve roots of the cauda equina was discovered in a 32-year-old man presenting with radiculopathic back pain and lower-extremity weakness.
  • An intracranial pPNET that mimicked a meningioma was found in a 21-year-old man presenting with headache and visual disturbances.
  • [MeSH-major] Brain Neoplasms / pathology. Cauda Equina / pathology. Neuroectodermal Tumors, Primitive, Peripheral / pathology. Peripheral Nervous System Neoplasms / pathology. Sarcoma, Ewing / pathology
  • [MeSH-minor] Adult. Antigens, CD / metabolism. Back Pain / etiology. Blotting, Southern. Cell Adhesion Molecules / metabolism. Chromosome Aberrations. Chromosomes, Human, Pair 22 / genetics. Diagnosis, Differential. Headache / etiology. Humans. Male. Meningioma / pathology. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Protein c-fli-1 / genetics. RNA-Binding Protein EWS. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16784984.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules; 0 / EWS-FLI fusion protein; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA-Binding Protein EWS
  • [Number-of-references] 68
  •  go-up   go-down


83. Khan ZH, Tabatabai SA, Saberi H, Aliari M: Vigilant surgical hemostasis challenged by ketamine or hypervolemia induced hemodynamic stress to minimize postoperative hemorrhage in patients with parasagittal/or parafalcian meningiomas: an interventional study. Acta Anaesthesiol Taiwan; 2005 Dec;43(4):217-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After accomplishing tumor resection and securing initial surgical hemostasis, the patients received one of the following treatment regimens, i.e. group 1, 1.5 mg/kg of ketamine given intravenously, group II, 1 liter of isotonic saline, and group III, as the control group receiving conventional maintenance fluids intraoperatively, and in all the three groups, the time consumed to achieve rehemostasis at the tumor bed was recorded.
  • Twenty four hours later, a brain computed tomogram was obtained to evaluate the hematoma volume to tumor volume ratio and extent of perifocal edema and the results were recorded.
  • RESULTS: The calculated hematoma volume to tumor volume ratio and the edema score in the ketamine group was significantly less than the control group (P < 0.05).
  • CONCLUSIONS: It is concluded from our data that, vigilant rehemostasis challenged by ketamine or hypervolemia-induced hemodynamic stress minimizes postoperative hemorrhage without producing troublesome brain edema.
  • [MeSH-major] Hemostasis, Surgical. Ketamine / therapeutic use. Meningeal Neoplasms / surgery. Meningioma / surgery. Postoperative Hemorrhage / prevention & control
  • [MeSH-minor] Adult. Aged. Central Venous Pressure / drug effects. Cerebrovascular Circulation / drug effects. Female. Humans. Intracranial Pressure / drug effects. Male. Middle Aged

  • Hazardous Substances Data Bank. KETAMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16450596.001).
  • [ISSN] 1875-4597
  • [Journal-full-title] Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists
  • [ISO-abbreviation] Acta Anaesthesiol Taiwan
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 690G0D6V8H / Ketamine
  •  go-up   go-down


84. Rossitti S: Preoperative embolization of lower-falx meningiomas with ethylene vinyl alcohol copolymer: technical and anatomical aspects. Acta Radiol; 2007 Apr;48(3):321-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A terminal branch of the middle cerebral artery in the proximity of the tumor was catheterized as near as possible or into the pre-falcine arterial anastomotic network around the superior sagittal sinus, and embolization with EVAC was performed with a standard injection technique.
  • RESULTS: This technique resulted in filling of the tumor-supplying dural arteries including all collaterals from both sides, filling of the dural territory of the tumor circulation, and some obliteration of the tumor's pial supply.
  • On later operation, the tumors could be removed from the inside out with minimal brain retraction.
  • [MeSH-major] Embolization, Therapeutic / methods. Meningeal Neoplasms / therapy. Meningioma / therapy. Polyvinyls / therapeutic use
  • [MeSH-minor] Adult. Feasibility Studies. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Preoperative Care. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17453504.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Sweden
  • [Chemical-registry-number] 0 / Polyvinyls; 25067-34-9 / ethylene-vinyl alcohol copolymer
  •  go-up   go-down


85. van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ: Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol; 2009 Sep;256(9):1519-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although seizures in brain tumor patients are common, the knowledge on optimal anti-seizure therapy in this patient group is limited.
  • An observational study was carried out using a database of all patients from the neuro-oncology service during the period 2000-2005, with data on seizure characteristics, therapy with AEDs, the underlying brain tumor and its treatment.
  • A total of 140 brain tumor patients were studied of whom 23.6% had a low-grade glioma, 53.6% a high-grade glioma, and 22.8% belonged to a mixed group existing of ependymoma, meningioma, and brain metastasis.
  • This indicates that adding levetiracetam may be preferable over sequential trials of AED monotherapy in treatment-resistant seizures in patients with brain tumors.
  • [MeSH-major] Anticonvulsants / therapeutic use. Brain Neoplasms / complications. Glioma / complications. Seizures / drug therapy. Seizures / etiology
  • [MeSH-minor] Adult. Carbamazepine / therapeutic use. Drug Therapy, Combination. Female. Follow-Up Studies. Humans. Kaplan-Meier Estimate. Male. Middle Aged. Neoplasm Staging. Piracetam / analogs & derivatives. Piracetam / therapeutic use. Time Factors. Treatment Outcome. Triazines / therapeutic use. Valproic Acid / therapeutic use


86. Schüz J, Böhler E, Berg G, Schlehofer B, Hettinger I, Schlaefer K, Wahrendorf J, Kunna-Grass K, Blettner M: Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany). Am J Epidemiol; 2006 Mar 15;163(6):512-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany).
  • The widespread use of cellular telephones has generated concern about possible adverse health effects, particularly brain tumors.
  • In this population-based case-control study carried out in three regions of Germany, all incident cases of glioma and meningioma among patients aged 30-69 years were ascertained during 2000-2003.
  • In total, 366 glioma cases, 381 meningioma cases, and 1,494 controls were interviewed.
  • Overall use of a cellular phone was not associated with brain tumor risk; the respective odds ratios were 0.98 (95% confidence interval (CI): 0.74, 1.29) for glioma and 0.84 (95% CI: 0.62, 1.13) for meningioma.
  • Among persons who had used cellular phones for 10 or more years, increased risk was found for glioma (odds ratio = 2.20, 95% CI: 0.94, 5.11) but not for meningioma (odds ratio = 1.09, 95% CI: 0.35, 3.37).
  • No excess of temporal glioma (p = 0.41) or meningioma (p = 0.43) was observed in cellular phone users as compared with nonusers.
  • Cordless phone use was not related to either glioma risk or meningioma risk.
  • In conclusion, no overall increased risk of glioma or meningioma was observed among these cellular phone users; however, for long-term cellular phone users, results need to be confirmed before firm conclusions can be drawn.
  • [MeSH-major] Brain Neoplasms / epidemiology. Cell Phones. Electromagnetic Fields / adverse effects. Glioma / epidemiology. Meningioma / epidemiology
  • [MeSH-minor] Adult. Aged. Case-Control Studies. Environmental Exposure / adverse effects. Female. Germany / epidemiology. Humans. Incidence. Interviews as Topic. Male. Middle Aged. Registries. Risk Assessment. Risk Factors


87. Komoribayashi N, Arai H, Kojo T, Obonai C, Wakabayashi J, Ogawa A: [Subfrontal schwannoma: case report]. No Shinkei Geka; 2005 Jun;33(6):601-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MRI features resembled an olfactory groove meningioma.
  • The left carotid angiography revealed that the tumor was supplied from the anterior ethomoidal artery, but no remarkable tumor stain was detected.
  • Bifrontal craniotomy with total excision of the tumor revealed a tumor in the left subfrontal lesion.
  • The tumor was attached to the falx, the left frontal lobe, and the skull base, but those structures were not invaded.
  • Subsequent histological examination proved that this tumor was schwannoma.
  • Further cases of subfrontal schwannoma are necessary to solve the enigma of the origin of this tumor.
  • [MeSH-major] Brain Neoplasms / surgery. Neurilemmoma / surgery
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Frontal Lobe / pathology. Humans. Magnetic Resonance Imaging. Neurosurgical Procedures / methods

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15952309.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 28
  •  go-up   go-down


88. Goldhoff P, Warrington NM, Limbrick DD Jr, Hope A, Woerner BM, Jackson E, Perry A, Piwnica-Worms D, Rubin JB: Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. Clin Cancer Res; 2008 Dec 1;14(23):7717-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.
  • PURPOSE: As favorable outcomes from malignant brain tumors remain limited by poor survival and treatment-related toxicity, novel approaches to cure are essential.
  • Here, we investigate the role of PDE4 in brain tumors and examine the utility of PDE4 as a therapeutic target.
  • EXPERIMENTAL DESIGN: Immunohistochemistry was used to evaluate the expression pattern of a subfamily of PDE4, PDE4A, in multiple brain tumor types.
  • To evaluate the effect of PDE4A on growth, a brain-specific isoform, PDE4A1 was overexpressed in xenografts of Daoy medulloblastoma and U87 glioblastoma cells.
  • RESULTS: We found that PDE4A is expressed in medulloblastoma, glioblastoma, oligodendroglioma, ependymoma, and meningioma.
  • Bioluminescence imaging indicated that whereas temozolomide and radiation therapy arrested intracranial tumor growth, the addition of Rolipram to this regimen resulted in tumor regression.
  • CONCLUSIONS: This study shows that PDE4 is widely expressed in brain tumors and promotes their growth and that inhibition with Rolipram overcomes tumor resistance and mediates tumor regression.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DACARBAZINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2005 Dec 15;65(24):11392-9 [16357147.001]
  • [Cites] Drug Discov Today. 2005 Nov 15;10(22):1503-19 [16257373.001]
  • [Cites] Mol Cell Biol. 2006 Mar;26(5):1666-78 [16478988.001]
  • [Cites] Expert Rev Anticancer Ther. 2006 May;6(5):733-54 [16759164.001]
  • [Cites] Biochem Soc Trans. 2006 Aug;34(Pt 4):504-9 [16856845.001]
  • [Cites] Clin Cancer Res. 2006 Aug 1;12(15):4738-46 [16899625.001]
  • [Cites] J Cell Sci. 2006 Sep 15;119(Pt 18):3799-810 [16940352.001]
  • [Cites] Pharmacol Rev. 2006 Sep;58(3):488-520 [16968949.001]
  • [Cites] Curr Top Dev Biol. 2006;75:225-59 [16984814.001]
  • [Cites] Cancer Res. 2007 Jan 15;67(2):651-8 [17234775.001]
  • [Cites] Cancer Res. 2007 Jun 1;67(11):5248-57 [17545604.001]
  • [Cites] Cancer Res. 2007 Sep 15;67(18):8588-95 [17875698.001]
  • [Cites] Chem Res Toxicol. 2000 Oct;13(10):944-8 [11080038.001]
  • [Cites] Cell Signal. 2001 Dec;13(12):911-8 [11728831.001]
  • [Cites] Science. 2002 Feb 1;295(5556):868-72 [11786607.001]
  • [Cites] J Biol Chem. 2002 Aug 2;277(31):28298-309 [11994273.001]
  • [Cites] Cancer Biol Ther. 2002 May-Jun;1(3):268-76 [12432276.001]
  • [Cites] Biochem J. 2003 Feb 15;370(Pt 1):1-18 [12444918.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8 [14595012.001]
  • [Cites] J Neurosurg. 1977 Apr;46(4):477-83 [191576.001]
  • [Cites] J Neurooncol. 1983;1(1):61-7 [6086852.001]
  • [Cites] Pharmacopsychiatry. 1984 Nov;17(6):188-90 [6393150.001]
  • [Cites] Biochem J. 1993 Jun 15;292 ( Pt 3):677-86 [7686364.001]
  • [Cites] Cancer Res. 1993 Jul 1;53(13):3058-61 [8391385.001]
  • [Cites] Biochem J. 1995 Jun 1;308 ( Pt 2):673-81 [7772057.001]
  • [Cites] Eur J Cancer. 1995;31A(5):714-7 [7640043.001]
  • [Cites] Biochem J. 1995 Sep 15;310 ( Pt 3):965-74 [7575434.001]
  • [Cites] J Neurooncol. 1997 Apr;32(2):161-8 [9120546.001]
  • [Cites] Neurosci Lett. 1998 Mar 6;244(1):41-6 [9578140.001]
  • [Cites] Biochem J. 1998 Aug 1;333 ( Pt 3):693-703 [9677330.001]
  • [Cites] J Med Chem. 1998 Nov 19;41(24):4733-43 [9822544.001]
  • [Cites] Brain Pathol. 1999 Jul;9(3):469-79 [10416987.001]
  • [Cites] Cancer Res. 2004 Dec 1;64(23):8604-12 [15574767.001]
  • [Cites] N Engl J Med. 2005 Mar 10;352(10):997-1003 [15758010.001]
  • [Cites] N Engl J Med. 2005 Mar 10;352(10):1036-8 [15758016.001]
  • [Cites] Cell Signal. 2005 Sep;17(9):1158-73 [15905070.001]
  • [Cites] J Immunol. 2005 Aug 1;175(3):1523-31 [16034090.001]
  • [Cites] Arch Toxicol. 2006 Feb;80(2):88-97 [16167140.001]
  • [Cites] Nat Methods. 2005 Aug;2(8):607-14 [16094386.001]
  • [Cites] J Biol Chem. 2005 Sep 30;280(39):33178-89 [16030021.001]
  • [CommentIn] Clin Cancer Res. 2009 May 1;15(9):3238; author reply 3238-9 [19406836.001]
  • (PMID = 19047098.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P50 CA094056; United States / NINDS NIH HHS / NS / P30 NS057105; United States / NCI NIH HHS / CA / P30 CA91842; United States / NCI NIH HHS / CA / P30 CA091842; United States / NCI NIH HHS / CA / R21 CA108677; United States / NCI NIH HHS / CA / P50 CA94056; United States / NCI NIH HHS / CA / P50 CA094056-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Phosphodiesterase Inhibitors; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide; EC 3.1.4.17 / Cyclic Nucleotide Phosphodiesterases, Type 4; K676NL63N7 / Rolipram
  • [Other-IDs] NLM/ NIHMS82831; NLM/ PMC2615415
  •  go-up   go-down


89. Garcia-Navarrete R, Garcia E, Arrieta O, Sotelo J: Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value. J Neurooncol; 2010 May;97(3):347-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We measured the HGF content of cerebrospinal fluid (CSF) from patients with malignant glioma glioblastoma multiforme (WHO IV; n = 14), anaplastic astrocytoma (WHO III; n = 4), and meningioma (WHO I; n = 9), and from control subjects (n = 25), and found a high concentration of HGF in patients with malignant glioma.
  • CSF concentrations of HGF higher than 500 pg/ml were associated with increased mortality whereas values higher than 850 pg/ml were associated with a brief tumor-free period after surgery (9 +/- 0.6 vs. 6 +/- 0.6 months, respectively, P < 0.001).
  • [MeSH-major] Brain Neoplasms / cerebrospinal fluid. Brain Neoplasms / mortality. Glioblastoma / cerebrospinal fluid. Glioblastoma / mortality. Hepatocyte Growth Factor / cerebrospinal fluid
  • [MeSH-minor] Adult. Analysis of Variance. Female. Humans. Kaplan-Meier Estimate. Male. Middle Aged

  • Genetic Alliance. consumer health - Glioblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurooncol. 2004 Jan;66(1-2):129-38 [15015778.001]
  • [Cites] Cancer Lett. 1998 Feb 27;124(2):149-55 [9500204.001]
  • [Cites] Int J Mol Med. 1999 May;3(5):531-6 [10202187.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2005 Mar 30;85(12):835-8 [15949402.001]
  • [Cites] Neurosurgery. 1999 May;44(5):1077-82; discussion 1082-3 [10232541.001]
  • [Cites] Cancer Res. 2006 Feb 1;66(3):1721-9 [16452232.001]
  • [Cites] Cancer. 2002 Jun 15;94(12):3210-8 [12115353.001]
  • [Cites] J Neurooncol. 2006 Nov;80(2):143-9 [16648987.001]
  • [Cites] Cancer Res. 2005 Oct 15;65(20):9355-62 [16230398.001]
  • [Cites] Int J Cancer. 2006 May 1;118(9):2182-9 [16331629.001]
  • [Cites] Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):517-30 [10571413.001]
  • [Cites] Int J Cancer. 2006 Feb 1;118(3):583-92 [16106403.001]
  • [Cites] Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6144-52 [17062691.001]
  • [Cites] Front Biosci. 2004 Sep 01;9:3105-23 [15353341.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7443-8 [11416216.001]
  • [Cites] Cancer Res. 1997 Dec 1;57(23):5391-8 [9393765.001]
  • [Cites] Clin Cancer Res. 2005 Jun 15;11(12):4479-86 [15958633.001]
  • [Cites] J Natl Cancer Inst. 1999 Sep 15;91(18):1548-56 [10491431.001]
  • [Cites] Neuro Oncol. 2001 Apr;3(2):82-8 [11296484.001]
  • [Cites] Neuro Oncol. 2005 Oct;7(4):436-51 [16212809.001]
  • [Cites] Int J Cancer. 1999 Feb 19;84(1):10-8 [9988225.001]
  • [Cites] FASEB J. 2002 Jan;16(1):108-10 [11729097.001]
  • [Cites] Clin Cancer Res. 2003 Oct 1;9(12):4578-85 [14555533.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Jun 24;273(1):287-93 [10873600.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Jun 27;235(3):743-7 [9207232.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Aug 10;249(1):73-7 [9705834.001]
  • [Cites] Mol Cancer Res. 2008 Jan;6(1):139-50 [18234969.001]
  • [Cites] Clin Cancer Res. 2006 Feb 15;12(4):1292-8 [16489086.001]
  • (PMID = 19856144.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 67256-21-7 / Hepatocyte Growth Factor
  •  go-up   go-down


90. Jabbour SK, Zhang Z, Arnold D, Wharam MD: Risk of second tumor in intracranial germinoma patients treated with radiation therapy: the Johns Hopkins experience. J Neurooncol; 2009 Jan;91(2):227-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk of second tumor in intracranial germinoma patients treated with radiation therapy: the Johns Hopkins experience.
  • BACKGROUND: We reviewed the risk of second tumor (ST), both malignant and benign, in germinoma survivors followed at the Johns Hopkins Hospital (JHH).
  • One developed a benign falcine meningioma.
  • [MeSH-minor] Adolescent. Adult. Brain Neoplasms / radiotherapy. Child. Combined Modality Therapy. Female. Follow-Up Studies. Germinoma / radiotherapy. Humans. Incidence. Male. Retrospective Studies. Risk Assessment. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Germinoma.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2007 Apr 20;25(12):1532-8 [17442996.001]
  • [Cites] Pediatr Blood Cancer. 2006 Jul;47(1):83-8 [16317732.001]
  • [Cites] J Neurosurg. 1998 Jan;88(1):66-72 [9420074.001]
  • [Cites] Cancer. 1997 Nov 1;80(9):1792-7 [9351549.001]
  • [Cites] J Natl Cancer Inst. 1989 Dec 20;81(24):1874-8 [2556586.001]
  • [Cites] Intern Med. 2000 Nov;39(11):920-4 [11065243.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):618-29 [11309438.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):65-73 [10924973.001]
  • [Cites] J Neurooncol. 2004 Oct;70(1):83-5 [15527112.001]
  • [Cites] Lung Cancer. 2007 Sep;57(3):410-3 [17475364.001]
  • [Cites] Pediatr Blood Cancer. 2007 Apr;48(4):453-9 [16767718.001]
  • [Cites] Neuropediatrics. 2005 Apr;36(2):71-7 [15822019.001]
  • [Cites] J Clin Oncol. 2007 Jul 1;25(19):2833-9 [17602088.001]
  • [Cites] J Clin Oncol. 1999 Aug;17(8):2585-92 [10561326.001]
  • [Cites] Ann Neurol. 1998 Sep;44(3):313-6 [9749596.001]
  • [Cites] Eur J Cancer. 1998 Jan;34(1):104-10 [9624246.001]
  • [Cites] N Engl J Med. 1988 Oct 20;319(16):1033-9 [3173432.001]
  • [Cites] Cancer Causes Control. 1997 Nov;8(6):865-71 [9427429.001]
  • [Cites] Ann Oncol. 1999 Jun;10(6):723-6 [10442196.001]
  • [Cites] Urol Oncol. 2001 Mar;6(2):49-52 [11166620.001]
  • [Cites] Lab Invest. 1989 Jan;60(1):14-21 [2536126.001]
  • [Cites] Cancer. 2006 Dec 1;107(11):2741-2; author reply 2742 [17039496.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):511-8 [12738328.001]
  • [Cites] Pediatr Blood Cancer. 2007 Sep;49(3):294-7 [17243137.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1165-70 [15001260.001]
  • [Cites] J Clin Pathol. 1994 Aug;47(8):771-2 [7962639.001]
  • [Cites] Ann Oncol. 2005 May;16(5):793-7 [15802277.001]
  • [Cites] Cancer. 2005 Jul 1;104(1):126-34 [15895370.001]
  • [Cites] J Clin Oncol. 2004 Mar 1;22(5):846-53 [14990640.001]
  • [Cites] J Clin Oncol. 1996 Nov;14(11):2908-15 [8918487.001]
  • [Cites] Pediatr Blood Cancer. 2006 Jul;47(1):77-82 [16047364.001]
  • [Cites] J Natl Cancer Inst. 2005 Sep 21;97(18):1354-65 [16174857.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):419-26 [9308946.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1171-6 [10725628.001]
  • (PMID = 18813873.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Takei H, Bhattacharjee MB, Rivera A, Dancer Y, Powell SZ: New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med; 2007 Feb;131(2):234-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors.
  • CONTEXT: Immunohistochemistry (IHC) has become an important tool in the diagnosis of brain tumors.
  • We discuss (1) placental alkaline phosphatase, c-Kit, and OCT4 for germinoma, (2) alpha-inhibin and D2-40 for capillary hemangioblastoma, (3) phosphohistone-H3 (PHH3), MIB-1/Ki-67, and claudin-1 for meningioma, (4) PHH3, MIB-1/Ki-67, and p53 for astrocytoma, (5) synaptophysin, microtubule-associated protein 2, neurofilament protein, and neuronal nuclei for medulloblastoma, (6) INI1 for atypical teratoid/rhabdoid tumor, and (7) epithelial membrane antigen for ependymoma.
  • All the markers presented here are used mainly for supporting or confirming the diagnosis, with the exception of the proliferation markers (MIB-1/Ki-67 and PHH3), which are primarily used to support grading and are reportedly associated with prognosis in certain categories of brain tumors.
  • In addition, IHC is also of great help in predicting the prognosis for certain brain tumors.
  • [MeSH-major] Biomarkers, Tumor / analysis. Central Nervous System Neoplasms / diagnosis. Central Nervous System Neoplasms / metabolism. Immunohistochemistry
  • [MeSH-minor] Adult. Antibodies. Astrocytoma / diagnosis. Astrocytoma / metabolism. Child. Diagnosis, Differential. Ependymoma / diagnosis. Ependymoma / metabolism. Germinoma / diagnosis. Germinoma / metabolism. Hemangioblastoma / diagnosis. Hemangioblastoma / metabolism. Humans. Medulloblastoma / diagnosis. Medulloblastoma / metabolism. Meningioma / diagnosis. Meningioma / metabolism. Rhabdoid Tumor / diagnosis. Rhabdoid Tumor / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17284108.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies; 0 / Biomarkers, Tumor
  • [Number-of-references] 96
  •  go-up   go-down


92. Epstein NE, Drexler S, Schneider J: Clear cell meningioma of the cauda equina in an adult: case report and literature review. J Spinal Disord Tech; 2005 Dec;18(6):539-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell meningioma of the cauda equina in an adult: case report and literature review.
  • Preoperative noncontrast MR studies of the brain and cervical and thoracic spine were negative.
  • Frozen-section diagnosis confirmed clear cell tumor.
  • Differential diagnoses included meningioma versus renal cell carcinoma.
  • Negative postoperative chest, abdominal, and pelvic computed tomography studies ruled out tumor of renal cell origin.
  • The high recurrence rate for clear cell meningiomas in children requires repeated tumor resection with or without secondary radiation therapy.
  • [MeSH-major] Cauda Equina / pathology. Cauda Equina / surgery. Meningioma / diagnosis. Meningioma / surgery. Peripheral Nervous System Neoplasms / diagnosis. Peripheral Nervous System Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Paresis / diagnosis. Paresis / etiology. Treatment Outcome

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16306847.001).
  • [ISSN] 1536-0652
  • [Journal-full-title] Journal of spinal disorders & techniques
  • [ISO-abbreviation] J Spinal Disord Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 10
  •  go-up   go-down


93. Bodi I, Gonzalez D, Epaliyange P, Gullan R, Fisher C: Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion. Neuropathology; 2009 Aug;29(4):460-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sarcoma metastatic to the brain is uncommon and rarely occurs as the initial manifestation of tumor.
  • A 39-year-old man presented with seizures due to a left temporal meningeal-enhancing lesion with striking brain edema on MRI.
  • The patient underwent neurosurgical resection for suspected meningioma.
  • Histology showed large tumor cells clustering and forming small nests, in places with pseudoalveolar pattern.
  • There was no evidence of primary extracranial tumor by physical examination and on chest and abdominal CT scan 11 months after presentation.
  • [MeSH-major] Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / genetics. Biomarkers, Tumor / genetics. Gene Fusion / genetics. Meningeal Neoplasms / genetics. Sarcoma, Alveolar Soft Part / genetics
  • [MeSH-minor] Adult. Humans. Male

  • Genetic Alliance. consumer health - Alveolar Soft Part Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18713311.001).
  • [ISSN] 1440-1789
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; 0 / Biomarkers, Tumor; 0 / TFE3 protein, human
  •  go-up   go-down


94. Lönn S, Ahlbom A, Hall P, Feychting M, Swedish Interphone Study Group: Long-term mobile phone use and brain tumor risk. Am J Epidemiol; 2005 Mar 15;161(6):526-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term mobile phone use and brain tumor risk.
  • The purpose of this population-based, case-control study was to test the hypothesis that long-term mobile phone use increases the risk of brain tumors.
  • The authors identified all cases aged 20-69 years who were diagnosed with glioma or meningioma during 2000-2002 in certain parts of Sweden.
  • Detailed information about mobile phone use was collected from 371 (74%) glioma and 273 (85%) meningioma cases and 674 (71%) controls.
  • For regular mobile phone use, the odds ratio was 0.8 (95% confidence interval: 0.6, 1.0) for glioma and 0.7 (95% confidence interval: 0.5, 0.9) for meningioma.
  • Furthermore, the odds ratio did not increase, regardless of tumor histology, type of phone, and amount of use.
  • This study includes a large number of long-term mobile phone users, and the authors conclude that the data do not support the hypothesis that mobile phone use is related to an increased risk of glioma or meningioma.
  • [MeSH-major] Brain Neoplasms / etiology. Cell Phones. Glioma / etiology. Meningioma / etiology
  • [MeSH-minor] Adult. Age Distribution. Aged. Case-Control Studies. Confidence Intervals. Female. Humans. Male. Middle Aged. Sex Distribution. Sweden / epidemiology. Time Factors

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Am J Epidemiol. 2005 Sep 15;162(6):600-1; author reply 601 [16107569.001]
  • [CommentIn] Am J Epidemiol. 2005 Sep 15;162(6):599-600; author reply 601 [16107571.001]
  • [CommentIn] Am J Epidemiol. 2005 Sep 15;162(6):599; author reply 601 [16107570.001]
  • (PMID = 15746469.001).
  • [ISSN] 0002-9262
  • [Journal-full-title] American journal of epidemiology
  • [ISO-abbreviation] Am. J. Epidemiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


95. Oh J, Cha S, Aiken AH, Han ET, Crane JC, Stainsby JA, Wright GA, Dillon WP, Nelson SJ: Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging; 2005 Jun;21(6):701-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema.
  • PURPOSE: To investigate the potential value and relationship of in vivo quantification of apparent diffusion coefficients (ADCs) and T2 relaxation times for characterizing brain tumor cellularity and tumor-related edema.
  • Regions of interest (ROIs) were drawn on conventional MR images to include tumor (as defined by contrast agent enhancement) and immediate and peripheral edema.
  • Tumor T2 values for gliomas (159.5+/-30.6 msec) were significantly higher than those for meningiomas or metastases (125.0+/-31.1 msec; P=0.005).
  • Both immediate- and peritumoral-edema ADCs and T2 values were significantly higher than those in tumor for both tumor types.
  • CONCLUSION: The higher immediate-edema T2 values for nonglial tumors than for gliomas suggest tumor-related edema (vasogenic vs. infiltrated) can be further characterized by using T2 values.
  • [MeSH-major] Brain Edema / pathology. Brain Neoplasms / pathology. Diffusion Magnetic Resonance Imaging / methods
  • [MeSH-minor] Adult. Aged. Contrast Media. Female. Gadolinium DTPA. Glioma / pathology. Humans. Image Enhancement. Image Processing, Computer-Assisted. Male. Meningioma / pathology. Middle Aged

  • Genetic Alliance. consumer health - Edema.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 Wiley-Liss, Inc.
  • (PMID = 15906339.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Grant] United States / NINDS NIH HHS / NS / NS045013
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


96. Vranic A, Popovic M, Cör A, Prestor B, Pizem J: Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery; 2010 Oct;67(4):1124-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients.
  • OBJECTIVE: To evaluate the prognostic significance of various histological and clinical parameters in AMMs, with an emphasis on location, mitotic count, brain invasion, and Ki67 labeling index.
  • RESULTS: High mitotic count, brain invasion, and the parasagittal-falcine location of the tumor were significantly associated with decreased recurrence-free survival in multivariate analysis.
  • Brain invasion was present in 25 of 37 cases in which brain tissue was identified in the tumor specimens.
  • When brain invasion was not included in the analysis because of the limited number of cases in which it could be assessed, high mitotic count, Ki67 index >4%, the presence of macronucleoli, and parasagittal-falcine location were significant predictors of shorter recurrence-free survival.
  • Recurrence-free survival can be further stratified by location and histological parameters, especially mitotic count, brain invasion, and Ki67 labeling index.
  • Not only brain invasion, but also the presence or absence of brain tissue in surgical specimens should be reported, because the absence of brain invasion, when brain tissue is identified, provides very important positive prognostic information.
  • [MeSH-major] Brain / pathology. Meningeal Neoplasms. Meningioma. Mitotic Index. Neoplasm Recurrence, Local / mortality
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Ki-67 Antigen / metabolism. Male. Middle Aged. Prognosis. Retrospective Studies. Survival Analysis. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20881577.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen
  •  go-up   go-down


97. Schittenhelm J, Ebner FH, Harter P, Bornemann A: Symptomatic intraspinal oncocytic adrenocortical adenoma. Endocr Pathol; 2009;20(1):73-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The excised tumor was composed of nests of large polygonal cells with eosinophilic partial granular cytoplasm.
  • The tumor showed diffuse positivity for melan-A, synaptophysin, and alpha-inhibin.
  • Ultrastructural examination showed abundant mitochondria, suggesting an oncocytic tumor.
  • Immunohistochemistry excluded oncocytic paraganglioma, oncocytic meningioma, renal cell carcinoma, alveolar soft part sarcoma, and granular cell tumor.
  • [MeSH-minor] Adult. Female. Humans. Immunohistochemistry. Magnetic Resonance Imaging

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Radiol. 2005 Sep;60(9):953-9 [16124976.001]
  • [Cites] Pediatr Neurosurg. 2002 May;36(5):260-5 [12053045.001]
  • [Cites] Spinal Cord. 2007 Feb;45(2):183-6 [16505829.001]
  • [Cites] Am J Surg Pathol. 1998 Jan;22(1):57-63 [9422316.001]
  • [Cites] Int J Surg Pathol. 2004 Jul;12(3):259-64 [15306940.001]
  • [Cites] J Neurosurg. 2001 Apr;94(2 Suppl):310-2 [11302638.001]
  • [Cites] J Pediatr Surg. 1980 Jun;15(3):289-92 [6103925.001]
  • [Cites] Neurosurgery. 2006 Nov;59(5):E1144; discussion E1144 [17143207.001]
  • [Cites] Am J Surg Pathol. 1991 Oct;15(10 ):949-56 [1928551.001]
  • [Cites] Neurosurgery. 1993 Apr;32(4):658-61; discussion 661-2 [8474656.001]
  • [Cites] Histopathology. 1997 Aug;31(2):167-73 [9279569.001]
  • [Cites] Mol Cell Endocrinol. 2005 Apr 15;233(1-2):47-56 [15767045.001]
  • [Cites] Am J Surg Pathol. 1997 Apr;21(4):375-82 [9130983.001]
  • [Cites] J Med Case Rep. 2008 Jul 13;2:228 [18620603.001]
  • [Cites] Am J Surg Pathol. 1990 May;14(5):481-4 [2327553.001]
  • [Cites] Histopathology. 1986 Mar;10(3):311-9 [2422107.001]
  • [Cites] Fetal Pediatr Pathol. 2006 Jul-Aug;25(4):191-7 [17162526.001]
  • [Cites] J Clin Pathol. 1998 Feb;51(2):114-6 [9602683.001]
  • [Cites] AMA Arch Pathol. 1959 Feb;67(2):228-33 [13616833.001]
  • [Cites] Neurosurgery. 2000 Sep;47(3):756-9 [10981764.001]
  • [Cites] Int J Surg Pathol. 2004 Jul;12(3):231-43 [15306935.001]
  • (PMID = 19039533.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Tena-Suck ML, Collado-Ortìz MA, Salinas-Lara C, García-López R, Gelista N, Rembao-Bojorquez D: Chordoid meningioma: a report of ten cases. J Neurooncol; 2010 Aug;99(1):41-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chordoid meningioma: a report of ten cases.
  • Chordoid meningioma is a rare variant of meningioma with histological features resembling those of chordoma.
  • This tumor has a great risk of recurrence and aggressive growth (WHO grade II).
  • This study was done to document the clinical and pathological features of ten patients with chordoid meningioma who submitted to surgery at the National Institute of Neurology and Neurosurgery in Mexico City.
  • The tumor was localized in eight cases in the supratentorial compartments.
  • Two of the ten tumors showed metaplasic changes, and seven showed brain invasion.
  • Tumor cells demonstrated CK7, EMA and focal S-100 protein and Ep-CAM.
  • The mean rate of the MIB-1 labeling index in recurrences was 7.1% versus 6.33% for no tumor recurrence.
  • Chordoid meningioma, World Health Organization grade II, is an uncommon variant of meningioma with a propensity for aggressive behavior and increased likelihood of recurrence.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Meningeal Neoplasms / metabolism. Meningeal Neoplasms / pathology. Meningioma / metabolism. Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Antigens, Neoplasm / metabolism. Cell Adhesion Molecules / metabolism. Epithelial Cell Adhesion Molecule. Female. Glial Fibrillary Acidic Protein / metabolism. Humans. Ki-67 Antigen / metabolism. Male. Middle Aged. Mucin-1 / metabolism. Retrospective Studies. S100 Proteins / metabolism. Vimentin / metabolism

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - TEN.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurooncol. 2006 Jul;78(3):263-9 [16628477.001]
  • [Cites] J Clin Pathol. 2007 Sep;60(9):1024-8 [16837627.001]
  • [Cites] Acta Cytol. 2009 May-Jun;53(3):297-302 [19534270.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2007 May-Jun;23(3):246-8 [17519674.001]
  • [Cites] Ultrastruct Pathol. 2006 Jul-Aug;30(4):309-14 [16971356.001]
  • [Cites] Histopathology. 2006 Aug;49(2):178-87 [16879395.001]
  • [Cites] Folia Neuropathol. 2006;44(1):34-41 [16565929.001]
  • [Cites] J Neurosurg. 2005 Apr;102(4):733-7 [15871519.001]
  • [Cites] Int Ophthalmol. 2008 Oct;28(5):355-7 [17898939.001]
  • [Cites] Ann Diagn Pathol. 2007 Jun;11(3):182-9 [17498592.001]
  • [Cites] Clin Neuropathol. 2004 Sep-Oct;23(5):232-7 [15581026.001]
  • [Cites] Neuropathol Appl Neurobiol. 2004 Apr;30(2):118-25 [15043709.001]
  • [Cites] Neurol Med Chir (Tokyo). 2006 Jan;46(1):37-40 [16434825.001]
  • [Cites] J Neurooncol. 2008 May;88(1):115-20 [18320142.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):131-8 [19521276.001]
  • [Cites] J Clin Neurosci. 2007 Aug;14(8):747-53 [17499508.001]
  • [Cites] Endocr Pathol. 2005 Fall;16(3):219-28 [16299405.001]
  • [Cites] Brain Pathol. 2006 Jan;16(1):15-9 [16612978.001]
  • [Cites] J Clin Neurosci. 2009 Mar;16(3):441-3 [19153045.001]
  • [Cites] Am J Surg Pathol. 2000 Jul;24(7):899-905 [10895812.001]
  • [Cites] Neuropathology. 2006 Oct;26(5):438-41 [17080722.001]
  • [Cites] Acta Cytol. 2004 Mar-Apr;48(2):259-63 [15085764.001]
  • [Cites] Brain Tumor Pathol. 2008;25(2):91-5 [18987835.001]
  • [Cites] Acta Cytol. 2006 Nov-Dec;50(6):691-6 [17152286.001]
  • [Cites] Am J Surg Pathol. 2009 May;33(5):669-81 [19194275.001]
  • [Cites] Acta Cytol. 2004 May-Jun;48(3):397-401 [15192958.001]
  • [Cites] Cancer. 1988 Jul 15;62(2):391-406 [3383139.001]
  • [Cites] Childs Nerv Syst. 2006 Oct;22(10):1344-50 [16607533.001]
  • (PMID = 20094774.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Cell Adhesion Molecules; 0 / EPCAM protein, human; 0 / Epithelial Cell Adhesion Molecule; 0 / Glial Fibrillary Acidic Protein; 0 / Ki-67 Antigen; 0 / Mucin-1; 0 / S100 Proteins; 0 / Vimentin
  •  go-up   go-down


99. Zhi L, Bing L, Yang L, Bo-ning L, Quan H: Cystic papillary meningioma with subarachnoid dissemination: a case report and review of the literature. Pathol Res Pract; 2009;205(8):582-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystic papillary meningioma with subarachnoid dissemination: a case report and review of the literature.
  • The development of the papillary variant of meningiomas with cyst formation in the central nervous system is extremely rare.
  • We report a case of cystic papillary meningioma in a young female occurring in the lateral ventricle with invasion of brain parenchyma and dissemination of subarachnoid space.
  • The tumor exhibits a marked peritumoral cyst, with contrast enhancement on magnetic resonance imaging (MRI) in accordance with type 2 of Zee's classification of cystic meningioma.
  • Histologically, the tumor displays a classical perivascular pseudopapillary pattern with focal necrosis and subarachnoid space dissemination.
  • Tumor cells are diffusely positive for epithelial membrane antigen (EMA) and vimentin, but lack immunoreactivity for cytokeratin (CK) and glial fibrillary acidic protein (GFAP).
  • MIB-1 labeling is high, accounting for 5% of tumor focally.
  • A diagnosis of primary intraventricular cystic papillary meningioma with subarachnoid space dissemination (WHO grade III) was made.
  • To our knowledge, there is no report describing the radiological and histological characteristics of cystic papillary meningioma presenting in the lateral ventricle.
  • In addition, the biological behavior and the clinical outcome of this tumor are also discussed.
  • [MeSH-major] Cerebral Ventricle Neoplasms / pathology. Cysts / pathology. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Female. Humans. Magnetic Resonance Imaging. Mucin-1 / metabolism. Neoplasm Staging. Treatment Outcome. Vimentin / metabolism. Young Adult

  • Genetic Alliance. consumer health - Meningioma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19307065.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Mucin-1; 0 / Vimentin
  •  go-up   go-down


100. Fuller CE, Perry A: Molecular diagnostics in central nervous system tumors. Adv Anat Pathol; 2005 Jul;12(4):180-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular diagnostics in central nervous system tumors.
  • Central nervous system (CNS) neoplasms can be diagnostically challenging, due to remarkably wide ranges in histologic appearance, biologic behavior, and therapeutic approach.
  • In this regard, the field is primed by recent advances in basic research, elucidating the molecular mechanisms of tumorigenesis and progression in the most common adult and pediatric brain tumors.
  • The goal of this article is to highlight the most common genetic alterations currently implicated in CNS tumors, focusing most on those that are either already in common use in ancillary molecular diagnostics testing or are likely to become so in the near future.
  • [MeSH-major] Astrocytoma / genetics. Brain Neoplasms / genetics. Central Nervous System Neoplasms / genetics. Ependymoma / genetics. Oligodendroglioma / genetics
  • [MeSH-minor] Animals. Biomarkers, Tumor / analysis. Biomarkers, Tumor / genetics. Chromosome Aberrations. Humans. In Situ Hybridization, Fluorescence. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / genetics. Meningioma / diagnosis. Meningioma / genetics. Neoplasms, Germ Cell and Embryonal / diagnosis. Neoplasms, Germ Cell and Embryonal / genetics. Polymerase Chain Reaction. Prognosis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16096380.001).
  • [ISSN] 1072-4109
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 260
  •  go-up   go-down






Advertisement